Document:

SECURED CONVERTIBLE NOTE PURCHASE AGREEMENT

      This Secured Convertible Note Purchase Agreement ("AGREEMENT") is made
this 28th day of September, 2004 (the "EFFECTIVE DATE") by and between
Integrated Healthcare Holdings, Inc., a Nevada public corporation (the
"COMPANY"), and Kali Chaudhuri, M.D., an individual ("PURCHASER").

      The Company desires to sell to Purchaser, and Purchaser desires to
purchase from the Company, a 5% Secured Convertible Promissory Note (the
"NOTE"), convertible into shares of the common stock of the Company (the "COMMON
Stock"), on the terms and conditions set forth in this Agreement.

      NOW, THEREFORE, in consideration of the promises and mutual covenants set
forth herein, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties agree as follows:

                                   ARTICLE I
                         AUTHORIZATION; ISSUANCE OF NOTE

      1.1 AUTHORIZATION AND ISSUANCE OF NOTE. The Company has authorized the
issuance and of, concurrently herewith, subject to the terms and conditions
contained herein, and in reliance upon the representations, warranties and
agreements contained herein, shall issue to Purchaser, pursuant to this
Agreement, the Note, in the original face amount of $500,000 in substantially
the form attached hereto as Exhibit A, which is presently convertible into up to
160,000,000 shares of the Company's Common Stock (the "SHARES"), which Shares
represent approximately 88.8% of the issued and outstanding shares of Common
Stock of the Company on a fully-diluted basis. The Company has previously
delivered to Purchaser copies of the Company's current Articles of Incorporation
and Bylaws. The Note shall be secured by a first lien (which may be subordinated
to Company's working capital lender) against all of the assets of the Company
now or hereafter acquired pursuant to a security agreement in the form attached
hereto as Exhibit B.

      1.2 NOTE ADVANCES. Until demand for repayment by Purchaser or full
conversion of the Note, the Company may borrow, by means of advances by
Purchaser in accordance with, and for purposes described in, Section 1.2.1
(amounts borrowed hereunder are referred to, singly or collectively, as an
"ADVANCE" or as "ADVANCES"); provided, however, that the aggregate principal
amount of Advances outstanding at any time under this Agreement shall never
exceed $500,000 unless the Note is amended and restated to provide a higher
amount as described in Section 1.2.4 (the "COMMITMENT LIMIT"); provided,
further, that the Note (including all accrued and unpaid interest thereon) must
be repaid in full no later than, and the commitment expires automatically on,
the earlier to occur if (a) demand for full repayment by Purchaser or (b)
conversion in full of the Note.

            1.2.1 ADVANCES. An initial Advance of $75,000 shall be made by
Purchaser to the Company immediately following execution of this Agreement, the
Note and the Security Agreement by the parties. A second Advance of $50,000
shall be made by Purchaser to the Company on November 1, 2004. These two
Advances may be used for general corporate purposes, including payment of
executive compensation. Additional Advances of up to $375,000 may be used to pay
transaction costs in connection with the Tenet Transaction (as defined in
Section 3.22) which is presently contemplated to close on November 30, 2004.
Within 60 days after the closing or termination of the Tenet Transaction, if
less than $375,000 in Advances has been made to pay the transaction costs, the
balance of the $375,000 shall be paid over to the Company as an Advance to be
used for general corporate purposes. Payment of the transaction costs shall be
made by Purchaser directly to the third party obligee by Purchaser upon receipt
from Company of substantiating documentation for such fees and costs, and each
such payment shall constitute an Advance.
<PAGE>

            1.2.2 CONDITION TO ADVANCES. It shall be a condition to any Advance
that the Company shall have renegotiated the employment agreements of James
Ligon, Bruce Mogel and Larry Anderson, in accordance with the Employment Side
Bar Agreement, a copy of which is attached as Exhibit C.

            1.2.3 NOTATIONS OF ADVANCES. Upon making each Advance, and upon
receipt of each payment of principal on an Advance, Purchaser (or the holder of
the Note) shall, and is hereby authorized to, make a notation on a schedule
attached to the Note of the amount and date of the Advance or payment, and the
aggregate unpaid principal balance shown on the schedule shall be presumed to be
correct in the absence of manifest error. Purchaser's (or the holder's) failure
to make the correct notation with respect to an Advance or with respect to any
payment of principal shall not limit or otherwise affect the Company's
obligations hereunder and under the Note to repay the Advance actually
outstanding. Purchaser's (or the holder's) failure to make the correct notation
shall not impair or otherwise affect such payment or Purchaser's (or the
holder's) rights and remedies to collect the Advance or the payment actually
outstanding, nor shall it impair Purchaser's rights to withhold Advances to the
extent that the Commitment Limit would be exceeded.

            1.2.4 FURTHER FINANCIAL ASSISTANCE FROM PURCHASER. As a material
inducement to the Company to enter into this Agreement, Purchaser agrees to
provide the following assistance to Company without which Company would be
unable to close the Tenet Transaction:

                  (a) Purchaser may assist Company with the payment of necessary
      transactional costs incurred in connection with the Tenet Transaction (as
      defined in Section 3.22) including fees necessary to secure financing in
      connection with the Tenet Transaction, which transaction costs and fees
      cannot be otherwise paid by the Company. The parties shall use their best
      efforts to negotiate and reduce the amount of such fees and costs. To the
      extent that such fees and costs exceed the $375,000 referred to in Section
      1.2.1, Purchaser may elect to, in his reasonable discretion, advance
      additional funds provided, however, before any payment by Purchaser, the
      Company shall amend and restate the Note to reflect the increased
      principal amount and to provide that all such payments of fees and costs
      by Purchaser on the Company's behalf for this purpose shall constitute
      additional Advances and shall either, at Purchaser's election to be made
      within five days after the closing or termination of the Tenet
      Transaction, (i) be repaid by the Company so that the outstanding
      principal balance of the amended and restated Note is reduced to $500,000
      or (ii) remain outstanding under the amended and restated Note, in which
      case a portion of the outstanding balance will be available for conversion
      into additional shares of Common Stock not to exceed an additional
      10,000,000 shares on the same terms and at the same conversion price as
      the Shares.

                                      -2-
<PAGE>

                  (b) Purchaser shall loan the $10,000,000 ("TEN MILLION DOLLAR
      LOAN") to be used solely as the good faith deposit for the Tenet
      Transaction. The Ten Million Dollar Loan may, at Purchaser's election, be
      made by a transfer of funds directly to the Tenet Escrow for the Company's
      benefit. The Ten Million Dollar Loan shall be made on the following terms
      and conditions: The Ten Million Loan shall be (i) due and payable upon the
      earlier of the closing of the Tenet Transaction or the termination, for
      any reason, of the purchase agreement relating to the Tenet Transaction,
      (ii) secured by a lien against all of the Company's assets pari passu with
      the first lien of the Note and subject to possible subordination as
      described in Section 1.1; (iii) bear interest at the rate of 7.25% per
      annum; and (iv) otherwise be in the form of Exhibit E, attached hereto and
      made a part hereof. If the Tenet Transaction fails to close, the Company
      shall assign its rights to Purchaser to proceed against Tenet with regard
      to recovery of the good faith deposit without Purchaser waiving or
      releasing any rights against the Company. Any refund of the good faith
      deposit shall be paid directly to Purchaser.

                  (c) In consideration of the Company's commitments under
      Section 1.4, Purchaser shall provide Tenet Healthcare Corporation (or its
      affiliate) a personal guaranty for Tenet's post closing liability on the
      Chapman Hospital lease (not to exceed $10,000,000).

                  (d) The Company represents to Purchaser that it will not
      require or request Purchaser's personal guaranty with respect to any
      financing the Company shall seek with respect to the Tenet Transaction.

      1.3 PURCHASER'S OPTION TO PURCHASE REAL ESTATE. In order to induce
Purchaser to enter into the foregoing transaction to provide the financial
support as set forth above, the Company grants an option to Purchaser (or his
assignee or designee) to acquire all of the real estate which the Company will
acquire in the Tenet Transaction (i.e. Western Medical Center - Santa Ana,
Western Medical Center - Anaheim and Coastal Community Hospital) for the price
of $5,000,000. The Company agrees to deliver title to the property free and
clear of all liens of all liens and encumbrances except only those exceptions to
title agreed to in the Tenet Transaction and the real estate loan the Company
will incur in connection with the closing of the Tenet Transaction. The Company
and Purchaser agree to cooperate in negotiating with Company's lenders to
organize the financing in a manner which permits Purchaser to exercise the
option and acquire the real property subject to the real estate loan while the
Company will remain liable for the working capital loan. Purchaser may exercise
the option to acquire the property at any time commencing with the closing of
the Tenet Transaction and for a period of five years thereafter. The option
shall be in the form attached hereto as Exhibit D.

      Purchaser may exercise the option and pay the purchase price by offsetting
Purchaser's purchase price obligation against any obligations due and owing by
the Company to Purchaser including those under the Note or the Ten Million
Dollar Note. Upon the exercise of the option, Purchaser agrees to lease the real
property back to the Company on a triple net lease at a fair market value rental
which shall not be less than a 2.5% margin over the financing cost paid by
Purchaser. The term of the lease shall be 15 years, with two 5-year renewal
options.

                                      -3-
<PAGE>

      1.4 CHAPMAN. In consideration of Purchaser's agreement to personally
guaranty Tenet's post-closing liabilities with respect to the Chapman Hospital
lease at the closing of the Tenet Transaction, the Company shall assign,
transfer and deliver to Purchaser all of its right, title and interest in the
Chapman Hospital lease and the Chapman Hospital operating assets. Purchaser and
the Company shall cooperate in processing licensure applications in Purchaser's
name (or that of his affiliate) pre-closing. Purchaser agrees to cause Chapman
Hospital to contract with the Company to provide management services at the
Chapman Hospital to the extent permitted by law on customary terms and at fair
market value.

      1.5 PURCHASER'S RIGHT TO PROCEED TO CLOSE FOR HIS OWN ACCOUNT. If the
Company is unable, for any reason, to obtain financing without the lender
requiring Purchaser's personal guaranty(other than the personal guaranty for the
Chapman Hospital Lease, as required to be given under Section 1.2.4(c) above),
Purchaser may elect to proceed to obtain his own financing and close the Tenet
Transaction without the Company's participation. In such event, all of the
assets to be acquired in the Tenet Transaction shall then be acquired by
Purchaser from Tenet and the Company shall waive and release any claim against
Purchaser and any right to the Tenet assets, and (ii) in consideration of the
Company's efforts in pursuing the Tenet transaction, Purchaser shall reduce his
conversion right to a maximum of Sixty Million (60,000,000) shares.

      1.6 FAILURE TO CLOSE TENET TRANSACTION. If, the Tenet Transaction fails to
close, Purchaser agrees that he shall not exercise his right to convert the Note
into Shares for a period 30 days within which Company shall have the opportunity
to repay all Advances made under the Note together with accrued interest thereby
fully satisfying the Note obligation and thus causing Purchaser's right of
conversion to lapse. This shall be the only circumstance under which the Company
shall have the right to pre-pay the Note and prevent Purchaser from exercising
his conversion rights..

      1.7 PRE-EMPTIVE RIGHT TO PURCHASE ADDITIONAL SHARES.

            (a) Subject to the terms and conditions specified in this Section
1.3, if the Note is fully converted into Common Stock of the Company, the
Company hereby grants to Purchaser a right of first refusal with respect to
future sales by the Company of its equity securities or securities convertible
into or exercisable for equity securities, where issuance of those securities
will result in a dilution of Purchaser's as-converted equity position to less
than 75% of the Common Stock of the Company on a fully-diluted basis. Each time
the Company proposes to offer any shares of, or securities convertible into or
exercisable for any shares of, any class of the Company's equity securities (the
"NEW SHARES"), the Company shall first make an offer to Purchaser of such
portion of the New Shares which equals the proportion that all securities in the
Company held by to Purchaser, on an as-converted basis, bears to the total
number of shares of Common Stock of the Company on a fully-diluted basis plus
the New Shares (the "PRO RATA SHARE"). The closing of the sale of the Pro Rata
Share shall occur simultaneously with the sale of the New Shares to other
investors.

                                      -4-
<PAGE>

            (b) The right of first refusal in this Section 1.3 shall not be
applicable to the issuance or sale of (i) securities issued pursuant to stock
splits, stock dividends, or similar transactions approved by Purchaser; (ii)
shares of Common Stock issued to employees, consultants, officers or directors
of the company pursuant to stock option plans or restricted stock plans or
agreements approved by the Company's Board of Directors and by Purchaser; (iii)
securities issued to financial institutions or lessors in connection with
commercial credit arrangements, equipment financings, commercial property lease
transactions, or similar transactions approved by the Board of Directors and
Purchaser and not for the purpose of raising capital, (iv) shares of Common
Stock issued in an underwritten public offering; or (v) securities issued in
connection with bona fide acquisition transactions approved by the Board of
Directors and by Purchaser.

            (c) The right of first refusal in this Section 1.3 shall terminate
and cease to have effect upon the closing of an acquisition of the Company to an
unrelated third party in a transaction approved by Purchaser.

                                   ARTICLE II
                               REGISTRATION RIGHTS

      2.1 DEFINITIONS. For purposes of this Agreement, the following terms have
the meanings specified with respect thereto below:

      "1933 ACT" means the Securities Act of 1933 and the rules and regulations
of the Commission thereunder, all as the same shall be in effect at the time.

      "1934 ACT" means the Securities Exchange Act of 1934 and the rules and
regulations of the Commission thereunder, all as the same shall be in effect at
the time.

      "COMMISSION" means the Securities and Exchange Commission or any other
Federal agency at the time administering the 1933 Act.

      "INDEMNIFIED PARTY" has the meaning specified in Section 2.4.3.

      "INDEMNIFYING PARTY" has the meaning specified in Section 2.4.3.

      "INSPECTORS" has the meaning specified in Section 2.3.1.8.

      "MAXIMUM NUMBERS OF SHARES" has the meaning specified in Section 2.2.2.

      "OTHER SHAREHOLDER" means any holder of shares of Common Stock or
securities convertible into or entitling the holder thereof to purchase Common
Stock who has Piggyback Registration rights, including Purchaser; collectively,
two or more such shareholders shall be referred to as "OTHER SHAREHOLDERS."

      "PIGGYBACK REGISTRATION" has the meaning specified in paragraph 2.2.1 (b).

      "RECORDS" has the meaning specified in paragraph 2.3.1(h).

                                      -5-
<PAGE>

      "REGISTRABLE SECURITIES" means, collectively, the Shares and any
securities issued or issuable upon any stock dividend, stock split,
recapitalization, merger, consolidation or similar event with respect to the
Shares. As to any particular Registrable Securities, such securities shall cease
to be Registrable Securities when (i) a registration statement covering such
securities shall have become effective under the 1933 Act and such securities
shall have been disposed of in accordance with such registration statement, (ii)
such securities shall have been distributed to the public pursuant to Rule 144
or Rule 144A (or any successor provisions) under the 1933 Act, or (iii) such
securities shall have ceased to be outstanding.

      "SHARES" has the meaning set forth in Section 1.1.

      "UNDERWRITER" means a securities dealer who purchases any Registrable
Securities as principal in an underwritten offering and not as part of such
dealer's market-making activities.

      2.2 REGISTRATION RIGHTS.

            2.2.1 PIGGYBACK RIGHTS. If at any time after the initial public
offering of the Company's securities, the Company proposes to file a
registration statement under the 1933 Act with respect to an offering of equity
securities, or securities convertible or exchangeable into equity securities, by
the Company for its own account other than a registration statement (i) on Form
S-4 or S-8 (or any substitute or successor form that may be adopted by the
Commission), (ii) filed in connection with any employee stock option or other
benefit plan, (iii) for an exchange offer or offering of securities solely to
the Company's existing shareholders, or (iv) for a dividend reinvestment plan,
then the Company shall:

                  (a) give written notice of such proposed filing to the Other
      Shareholders as soon as practicable but in no event less than 30 days
      before the anticipated filing date, which notice shall describe the amount
      and type of securities to be included in such offering, the intended
      method(s) of distribution, and the name of the proposed managing
      Underwriter or Underwriters, if any, of the offering; and

                  (b) offer in such notice to the Other Shareholders the
      opportunity to register such number of shares of Registrable Securities or
      shares of Common Stock as each such Other Shareholder may request in
      writing within ten days following receipt of such notice (a "PIGGYBACK
      REGISTRATION"). The Company shall cause such Registrable Securities and
      shares of Common Stock to be included in such registration and shall use
      its best efforts to cause the managing Underwriter or Underwriters of a
      proposed underwritten offering to permit the Registrable Securities and
      shares of Common Stock requested to be included in a Piggyback
      Registration to be included on the same terms and conditions as any
      similar securities of the Company and to permit the sale or other
      disposition of such Registrable Securities and shares of Common Stock in
      accordance with the intended method of distribution thereof.

      In the case of an initial public offering of the Company's securities, all
of the provisions of this Agreement shall apply, except that the Company's
obligation with respect to registration shall only apply if the underwriters
agree to include Cutler's Registrable Securities in registration, and the
Company shall use its reasonable best efforts to cause the underwriters to so
agree.

                                      -6-
<PAGE>

            2.2.2 REDUCTION OF OFFERING. If the managing Underwriter or
Underwriters for a Piggyback Registration that is to be an underwritten offering
advises the Company and the Other Shareholders requesting inclusion in the
Piggyback Registration, in writing, that the dollar amount or number of shares
of Registrable Securities and other shares of Common Stock to be included in the
offering exceeds the maximum dollar amount or number that can be sold in such
offering without adversely affecting the proposed offering price, the timing,
the distribution method or the probability of success of such offering ("MAXIMUM
NUMBER OF SHARES") then the Company shall include in such registration: (i)
first, the shares of Common Stock or other securities that the Company proposes
to sell which can be sold without exceeding the Maximum Number of Shares; (ii)
second, to the extent the Maximum Number of Shares has not been reached under
the foregoing clause (i), the Registrable Securities as to which registration
has been requested by Purchaser pursuant to his Piggyback Registration rights
which can be sold without exceeding the Maximum Number of Shares, and (iii)
third, to the extent the Maximum Number of Shares has not been reached under the
foregoing clauses (i) and (ii), the shares of Common Stock requested to be
included in such registration by Other Shareholders (other than Purchaser) which
can be sold without exceeding the Maximum Number of Shares.

            2.2.3 WITHDRAWAL. The Holder may elect to withdraw his request for
inclusion of his Registrable Securities in any Piggyback Registration by giving
written notice to the Company of his request to withdraw prior to the
effectiveness of the registration statement. The Company may also elect to
withdraw a registration statement including shares being registered pursuant to
an Other Shareholder's Piggyback Registration rights at any time prior to the
effectiveness of the registration statement. Notwithstanding any such
withdrawal, the Company shall pay all expenses incurred by Purchaser in
connection with such Piggyback Registration as provided in Section 2.3.3.

      2.3 REGISTRATION PROCEDURES.

            2.3.1 FILINGS; INFORMATION. If and whenever the Company is required
to effect the registration of any Registrable Securities under the 1933 Act
pursuant to Section 2.2.1, the Company shall use its best efforts to effect the
registration and the sale of such Registrable Securities in accordance with the
intended method of disposition thereof as expeditiously as practicable, and in
connection with any such request:

                  2.3.1.1 FILING REGISTRATION STATEMENT. The Company shall, as
expeditiously as possible, prepare and file with the Commission a registration
statement on any form for which the Company then qualifies or which counsel for
the Company shall deem appropriate and which form shall be available for the
sale of the Registrable Securities to be registered thereunder in accordance
with the intended method of distribution thereof, and use its best efforts to
cause such filed registration statement to become and remain effective.

                  2.3.1.2 COPIES. The Company shall, prior to filing a
registration statement or prospectus or any amendment or supplement thereto,
furnish without charge to Purchaser and legal counsel for Purchaser, copies of
such registration statement as proposed to be filed, each amendment and
supplement to such registration statement (in each case including all exhibits
thereto and documents incorporated by reference therein), the prospectus
included in such registration statement (including each preliminary prospectus),
and such other documents as Purchaser may request in order to facilitate the
disposition of the Registrable Securities owned by Purchaser.

                                      -7-
<PAGE>

                  2.3.1.3 AMENDMENTS AND SUPPLEMENTS. The Company shall prepare
and file with the Commission such amendments, including post-effective
amendments, and supplements to such registration statement and the prospectus
used in connection therewith as may be necessary to keep such registration
statement effective and in compliance with the provisions of the 1933 Act until
all Registrable Securities and other securities covered by such registration
statement have been disposed of in accordance with the intended methods of
disposition set forth in such registration statement (which period shall not
exceed the sum of nine months plus any period during which any such disposition
is interfered with by any stop order, injunction or other order or requirement
of the Commission or any governmental agency or court) or such securities have
been withdrawn.

                  2.3.1.4 NOTIFICATION. After the filing of the registration
statement, the Company shall promptly, and in no event more than two Business
Days, notify Purchaser, and confirm such advice in writing, (i) when such
registration statement becomes effective, (ii) when any post-effective amendment
to such registration statement becomes effective, (iii) of any stop order issued
or threatened by the Commission (and the Company shall take all actions required
to prevent the entry of such stop order or to remove it if entered) and (iv) of
any request by the Commission for any amendment or supplement to such
registration statement or any prospectus relating thereto or for additional
information or of the occurrence of an event requiring the preparation of a
supplement or amendment to such prospectus so that, as thereafter delivered to
the purchasers of such Registrable Securities covered by such Registration
Statement, such prospectus will not contain an untrue statement of a material
fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading and promptly make
available to Purchaser any such supplement or amendment; except that before
filing with the Commission a registration statement or prospectus or any
amendment or supplement thereto, including documents incorporated by reference,
the Company shall furnish to Purchaser and to legal counsel representing
Purchaser, copies of all such documents proposed to be filed sufficiently in
advance of filing to provide Purchaser, Underwriters and legal counsel with a
reasonable opportunity to review such documents and comment thereon, and the
Company shall not file any registration statement or prospectus or amendment or
supplement thereto, including documents incorporated by reference to which
Purchaser or legal counsel representing Purchaser, shall object on a timely
basis in light of the requirements of the 1933 Act or any other applicable laws
and regulations.

                  2.3.1.5 STATE SECURITIES LAWS COMPLIANCE. The Company shall
use its best efforts to (i) register or qualify the Registrable Securities
covered by the registration statement under such securities or blue sky laws of
such jurisdictions in the United States as Purchaser (in light of Purchaser's
intended plan of distribution) requests and (ii) cause such Registrable
Securities covered by the registration statement to be registered with or
approved by such other governmental agencies or authorities in the United States
as may be necessary by virtue of the business and operations of the Company and
do any and all other acts and things that may be necessary or advisable to
enable Purchaser to consummate the disposition of the Registrable Securities
owned by Purchaser in such jurisdictions; provided, however, that the Company
shall not be required to qualify generally to do business in any jurisdiction
where it would not otherwise be required to qualify but for this Section
2.3.1.5, or subject itself to taxation in any such jurisdiction.

                                      -8-
<PAGE>

                  2.3.1.6 AGREEMENTS FOR DISPOSITION. The Company shall enter
into customary agreements (including, if applicable, an underwriting agreement
in customary form) and take such other actions as are reasonably required in
order to expedite or facilitate the disposition of such Registrable Securities.
The Holder may, at his option, require that any or all of the representations,
warranties and covenants of the Company in any underwriting agreement to or for
the benefit of any Underwriters also be made to and for the benefit of
Purchaser. The Holder shall not be required to make any representations or
warranties in the underwriting agreement except with respect to its
organization, good standing, authority, title to Registrable Securities, lack of
conflict of such sale with its material agreements and organizational documents,
and with respect to written information relating to Purchaser that Purchaser has
furnished expressly for inclusion in such registration statement.

                  2.3.1.7 COOPERATION. The Chief Executive Officer and President
of the Company, the Chief Financial Officer of the Company, any Senior Vice
President of the Company and other members of the management of the Company
shall cooperate fully in any offering of Registrable Securities hereunder, which
cooperation shall include, without limitation, the preparation of the
Registration Statement and all other offering materials and related documents,
and participation in meetings with Underwriters, attorneys, accountants and
potential investors.

                  2.3.1.8 RECORDS. The Company shall make available for
inspection by Purchaser, any Underwriter participating in any disposition
pursuant to such registration statement and any attorney, accountant or other
professional retained by Purchaser or any Underwriter (collectively, the
"INSPECTORS"), all financial and other records, pertinent corporate documents
and properties of the Company (collectively, the "RECORDS"), as shall be
necessary to enable them to exercise their due diligence responsibility, and
cause the Company's officers, directors and employees to supply all information
requested by any Inspectors in connection with such registration statement.

                  2.3.1.9 OPINIONS AND COMFORT LETTERS. The Company shall
furnish to Purchaser a signed counterpart, addressed to Purchaser, of (i) any
opinion of counsel to the Company delivered to any Underwriter and (ii) any
comfort letter from the Company's independent public accountants delivered to
any Underwriter. If no legal opinion is delivered to any Underwriter, the
Company shall furnish to Purchaser, at any time that Purchaser elects to use a
prospectus, an opinion of counsel to the Company to the effect that the
registration statement containing such prospectus has been declared effective
and that no stop order is in effect.

                  2.3.1.10 EARNINGS STATEMENT. The Company shall comply with all
applicable rules and regulations of the Commission and the 1933 Act, and make
available to its shareholders, as soon as practicable, an earnings statement
covering a period of 12 months, beginning within three months after the
effective date of the registration statement, which earnings statement shall
satisfy the provisions of Section 11(a) of the 1933 Act and Rule 158 thereunder.

                                      -9-
<PAGE>

                  2.3.1.11 LISTING. The Company shall use its best efforts to
cause all such Registrable Securities registered pursuant to this Agreement to
be listed on such exchanges or otherwise designated for trading in the same
manner as similar securities issued by the Company are then listed or designated
or, if no such similar securities are then listed or designated, in a manner
satisfactory to Purchaser.

                  2.3.1.12 OBLIGATION TO SUSPEND DISTRIBUTION. The Holder agrees
that, upon receipt of any notice from the Company of the happening of any event
of the kind described in clause 2.3.1.4(iv), Purchaser will forthwith
discontinue disposition of Registrable Securities pursuant to the registration
statement covering such Registrable Securities until Purchaser' receipt of the
copies of the supplemented or amended prospectus contemplated by clause
2.3.1.4(iv), and, if so directed by the Company, Purchaser will deliver to the
Company all copies, other than permanent file copies then in Purchaser's
possession, of the most recent prospectus covering such Registrable Securities
at the time of receipt of such notice. If the Company gives such notice, the
Company shall extend the period during which such registration statement shall
be maintained effective by the number of days during the period from and
including the date of the giving of notice pursuant to clause 2.3.14(iv) to the
date when the Company shall make available to Purchaser a prospectus
supplemented or amended to conform with the requirements of clause 2.3.1.4(iv).

                  2.3.1.13 REGISTRATION EXPENSES. The Company shall pay all
expenses incurred in connection with any Piggyback Registration pursuant to
Section 2.2, and all expenses incurred in performing or complying with the
Company's obligations under this Section 2.3, whether or not the registration
statement becomes effective, in each case including, but not limited to: (i) all
registration and filing fees, (ii) fees and expenses of compliance with
securities or blue sky laws (including fees and disbursements of counsel in
connection with blue sky qualifications of the Registrable Securities), (iii)
printing expenses, (iv) the Company's internal expenses (including, without
limitation, all salaries and expenses of its officers and employees performing
legal or accounting duties), (v) the fees and expenses incurred in connection
with the listing of the Registrable Securities as required by Section 2.3.1.11,
(vi) National Association of Securities Dealers, Inc. or Nasdaq, Inc. fees,
(vii) fees and disbursements of counsel for the Company and fees and expenses
for independent certified public accountants retained by the Company (including
the expenses or costs associated with the delivery of any opinions or comfort
letters requested pursuant to Section 2.3.1.9, (viii) the fees and expenses of
any special experts retained by the Company in connection with such
registration, and (ix) all fees and expenses incurred by Purchaser in connection
with his participation in such registration, including, without limitation, the
fees and expenses of legal counsel, and any accountants and other experts for,
and chosen by, Purchaser. The Company shall have no obligation to pay any
underwriting fees, discounts or selling commissions attributable to the
Registrable Securities being sold by Purchaser, which expenses shall be borne by
Purchaser.

                                      -10-
<PAGE>

      2.4 INDEMNIFICATION AND CONTRIBUTION.

            2.4.1 INDEMNIFICATION BY THE COMPANY. The Company agrees to
indemnify and hold harmless Purchaser and his affiliates and agents from and
against any loss, claim, damage or liability and any action in respect thereof
to which Purchaser and his affiliates and agents may become subject under the
1933 Act or the 1934 Act or any other statute or common law, insofar as such
loss, claim, damage, liability or action arises out of, or is based upon, (a)
any untrue statement or alleged untrue statement of a material fact made in
connection with the sale of Registrable Securities or shares of Common Stock,
whether or not such statement is contained or incorporated by reference in any
registration statement or prospectus relating to the Registrable Securities (as
amended or supplemented if the Company shall have furnished any amendments or
supplements thereto) or any preliminary prospectus, (b) any omission or alleged
omission to state a material fact required to be stated in any registration
statement or prospectus or necessary to make the statements therein not
misleading, or (c) any violation by the Company of any Federal, state or common
law, rule or regulation applicable to the Company and relating to action
required of or inaction by the Company in connection with such registration. The
Company also shall promptly, but in no event more than ten Business Days after
request for payment, pay directly or reimburse Purchaser and his affiliates and
agents for any legal and other expenses incurred by Purchaser and his affiliates
and agents in investigating or defending or preparing to defend against any such
loss, claim, damage, liability or action. The Company shall either promptly, but
in no event in more than ten Business Days after request for payment, pay
directly all amounts that it is required to pay hereunder or shall reimburse the
requesting party for such amounts within ten Business Days after any request for
such reimbursement. The Company also shall indemnify any Underwriter of the
Registrable Securities, their officers, affiliates, directors, partners, members
and agents and each person who controls such Underwriters on substantially the
same basis as that of the indemnification of Purchaser provided in this Section
2.4.1.

            The indemnity agreement contained in this Section 2.4.1 shall not
apply to amounts paid in settlement of any such loss, claim, damage or liability
or any action in respect thereof if such settlement is effected without the
consent of the Company (which consent shall not be unreasonably withheld), nor
shall the Company be liable to Purchaser and his affiliates and agents in any
such case for any loss, claim, damage, liability or any action in respect
thereof to the extent that it arises solely from or is based solely upon and is
in conformity with information related to Purchaser furnished in writing by
Purchaser expressly for use in connection with such registration by Purchaser,
nor shall the Company be liable to Purchaser for any such loss, claim, damage or
liability or any action in respect thereof to the extent it arises solely from
or is based solely upon (i) any untrue statement or alleged untrue statement of
a material fact contained in any registration statement or prospectus relating
to the Registrable Securities delivered by Purchaser after the Company had
provided written notice to Purchaser that such registration statement or
prospectus contained such untrue statement or alleged untrue statement of a
material fact, or (ii) any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading after the Company had provided written notice to
Purchaser that such registration statement or prospectus contained such omission
or alleged omission.

                                      -11-
<PAGE>

            2.4.2 INDEMNIFICATION BY PURCHASER. The Holder shall indemnify and
hold harmless the Company, its officers, directors, partners, members and agents
and each person, if any, who controls the Company within the meaning of Section
15 of the 1933 Act or Section 20 of the 1934 Act to the same extent as the
foregoing indemnity from the Company to Purchaser, but solely with reference to
information in conformity with and related to Purchaser furnished in writing by
Purchaser expressly for use in any registration statement or prospectus relating
to the Registrable Securities, or any amendment or supplement thereto, or any
preliminary prospectus. The Holder also indemnify and hold harmless any
Underwriter of the Registrable Securities, their officers, directors, partners,
members and agents and each person who controls such Underwriters on
substantially the same basis as that of the indemnification of the Company
provided in this Section 2.4.2; provided, however, that in no event shall any
indemnity obligation under this Section 2.4.2 exceed the dollar amount of the
net proceeds actually received by Purchaser from the sale of Registrable
Securities which gave rise to such indemnification obligation under such
registration statement or prospectus.

            2.4.3 CONDUCT OF INDEMNIFICATION PROCEEDINGS. Promptly after receipt
by any person of any notice of any loss, claim, damage or liability or any
action in respect of which indemnity may be sought pursuant to Section 2.4.1 or
2.4.2, such person ("INDEMNIFIED PARTY") shall, if a claim in respect thereof is
to be made against any other person for indemnification hereunder, notify such
other person ("INDEMNIFYING PARTY") in writing of the loss, claim damage,
liability or action; provided, however, that the failure by the Indemnified
Party to notify the Indemnifying Party shall not relieve the Indemnifying Party
from any liability which the Indemnifying Party may have to such Indemnified
Party hereunder. If the Indemnified Party is seeking Indemnification with
respect to any claim or action brought against the Indemnified Party, then the
Indemnifying Party shall be entitled to participate in such claim or action,
and, to the extent that it wishes, jointly with all other Indemnifying Parties,
to assume the defense thereof with counsel satisfactory to the Indemnified
Party. After notice from the Indemnifying Party to the Indemnified Party of its
election to assume the defense of such claim or action, the Indemnifying Party
shall not be liable to the Indemnified Party for any legal or other expenses
subsequently incurred by the Indemnified Party in connection with the defense
thereof other than reasonable costs of investigation; provided, however, that in
any action in which both the Indemnified Party and the Indemnifying Party are
named as defendants, the Indemnified Party shall have the right to employ
separate counsel (but no more than one such separate counsel) to represent the
Indemnified Party and its controlling persons who may be subject to liability
arising out of any claim in respect of which indemnity may be sought by the
Indemnified Party against the Indemnifying Party, with the fees and expenses of
such counsel to be paid by such Indemnifying Party if, based upon the written
opinion of counsel of such Indemnified Party, representation of both parties by
the same counsel would be inappropriate due to actual or potential differing
interests between them. No Indemnifying Party shall, without the prior written
consent of the Indemnified Party, consent to entry of judgment or effect any
settlement of any claim or pending or threatened proceeding in respect of which
the Indemnified Party is or could have been a party and indemnity could have
been sought hereunder by such Indemnified Party, unless such judgment or
settlement includes an unconditional release of such Indemnified Party from all
liability arising out of such claim or proceeding.

                                      -12-
<PAGE>

            2.4.4 CONTRIBUTION. If the indemnification provided for in the
foregoing Sections 2.4.1, 2.4.2 and 2.4.3 is unavailable to any Indemnified
Party in respect of any loss, claim, damage, liability or action referred to
herein, then each such Indemnifying Party, in lieu of indemnifying such
Indemnified Party, shall contribute to the amount paid or payable by such
Indemnified Party as a result of such loss, claim, damage, liability or action
in such proportion as is appropriate to reflect the relative fault of the
Indemnified Parties and the Indemnifying Parties in connection with the actions
or omissions which resulted in such loss, claim, damage, liability or action, as
well as any other relevant equitable considerations. The relative fault of any
Indemnified Party and any Indemnifying Party shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact
relates to information supplied by such Indemnified Party or such Indemnifying
Party and the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The parties hereto
agree that it would not be just and equitable if contribution pursuant to this
Section 2.4.4 were determined by pro rata allocation or by any other method of
allocation which does not take account of the equitable considerations referred
to in the immediately preceding paragraph. The amount paid or payable by an
Indemnified Party as a result of any loss, claim, damage, liability or action
referred to in the immediately preceding paragraph shall be deemed to include,
subject to the limitations set forth above, any legal or other expenses incurred
by such Indemnified Party in connection with investigating or defending any such
action or claim. Notwithstanding the provisions of this Section 2.4.4, Purchaser
shall not be required to contribute any amount in excess of the dollar amount of
the net proceeds actually received by Purchaser from the sale of Registrable
Securities which gave rise to such contribution obligation. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933
Act) shall be entitled to contribution from any person who was not guilty of
such fraudulent misrepresentation.

      2.5 UNDERWRITING AND DISTRIBUTION.

            2.5.1 RULE 144. The Company covenants that it shall file any reports
required to be filed by it under the 1933 Act and the 1934 Act and shall take
such further action as Purchaser may reasonably request, all to the extent
required from time to time to enable Purchaser to sell Registrable Securities
without registration under the 1933 Act within the limitation of the exemptions
provided by Rule 144 or Rule 144A under the 1933 Act, as such Rules may be
amended from time to time, or any similar Rule or regulation hereafter adopted
by the Commission.

            2.5.2 "LOCK-UP" AGREEMENT BY PURCHASER. The Holder, by his
acceptance hereof, agrees that, upon request, in connection with any
underwritten public offering by the Company, Purchaser will enter "lock-up"
agreements, in customary form, pursuant to which he will agree not to effect any
sale or distribution of any securities similar to those being registered by the
Company, or any securities convertible into or exchangeable or exercisable for
such securities, including a sale pursuant to Rule 144 or 144A under the 1933
Act, during the 14 days prior to, and during the 180-day period beginning on,
the effective date of the registration statement relating to such offering
(except as part of such registration statement); provided, however, that the
obligation of Purchaser to execute a lock-up agreement is subject to the
execution of similar agreements by all of the officers, directors and other
shareholders of the Company who hold shares of Common Stock or options or other
securities exercisable or convertible for or into shares of Common Stock.

                                      -13-
<PAGE>

      2.6 NO INCONSISTENT OR SUPERIOR REGISTRATION RIGHTS. From and after the
date of this Agreement, the Company shall not, without the prior written consent
of Purchaser, (i) enter into any agreement granting demand registration rights
with respect to its Common Stock or other securities, (ii) enter into any
agreement granting Piggyback Registration rights with respect to the Common
Stock or other securities which are inconsistent with or superior to the rights
granted to Purchaser hereunder; or (iii) amend any agreement in effect as of the
date hereof which grants registration rights to any other person or entity so as
to cause such registration rights to be inconsistent with or superior to the
rights granted to Purchaser hereunder or to otherwise adversely affect the
registration rights granted to Purchaser hereunder.

                                  ARTICLE III
                         REPRESENTATIONS OF THE COMPANY

      The Company hereby makes the following representations and warranties to
Purchaser, upon which representations and warranties Purchaser has relied in
entering into this Agreement:

      3.1 ORGANIZATION, GOOD STANDING AND POWER. The Company is a corporation
duly incorporated validly existing and in good standing under the laws of the
State of Nevada and has all requisite corporate authority to own, lease and
operate its properties and assets and to carry on its business as now being
conducted. The Company's only subsidiary is the Mogel Management Group, Inc., a
Nevada corporation ("MMG"), which functions as its operating Company. MMG is
wholly owned by the Company. MMG itself has a wholly owned subsidiary, Mogel
Management Group, LLC, a California limited liability company which conducts no
business. The Company is duly qualified to do business and is in good standing
as a foreign corporation in every jurisdiction in which the nature of the
business conducted or property owned by it makes such qualification necessary.

      3.2 AUTHORIZATION, ENFORCEMENT. (i) The Company has the requisite
corporate power and corporate authority to enter into and perform its
obligations under this Agreement and to issue the Note and, upon conversion, the
Shares, (ii) the execution and delivery of this Agreement by the Company and the
consummation by it of the transactions contemplated hereby have been duly
authorized by all necessary corporate action and no further consent or
authorization of the Company or its Board of Directors or stockholders is
required, and (iii) this Agreement has been duly executed and delivered by the
Company and constitutes the valid and binding obligations of the Company
enforceable against the Company in accordance with their terms.

      3.3 CAPITALIZATION. The authorized capital stock of the Company consists
of 250,000,000 shares of Common Stock of which 20,220,000 shares are issued and
outstanding. All of the outstanding shares of the Company's Common Stock have
been duly and validly authorized and are fully paid and non-assessable. No
shares of Common Stock are entitled to preemptive rights or registration rights
and there are no outstanding options, warrants, scrip, rights to subscribe to,
calls or commitments of any character whatsoever relating to, or securities or
rights convertible into, any shares of capital stock of the Company.
Furthermore, there are no contracts, commitments, understandings, or
arrangements by which the Company is or may become bound to issue additional
shares of the capital stock of the Company or options, securities or rights
convertible into shares of capital stock of the Company. The Company is not a
party to any agreement granting registration rights to any person with respect
to any of its equity or debt securities. The Company is not a party to, and it
has no knowledge of, any agreement restricting the voting or transfer of any
shares of the capital stock of the Company. The offer and sale of all capital
stock, convertible securities, rights, warrants, or options of the Company
issued prior to the Effective Date complied with all applicable federal and
state securities laws, and no stockholder has a right of rescission or damages
with respect thereto. Exhibit F contains an accurate and current copy of the
Company's Articles of Incorporation. Exhibit G contains an accurate and current
copy of the Company's Bylaws.

                                      -14-
<PAGE>

      3.4 ISSUANCE OF NOTE AND SHARES. The Note to be issued under this
Agreement and the Shares to be issued upon conversion of the Note have been duly
authorized by all necessary corporate action and, when paid for and issued in
accordance with the terms hereof and the Shares shall be validly issued and
outstanding, fully paid and non-assessable, and Purchaser shall be entitled to
all rights accorded to a holder of Common Stock. The Shares Company, on a
fully-diluted basis, including shares of all classes and types, common and
preferred, and all shares authorized for issuance under any Company equity
option plan or authorized for issuance pursuant to any other options or warrants
issued by the Company.

      3.5 NO CONFLICTS. The execution, delivery and performance of this
Agreement by the Company and the consummation by the Company of the transactions
contemplated herein do not and will not (i) violate any provision of the
Company's Articles of Incorporation or Bylaws, (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, mortgage, deed of trust,
indenture, note, bond, license, lease agreement, instrument or obligation to
which the Company is a party, (iii) create or impose a lien, charge or
encumbrance on any property of the Company under any agreement or any commitment
to which the Company is a party or by which the Company is bound or by which any
of its respective properties or assets are bound, or (iv) result in a violation
of any federal, state, local or other foreign statute, rule, regulation, order,
judgment or decree (including any federal or state securities laws and
regulations) applicable to the Company or by which any property or asset of the
Company are bound or affected. The business of the Company is not being
conducted in violation of any laws, ordinances or regulations of any
governmental entity, except for possible violations that singularly or in the
aggregate do not and will not have a material adverse effect. The Company is not
required under any federal, state or local law, rule or regulation to obtain any
consent, authorization or order of, or make any filing or registration with, any
court or governmental agency in order for it to execute, deliver or perform any
of its obligations under this Agreement, or issue and sell the Shares and Option
Shares in accordance with the terms hereof (other than any registration
statement which may be filed pursuant hereto).

                                      -15-
<PAGE>

      3.6 SEC DOCUMENTS, FINANCIAL STATEMENTS. A certain number of shares of the
Common Stock of the Company is registered pursuant to Section 12(g)of the 1934
Act, and, the Company has timely filed all reports, schedules, forms, statements
and other documents required to be filed by it with the Commission pursuant to
the reporting requirements of the Exchange Act, including material filed
pursuant to Section 13(a) or 15(d) of the 1934 Act. The Company has delivered or
made available to Purchaser, true and complete copies of the documents filed
with the Commission by Company since November 18, 2003, (the "SEC DOCUMENTS").
As of their respective filing dates, the SEC Documents complied in all material
respects with the requirements of the 1934 Act or the 1933 Act, as applicable,
and the rules and regulations of the Commission promulgated thereunder
applicable to such documents, and, as of their respective filing dates, none of
the SEC Documents contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were
made, not misleading. The financial statements of the Company included in the
SEC Documents comply as to form in all material respects with applicable
accounting requirements under GAAP and the published rules and regulations of
the SEC or other applicable rules and regulations with respect thereto. Such
financial statements have been prepared in accordance with GAAP applied on a
consistent basis during the periods involved (except (i) as may be otherwise
indicated in such financial statements or the notes thereto or (ii) in the case
of unaudited interim statements, to the extent they may not include footnotes or
may be condensed or summary statements), and fairly present in all material
respects the financial position of the Company as of the dates thereof and the
results of operations and cash flows for the periods then ended (subject, in the
case of unaudited statements, to normal year-end audit adjustments).

      3.7 SARBANES-OXLEY ACT OF 2002. There has been no change in the Company's
accounting policies since November 18, 2003, other than as required by
applicable law, regulation or generally accepted accounting Principles (GAAP).
Each required form, report and document containing financial statements that has
been filed with or submitted to the Commission since November 18, 2003, was
accompanied by the certifications required to be filed or submitted by Parent's
chief executive officer and chief financial officer pursuant to the
Sarbanes-Oxley Act of 2002 (the "SARBANES-OXLEY Act"), and at the time of filing
or submission of each such certification, such certification was true and
accurate and complied with the Sarbanes-Oxley Act and the rules and regulations
promulgated thereunder. Since November 18, 2003, neither the Company nor any of
its subsidiaries nor, to the knowledge of the Company, any director, officer,
employee, auditor, accountant or representative of the Company or any of its
subsidiaries has received or otherwise had or obtained knowledge of any
complaint, allegation, assertion or claim, whether written or oral, regarding
the accounting or auditing practices, procedures, methodologies or methods of
the Company or any of its subsidiaries or their respective internal accounting
controls, including any complaint, allegation, assertion or claim that Parent or
any of it subsidiaries has engaged in questionable accounting or auditing
practices, except for (A) any complaint, allegation, assertion or claim as has
been resolved without any resulting change to the Company's accounting or
auditing practices, procedures methodologies or methods of the Company or any of
its subsidiaries or their respective internal accounting controls and (b)
questions regarding such matters raised and resolved in the ordinary course in
connection with the preparation and review of the Company's financial statements
and periodic reports. Since November 18, 2003, no attorney representing the
Company or any of its subsidiaries, whether or not employed by the Company or
any such subsidiary, has reported evidence of a material violation of securities
laws, breach of fiduciary duty or similar violation by the Company or any of its
officers, directors, employees or agents to the Board of Directors of the
Company or any committee thereof or to any director or officer of the Company or
any of its subsidiaries. To the knowledge of the Company and its subsidiaries,
since November 18, 2003, no employee of the Company or any of its subsidiaries
has provided or is providing information to any law enforcement agency regarding
the commission or possible commission of any crime or the violation or possible
violation of any applicable law.

                                      -16-
<PAGE>

      3.8 NO MATERIAL ADVERSE EFFECT. Since the date of the financial statements
provided by Company to Purchaser, including those contained in the most recently
filed Form 10-QSB or Form 10-KSB, whichever is most current, no material adverse
effect has occurred or exists with respect to the Company, except as disclosed
in the SEC Documents.

      3.9 NO UNDISCLOSED LIABILITIES. The Company does not have any liabilities,
obligations, claims or losses (whether liquidated or unliquidated, secured or
unsecured, absolute, accrued, contingent or otherwise) that would be required to
be disclosed on a balance sheet of the Company or any subsidiary (including the
notes thereto) in conformity with GAAP which are not disclosed in the SEC
Documents, other than those incurred in the ordinary course of the Company's
business since such date and which, individually or in the aggregate, do not or
would not have a material adverse effect on the Company.

      3.10 NO UNDISCLOSED EVENTS OR CIRCUMSTANCES. Since the date of the
financial statement contained in the most recently filed Form 10-QSB or Form
10-KSB, whichever is most current, no event or circumstance has occurred or
exists with respect to the Company or its businesses, properties, prospects,
operations or financial condition, that, under applicable law, rule or
regulation, requires public disclosure or announcement prior to the date hereof
by the Company but which has not been so publicly announced or disclosed in the
SEC Documents.

      3.11 INDEBTEDNESS. The SEC Documents set forth as of the date hereof all
outstanding secured and unsecured Indebtedness of the Company, or for which the
Company has commitments. For the purposes of this Agreement, "INDEBTEDNESS"
shall mean (A) any liabilities for borrowed money or amounts owed in excess of
$50,000 (other than trade accounts payable incurred in the ordinary course of
business), (B) all guaranties, endorsements and contingent obligations in
respect of Indebtedness of others, whether or not the same are or should be
reflected in the Company's balance sheet (or the notes thereto), except
guaranties by endorsement of negotiable instruments for deposit or collection or
similar transactions in the ordinary course of business, (C) the present value
of any lease payments in excess of $50,000 due under leases required to be
capitalized in accordance with GAAP, (D) expenses incurred related to due
diligence investigations of the four (4) hospitals, not otherwise reported may
exceed $50,000. The Company is not in default with respect to any Indebtedness.

      3.12 TITLE TO ASSETS. The Company has good and marketable title to all of
its real and personal property, free of any mortgages, pledges, charges, liens,
security interests or other encumbrances, except for those indicated in the SEC
Documents. All said leases of the Company are valid and subsisting and in full
force and effect.

      3.13 ACTIONS PENDING. There is no action, suit, claim, investigation or
proceeding pending or, to the knowledge of the Company, threatened against the
Company which questions the validity of this Agreement or the transactions
contemplated hereby or any action taken or to be taken pursuant hereto or
thereto. There is no action, suit, claim, investigation or proceeding pending
or, to the knowledge of the Company, threatened, against or involving the
Company or any of its properties or assets. There are no outstanding orders,
judgments, injunctions, awards or decrees of any court, arbitrator or
governmental or regulatory body against the Company or any subsidiary.

                                      -17-
<PAGE>

      3.14 COMPLIANCE WITH LAW. The Company has all permits, licenses, consents
and other governmental or regulatory authorizations and approvals necessary for
the conduct of its businesses as now being conducted.

      3.15 TAXES. Since November 18, 2003, the Company has filed all Tax Returns
which it is required to file under applicable laws; all such Tax Returns are
true and accurate and have been prepared in compliance with all applicable laws;
the Company has paid all Taxes due and owing by it (whether or not such Taxes
are required to be shown on a Tax Return) and has withheld and paid over to the
appropriate taxing authorities all Taxes which it is required to withhold from
amounts paid or owing to any employee, stockholder, creditor or other third
parties. Since November 18, 2003, no claim has been made by a taxing authority
in a jurisdiction where the Company does not file tax returns that the Company
is or may be subject to taxation by that jurisdiction. There are no foreign,
federal, state or local tax audits or administrative or judicial proceedings
pending or being conducted with respect to the Company. To the Company's
knowledge, there are no material unresolved questions or claims concerning the
Company's Tax liability. For purposes of this Section: "IRS" means the United
States Internal Revenue Service; "TAX" or "TAXES" means federal, state, county,
local, foreign, or other income, gross receipts, ad valorem, franchise, profits,
sales or use, transfer, registration, excise, utility, environmental,
communications, real or personal property, capital stock, license, payroll, wage
or other withholding, employment, social security, severance, stamp, occupation,
alternative or add-on minimum, estimated and other taxes of any kind whatsoever
(including, without limitation, deficiencies, penalties, additions to tax, and
interest attributable thereto) whether disputed or not; and "TAX RETURN" means
any return, information report or filing with respect to Taxes, including any
schedules attached thereto and including any amendment thereof.

      3.16 CERTAIN FEES. No brokers, finders or financial advisory fees or
commissions will be payable by the Company with respect to the transactions
contemplated by this Agreement.

      3.17 DISCLOSURE. To the best of the Company's knowledge, neither this
Agreement or the exhibits hereto nor any other documents, certificates or
instruments furnished to Purchaser by or on behalf of the Company or any
subsidiary in connection with the transactions contemplated by this Agreement
contains any untrue statement of a material fact or omits to state a material
fact necessary in order to make the statements made herein or therein, in the
light of the circumstances under which they were made herein or therein, not
misleading.

      3.18 BOOKS AND RECORDS. The records and documents of the Company
accurately reflect in all material respects the information relating to the
business of the Company, the location and collection of their assets, and the
nature of all transactions giving rise to the obligations or accounts receivable
of the Company.

      3.19 SECURITIES LAWS. The Company has complied and will comply with all
applicable federal and state securities laws in connection with the offer,
issuance and sale of the Note and the Shares hereunder. Neither the Company nor
anyone acting on its behalf, directly or indirectly, has or will sell, offer to
sell or solicit offers to buy the Shares or similar securities to, or solicit
offers with respect thereto from, or enter into any preliminary conversations or
negotiations relating thereto with, any person (other than Purchaser), so as to
bring the issuance and sale of the Shares under the registration provisions of
the 1933 Act and applicable state securities laws. Neither the Company nor any
of its affiliates, nor any person acting on its or their behalf, has engaged in
any form of general solicitation or general advertising (within the meaning of
Regulation D under the 1933 Act) in connection with the offer or sale of the
Note and the Shares.

                                      -18-
<PAGE>

      3.20 ABSENCE OF CERTAIN DEVELOPMENTS. Except as disclosed in SEC
Documents, since the date of the financial statement contained in the most
recently filed Form 10-Q or Form 10-K, whichever is most current, the Company
has not: (i) issued any stock, bonds or other corporate securities or any
rights, options or warrants with respect thereto; (ii) borrowed any amount or
incurred or become subject to any liabilities (absolute or contingent) except
current liabilities incurred in the ordinary course of business which are
comparable in nature and amount to the current liabilities incurred in the
ordinary course of business during the comparable portion of its prior fiscal
year, as adjusted to reflect the current nature and volume of the Company's
business; (iii) discharged or satisfied any lien or encumbrance or paid any
obligation or liability (absolute or contingent), other than current liabilities
paid in the ordinary course of business; (iv) declared or made any payment or
distribution of cash or other property to stockholders with respect to its
stock, or purchased or redeemed, or made any agreements so to purchase or
redeem, any shares of its capital stock; (v) sold, assigned or transferred any
other tangible assets, or canceled any debts or claims, except in the ordinary
course of business; (vi) sold, assigned or transferred any intangible assets or
intellectual property rights, or disclosed any proprietary confidential
information to any person except to customers in the ordinary course of business
or to Purchaser or his representatives; (vii) suffered any material losses; or
(viii) made capital expenditures or commitments therefor that aggregate in
excess of $50,000.

      3.21 GOVERNMENTAL APPROVALS. Except as may be required by Article II, no
authorization, consent, approval, license, exemption of, filing or registration
with any court or governmental department, commission, board, bureau, agency or
instrumentality, domestic or foreign, is or will be necessary for, or in
connection with, the delivery of the Note and the Shares, or for the performance
by the Company of its obligations under this Agreement.

      3.22 OFFER TO CITIGROUP/TENET HEALTHCARE SYSTEM. The Company has
negotiated a Non-Binding Letter of Intent with Citigroup/Tenet Healthcare
Corporation (the "LETTER") to purchase four hospitals (the "HOSPITALS") in
Orange County, California known as Western Medical Center - Santa Ana, Western
Medical Center - Anaheim, Costal Communities Hospital, and Chapman Medical
Center (the "TENET TRANSACTION"). A copy of the Letter is attached hereto as
Exhibit H.

                                   ARTICLE IV
                          REPRESENTATIONS OF PURCHASER

      The Purchaser hereby makes the following representations and warranties to
the Company, upon which representations and warranties the Company has relied in
entering into this Agreement:

                                      -19-
<PAGE>

      4.1 AUTHORIZATION AND POWER. Purchaser has the requisite power and
authority to enter into and perform this Agreement and to purchase the Note and
the Shares being sold to it hereunder. The execution, delivery and performance
of this Agreement by Purchaser shall constitute valid and binding obligations of
Purchaser enforceable against Purchaser in accordance with their terms.

      4.2 FINANCIAL RISKS. Purchaser acknowledges that it is able to bear the
financial risks associated with an investment in the Note and the Shares and
that it has been given full access to such records of the Company and the
subsidiaries and to the officers of the Company and the subsidiaries as it has
deemed necessary or appropriate to conduct its due diligence investigation.
Purchaser is capable of evaluating the risks and merits of an investment in the
Note and the Shares by virtue of his experience as an investor and his
knowledge, experience, and sophistication in financial and business matters and
Purchaser is capable of bearing the entire loss of its investment in the Note
and the Shares.

      4.3 ACCREDITED INVESTOR. Purchaser is an "accredited investor" as defined
in Regulation D promulgated under the 1933 Act.

      4.4 CALIFORNIA RESIDENT. Purchaser is a bona fide resident of, is
domiciled in and received the offer and made the decision to invest in the Note
and the Shares in the State of California.

      4.5 RELIANCE. Purchaser understands and agrees that the Company is relying
upon the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of Purchaser set forth herein in order to
determine the suitability of Purchaser to acquire the Note and the Shares.

                                   ARTICLE V
                                    COVENANTS

      The Company covenants that, until such time as (a) the Company has fully
satisfied its obligations with respect to the payment of all principal, interest
and other amounts that are or may become due and payable under the Note, or (b)
if the Note has been converted in its entirety, Purchaser no longer owns Shares
representing at least 5% of Company's then issued and outstanding Common Stock,
or (c) the Company has completed an underwritten public offering of its Common
Stock, the Company shall perform the covenants set forth in this Section 5.

      5.1 VISITATION RIGHTS FOR BOARD MEETINGS. Visitation Rights for Board
Meetings. Purchaser shall receive notice of and be entitled to have a
representative attend as a observer all meetings of the Boards of Directors of
the Company and of all committees thereof. Notice of such meetings shall be
given to Purchaser in the same manner and at the same times as to members of the
Board of Directors or such committees (which shall not be less than 48 hours
prior to such meeting unless otherwise agreed to by Purchaser). Purchaser shall
be provided with copies of (a) a meeting agenda, if any is prepared, (b) all
information which is provided to the members of the Board of Directors or
committee thereof (whether prior to, at, or subsequent to any such meetings) at
the same time as such materials are provided to the members of the Board of
Directors or such committees, as the case may be and (c) copies of the minutes
of all such meetings concurrently with the distribution of such minutes to the
members of the Board of Directors, but in no event later than 45 days after each
such meeting.

                                      -20-
<PAGE>

      5.2 RESTRICTION ON FUNDAMENTAL CHANGES. Without Purchaser's written
consent, the Company shall not do any of the following to the extent that they
could in any way adversely affect the repayment of the Note, impair any of
Purchaser's other rights or have a material adverse effect on the Company: (a)
make any change in its business objectives, purposes, structure or operations,
(b) amend its articles of incorporation or bylaws, (c) make any change in its
capital structure, including the issuance of any shares of its capital stock,
option rights or convertible securities or any revision of the terms of its
outstanding capital stock or the granting of any preemptive rights, (d) issue
any preferred stock, (e) increase management compensation, or (f) sell or
otherwise dispose of assets, other than dispositions in the ordinary course of
business consistent with past practice.

      5.3 BOOKS, RECORDS AND INSPECTIONS. The Company shall keep proper books of
record and account in which full, true and correct entries in conformity with
GAAP and all requirements of law shall be made of all dealings and transactions
in relation to its business and activities. The Company shall permit officers
and designated representatives and/or agents of Purchaser to visit and inspect
any of the properties of the Company, and to examine the books of account of the
Company and discuss the affairs, finances and accounts of the Company with, and
be advised as to the same by, its officers and independent accountants, all at
such reasonable times and intervals and to such reasonable extent as Purchaser
may request.

                                   ARTICLE VI
                                  MISCELLANEOUS

      6.1 AMENDMENT. This Agreement may be modified or amended only by mutual
written agreement of the parties. Any such modification or amendment must be in
writing, dated and signed by the parties and attached to this Agreement.

      6.2 ASSIGNMENT. The Company may not assign any interest or obligation
under this Agreement without Purchaser's prior written consent. Purchaser may
freely assign his interests and/or obligations under this Agreement without the
consent of the Company.

      6.3 BINDING EFFECT. Subject to the foregoing, this Agreement shall be
binding on and shall inure to the benefit of the parties and their respective
successors and assigns.

      6.4 ATTORNEYS' FEES. In any action or dispute, at law or in equity, that
may arise under or otherwise relate to this Agreement, the prevailing party
shall be entitled to the award of reasonable attorneys' fees and costs, in
addition to whatever relief the prevailing party may be awarded.

      6.5 VENUE. The parties agree that Orange County, California shall be the
only proper venue for disputes related to this Agreement.

      6.6 ENTIRE AGREEMENT. This Agreement is the entire understanding and
agreement of the parties regarding its subject matter, and supersedes any prior
oral or written agreements, representations, understandings or discussions
between the parties. No other understanding between the parties shall be binding
on them unless set forth in writing, signed and attached to this Agreement.

                                      -21-
<PAGE>

      6.7 GOVERNING LAW. This Agreement shall be construed in accordance with
and governed by the laws of the State of California, except the conflicts of
laws provisions that would require the application of the laws of any other
jurisdiction.

      6.8 SPECIFIC PERFORMANCE. The parties acknowledge that the Note and the
Shares are unique, and that damages would not be an adequate remedy for
Purchaser in the event of the Company's failure to perform any of its
obligations hereunder and under the Note (including, without limitation, its
obligation to deliver the Shares if Purchaser elects to convert the Note). As a
result, the parties agree that this Agreement may be enforced by specific
performance.

      6.9 HEADINGS. The headings in this Agreement are intended solely for
convenience of reference and shall be given no effect in the construction or
interpretation of this Agreement.

      6.10 MEANING OF CERTAIN WORDS. Wherever the context may require, any
pronouns used in this Agreement shall include the corresponding masculine,
feminine, or neuter forms, and the singular form of nouns shall include the
plural and vice versa.

      6.11 NO THIRD-PARTY BENEFICIARY RIGHTS. The parties do not intend to
confer and this Agreement shall not be construed to confer any rights or
benefits to any person, firm, corporation or entity other than the parties.

      6.12 NOTICES. All notices or communications required or permitted under
this Agreement shall be given in writing and delivered personally or sent by
United States registered or certified mail with postage prepaid and return
receipt requested or by overnight delivery service (e.g., Federal Express, DHL).
Notice shall be deemed given when sent, if sent as specified in this Section, or
otherwise deemed given when received. In each case, notice shall be delivered or
sent to:

         IF TO COMPANY, ADDRESSED TO:
         Integrated Healthcare Holdings, Inc.
         695 Town Center Drive, Suite 260
         Costa Mesa, CA 92626
         Attention: Chief Executive Officer

         IF TO PURCHASER, ADDRESSED TO:
         c/o Strategic Global Management, Inc.
         6800 Indiana Avenue, Suite 130
         |Riverside, CA 92506
         Attention: Kali Chaudhuri, M.D.

      6.13 SEVERABILITY. If any provision of this Agreement is determined to be
illegal or unenforceable, that provision shall be severed from this Agreement,
and such severance shall have no effect upon the enforceability of the remainder
of this Agreement.

                                      -22-
<PAGE>

      6.14 WAIVER. No delay or failure to require performance of any provision
of this Agreement shall constitute a waiver of that provision as to that or any
other instance. Any waiver granted by a party must be in writing to be
effective, and shall apply solely to the specific instance expressly stated.

      6.15 CONFIDENTIALITY. Neither party shall disclose any of the terms of
this Agreement to any person or entity (other than its attorneys or accountants)
without the prior written consent of the other party, unless and only to the
extent such disclosure is required by law, including the 1933 Act.

      6.16 COUNTERPARTS. This Agreement may be executed in one or more
counterparts, each of which shall be deemed to be an original, and all of which
together shall constitute one and the same instrument. 6.17 CORPORATE NAME. If
Purchaser elects to convert his Note into the Shares, the parties recognize he
may elect to cause the Company to change its corporate name.

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
Effective Date.

                                    COMPANY

                                    Integrated Healthcare Holdings, Inc.,
                                    a Nevada corporation

                                    /s/ Larry Anderson
                                    --------------------------------------------
                                    Larry B. Anderson, President

                                    PURCHASER

                                    /s/ Kali Chaudhuri
                                    --------------------------------------------
                                    Kali Chaudhuri, M.D., an individual

                                      -23-
<PAGE>

                                    EXHIBIT A
                            FORM OF CONVERTIBLE NOTE
<PAGE>

THE SECURITIES REPRESENTED BY THIS CONVERTIBLE PROMISSORY NOTE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF
COUNSEL SATISFACTORY TO THE DEBTOR THAT SUCH REGISTRATION IS NOT REQUIRED.

$500,000.00                                               Costa Mesa, California
                                                              September 28, 2004

                       SECURED CONVERTIBLE PROMISSORY NOTE

      FOR VALUE RECEIVED, the undersigned, INTEGRATED HEALTHCARE HOLDINGS, INC.,
a Nevada corporation (the "COMPANY"), promises to pay to Kali Chaudhuri, M.D.
("PURCHASER"), at c/o 6800 Indiana Avenue, Suite 130, Riverside, California
92506, or at such other location as is designated by Purchaser in writing
hereunder, the aggregate sum of Five Hundred Thousand Dollars ($500,000),
bearing simple interest on the unpaid principal balance of this Note, from the
date of this Note until this Note is paid in full at a rate of five percent
(5.0%) per annum. Accrued interest shall be computed based on the actual number
of days elapsed. Interest only shall be payable on the first Business Day of
each calendar quarter beginning January 2, 2005. All principal and accrued but
unpaid interest will be due and payable in full on demand at any time after
December 31, 2004 if the Tenet Transaction has not closed by that date, or
otherwise on September 29, 2005 (the "DUE DATE"), if not earlier converted to
equity as set forth below. All payments shall be made in lawful money of the
United States, without offset, deduction, or counterclaim of any kind.

      1. TERMS. Capitalized terms used herein without definition have the
meanings ascribed to them in the Secured Convertible Note Purchase Agreement of
even date herewith (as amended from time to time in accordance with the terms
thereof, the "AGREEMENT"), by and between the Company and Purchaser.

      2 PAYMENTS AND COMPUTATIONS. All payments on account of indebtedness
evidenced by this Note shall be made not later than 11:00 A.M. (California time)
on the day when due in lawful money of the United States and shall be first
applied to interest due on the unpaid principal balance and the remainder to any
principal due (it being understood that unless otherwise specified in writing by
the Company, any payment which is applied to reduce the principal balance
outstanding shall be applied to the last Advance evidenced by this Note first).
Payments are to be made at such place as Purchaser or the legal holders of this
Note may, from time to time, in writing specify, and in the absence of a
specification, at the principal place of business of Purchaser as set forth in
the first paragraph of this Note. This Note may not be prepaid without the
express written consent of Purchaser, except that if the letter of intent of
purchase agreement between the Company and Tenet Healthcare Corporation and/or
its affiliates relating to the Tenet Transaction is terminated for any reason,
the Company may, within 30 days of such termination, pay the full amount of all
principal of and accrued interest under this Note without premium or penalty,
and without the right of Purchaser to convert this Note in accordance with
Section 3.

                                       1
<PAGE>

      3. CONVERSION OF NOTE. Subject to the last sentence of Section 2, this
Note is convertible into equity of the Company at the option of Purchaser and
upon the other terms and conditions set forth below.

            3.1 VOLUNTARY CONVERSION. Unless payment in full on this Note has
earlier been made, all or any portion of the then outstanding principal and
interest accrued thereon under this Note may be converted, at the option of
Purchaser, into shares of the Company's Common Stock ("CONVERSION SHARES") at a
conversion price of $0.003125 per share (as adjusted pursuant to the terms and
conditions of this Note) ("CONVERSION PRICE").

            3.2 ANTIDILUTION ADJUSTMENTS. The Conversion Price in effect at any
time and the number and kind of securities purchasable upon the conversion of
this Note shall be subject to adjustment from time to time upon the happening of
any of the following events:

                  (i) If the Company issues or sells (or, pursuant to paragraph
      (ii) below, is deemed to have issued or sold) any shares of Common Stock
      (except as provided in paragraph (v) below) for a consideration per share
      less than the Conversion Price in effect immediately prior to such
      issuance or sale, then the Conversion Price, as of the date of such
      issuance or sale, shall be reduced to a price equal to such consideration
      per share.

                  (ii) For the purposes of paragraph (i) above, the following
      subparagraphs (A) to (E), inclusive, shall be applicable:

                        (A) If at any time the Company issues or sells any
            rights to subscribe for, or any rights or options to purchase,
            Common Stock or any stock or other securities convertible into or
            exchangeable for Common Stock (such convertible or exchangeable
            stock or securities being hereinafter called "CONVERTIBLE
            SECURITIES"), whether or not such rights or options or the right to
            convert or exchange any such Convertible Securities is immediately
            exercisable, and the price per share for which Common Stock is
            issuable upon the exercise of such rights or options or upon
            conversion or exchange of such Convertible Securities (determined by
            dividing (1) the total amount, if any, received or receivable by the
            Company as consideration for the granting of such rights or options,
            plus the minimum aggregate amount of additional consideration
            payable to the Company upon the exercise of such rights or options,
            plus, in the case of any such rights or options which shall relate
            to Convertible Securities, the minimum aggregate amount of
            additional consideration, if any, payable upon the issue or sale of
            such Convertible Securities and upon the conversion or exchange
            thereof, by (2) the total number of shares of Common Stock issuable
            upon the exercise of such rights or options or upon the conversion
            or exchange of all such Convertible Securities issuable upon the
            exercise of such rights or options) is less than the Conversion
            Price in effect immediately prior to the time of the issue or sale
            of such rights or options, then the total number of shares of Common
            Stock issuable upon the exercise of such rights or options or upon
            conversion or exchange of the total amount of such Convertible
            Securities issuable upon the exercise of such rights or options
            shall (as of the date of granting of such rights or options) be
            deemed to be outstanding and to have been issued for such price per
            share, and except as provided in paragraph (iv), no further
            adjustments of the Conversion Price shall be made upon the actual
            issuance of such Common Stock or of such Convertible Securities,
            upon the exercise of such rights or options or upon the actual
            issuance of such Common Stock upon conversion or exchange of such
            Convertible Securities.

                                       2
<PAGE>

                        (B) If at any time the Company issues or sells any
            Convertible Securities, whether or not the rights to exchange or
            convert thereunder are immediately exercisable, and the price per
            share for which Common Stock is issuable upon such conversion or
            exchange (determined by dividing (1) the total amount received or
            receivable by the Company as consideration for the issue or sale of
            such Convertible Securities, plus the minimum aggregate amount of
            additional consideration, if any, payable to the Company upon the
            conversion or exchange thereof, by (2) the total number of shares of
            Common Stock issuable upon the conversion or exchange of all such
            Convertible Securities) is less than the Conversion Price in effect
            immediately prior to the time of such issuance or sale, then the
            total number of shares of Common Stock issuable upon conversion or
            exchange of all such Convertible Securities shall (as of the date of
            the issue or sale of such Convertible Securities) be deemed to be
            outstanding and to have been issued for such price per share, and,
            except as provided in paragraph (iv) no further adjustments of the
            Conversion Price shall be made upon the actual issuance of such
            Common Stock, upon conversion or exchange of such Convertible
            Securities. In addition, if any issuance or sale of such Convertible
            Securities is made upon exercise of any rights to subscribe for or
            to purchase or any option to purchase any such Convertible
            Securities for which adjustments of the Conversion Price have been
            or shall be made pursuant to other provisions of this paragraph
            (ii), no further adjustment of the Conversion Price shall be made by
            reason of such issuance or sale.

                        (C) If at any time the Company declares and pays a
            dividend or makes any other distribution upon the Common Stock
            payable in Common Stock or Convertible Securities, any such Common
            Stock or Convertible Securities, as the case may be, issuable in
            payment of such dividend or distribution shall be deemed to have
            been issued or sold without consideration; provided, that this
            provision shall not apply to any shares of Common Stock issuable for
            additional consideration upon conversion of such Convertible
            Securities.

                        (D) If at any time any shares of Common Stock or
            Convertible Securities or any rights or options to purchase any such
            Common Stock or Convertible Securities are issued or sold for cash,
            the consideration received therefor shall be deemed to be the amount
            received by the Company therefor, without deduction therefrom of any
            expenses incurred or any underwriting commissions or concessions or
            discounts paid or allowed by the Company in connection therewith. If
            any shares of Common Stock or Convertible Securities or any rights
            or options to purchase any such Common Stock or Convertible
            Securities are issued or sold for a consideration other than cash,
            the amount of the consideration other than cash received by the
            Company shall be deemed to be the fair value of such consideration
            as determined by the Board of Directors, without deduction therefrom
            of any expenses incurred or any underwriting commissions or
            concessions or discounts paid or allowed by the Company in
            connection therewith. If any shares of Common Stock or Convertible
            Securities or any rights or options to purchase any such Common
            Stock or Convertible Securities are issued in connection with any
            merger of another corporation into the Company, the amount of
            consideration therefor shall be deemed to be the fair value of such
            merged corporation as determined by the Board of Directors reduced
            by all cash and other consideration (if any) paid by the Company in
            connection with such merger.

                                       3
<PAGE>

                        (E) If at any time the Company fails to set a record
            date of the holders of Common Stock for the purpose of entitling
            them (1) to receive a dividend or other distribution payable in
            Common Stock or in Convertible Securities, or (2) to subscribe for
            or purchase Common Stock or Convertible Securities, then such record
            date shall be deemed to be the date of the issuance or sale of the
            shares of Common Stock deemed to have been issued or sold upon the
            declaration of such dividend or the making of such other
            distribution or the date of the granting of such right of
            subscription or purchase, as the case may be.

                  (iii) If at any time the Company subdivides its outstanding
      shares of Common Stock into a greater number of shares, the Conversion
      Price in effect immediately prior to such subdivision shall be
      proportionately reduced. If at any time the outstanding shares of Common
      Stock of the Company are combined into a smaller number of shares, the
      Conversion Price in effect immediately prior to such combination shall be
      proportionately increased.

                  (iv) If the purchase or exercise price provided for in any
      right or option referred to in paragraph (ii) (A), or the rate at which
      any Convertible Securities referred to in paragraph (ii) (A) or (B) is
      convertible into or exchangeable for Common Stock, changes or a different
      purchase or exercise price or rate becomes effective at any time or from
      time to time, then, upon such change becoming effective, the Conversion
      Price then in effect hereunder shall forthwith be increased or decreased
      to such Conversion Price as would have been in effect had the adjustments
      made upon the granting or issuance of such rights or options or
      Convertible Securities been made upon the basis of (A) the issuance of the
      number of shares of Common Stock theretofore actually delivered upon the
      exercise of such options or rights or upon the conversion or exchange of
      such Convertible Securities consideration received therefor and (B) the
      granting or issuance at the time of such change of any such options,
      rights or Convertible Securities then still outstanding for the
      consideration, if any, received by the Company therefor and to be received
      on the basis of such changed price.

                                       4
<PAGE>

                  (v) The Company shall not be required to make any adjustment
      to the Conversion Price in the case of:

                        (A) the granting, after the date hereof, by the Company
            of stock options or stock awards with respect to shares of Common
            Stock under stock option plans of the Company in existence as of the
            date hereof and disclosed to Purchaser;

                        (B) the issuance of shares of Common Stock pursuant to
            the exercise of the options referred to in paragraph (v) (A) above
            or any other options or other convertible securities outstanding as
            of the date hereof and disclosed to Purchaser;

                        (C) the issuance of shares of Common Stock pursuant to
            the exercise of any warrants outstanding on the date hereof and
            disclosed to Purchaser.

                  (vi) The Company shall give notice to Purchaser of any event
      or transaction that results in an adjustment in the Conversion Price,
      within ten business days thereof, at Purchaser's address as it appears on
      the books of the Company, including a computation of such adjustment and
      any further information as shall be necessary to confirm the computation
      of such adjustments.

            3.3 CONVERSION PROCEDURE. Before Purchaser shall be entitled to
receive a certificate for the Conversion Shares and any other instruments in
connection with a conversion hereunder, Purchaser shall enter into any
agreements required by the terms of such conversion and surrender the original
of this Note, duly endorsed, at the principal office of the Company. At its
expense, the Company shall, as soon as practicable thereafter, issue and deliver
to Purchaser at such principal office a certificate or certificates for the
number of Conversion Shares to which Purchaser shall be entitled upon such
conversion (bearing such legends as are required by the terms of the conversion
and applicable state and federal securities law in the opinion of counsel to the
Company), together with any other securities and property to which Purchaser is
entitled upon such conversion under the terms of this Note and, if the
conversion is for less than all of the then outstanding balance of principal and
interest on this Note, a replacement Note of like tenor in the proper
denomination.

            3.4 MECHANICS AND EFFECT OF CONVERSION. No fractional shares shall
be issued upon conversion of this Note. In lieu of the Company issuing any
fractional shares to Purchaser upon the conversion of this Note, the Company
shall pay to Purchaser the amount of outstanding principal or interest that is
not so converted, such payment to be in cash as provided below. Upon conversion
of all principal of and accrued interest on this Note and/or payment of all
principal and accrued interest, the Company shall be forever released from all
its obligations and liabilities under this Note.

            3.5 RESERVATION OF STOCK ISSUABLE UPON CONVERSION. The Company shall
at all times reserve and keep available out of its authorized but unissued
shares solely for the purpose of effecting the conversion of the Note such
number of its shares as shall from time to time be sufficient to effect the
conversion of the Note; and if at any time the number of authorized but unissued
shares is not sufficient to effect the conversion of this Note, then, in
addition to such other remedies as shall be available to Purchaser, the Company
will use its best efforts to take such corporate action as may, in the opinion
of its counsel, be necessary to increase its authorized but unissued shares to
such number of shares as shall be sufficient for such purposes.

                                       5
<PAGE>

            3.6 LEGEND. Each certificate or instrument evidencing Conversion
Shares and any other securities issued upon any stock split, stock dividend,
recapitalization, merger, consolidation or similar event (unless no longer
required in the opinion of the counsel for the Company) shall be imprinted with
a legend substantially in the following form:

      THE SECURITIES TO WHICH THIS INSTRUMENT RELATES HAVE NOT BEEN REGISTERED
      UNDER THE SECURITIES ACT OF 1933, AS AMENDED ("SECURITIES ACT"), OR UNDER
      ANY STATE SECURITIES LAWS ("BLUE SKY LAWS"), AND MAY NOT BE OFFERED OR
      SOLD WITHOUT REGISTRATION UNDER THE SECURITIES ACT, AND AS REQUIRED BY
      BLUE SKY LAWS IN EFFECT AS TO SUCH TRANSFER, UNLESS THIS CORPORATION HAS
      RECEIVED AN OPINION FROM COUNSEL, SATISFACTORY TO THIS CORPORATION AND ITS
      COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

      The Company shall be entitled to enter stop transfer notices on its
transfer books with respect to such securities.

      4. SECURITY. Repayment of this Note is secured pursuant to the terms of a
Security Agreement dated the date of this Note by and between the Company and
Purchaser.

      5. ATTORNEYS' FEES. If any action is instituted on this Note, the
successful or prevailing party or parties shall be entitled to recover
reasonable attorneys' fees and other costs incurred in that action or
proceeding, in addition to any other relief to which the party or parties may be
entitled. Diligence, demand, presentment, notice of dishonor, and protest are
waived by the Company, and any and all makers, sureties, guarantors, and
endorsers of this Note, and their successors and assigns. Time is of the essence
for every obligation under this Note.

      6. LAW. This Note shall be construed under the laws of the State of
California, as such laws are applied to contracts entered into and performed
entirely within that state by residents thereof.

      7. RULES OF CONSTRUCTION/REPRESENTATION. The parties hereto agree that
they are sophisticated business persons or entities who have had the opportunity
to be represented by counsel during the negotiation and execution of this Note
and, therefore, waive the application of any law, regulation, holding or rule of
construction providing that ambiguities in an agreement or other document will
be construed against the party drafting such agreement or document.

                                       6
<PAGE>

      IN WITNESS WHEREOF, the Company has executed and delivered this Note as of
the day and year and at the place first above written.

                                            INTEGRATED HEALTHCARE HOLDINGS, INC.

                                            By:
                                               ---------------------------------
                                                 Larry B. Anderson, President

                                       7
<PAGE>

Schedule attached to Note dated September 28, 2004 made by INTEGRATED HEALTHCARE
HOLDINGS, INC. and payable to the order of KALI CHAUDHURI, M.D.

                         ADVANCES AND PRINCIPAL PAYMENTS

--------------------------------------------------------------------------------
          AMOUNT OF       AMOUNT OF       UNPAID PRINCIPAL       NOTATION
  DATE     ADVANCE    PRINCIPAL REPAID        BALANCE             MADE BY
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
<PAGE>

                                    EXHIBIT B
                           FORM OF SECURITY AGREEMENT
<PAGE>

                               SECURITY AGREEMENT

      THIS SECURITY AGREEMENT (this "Agreement"), dated as of September 28,
2004, is made in favor of and for the benefit of Kali Chaudhuri, M.D., with an
office at c/o Strategic Global Management, Inc., 6800 Indiana Avenue, Suite 130,
Riverside, California 92506 ("PURCHASER"), by Integrated Healthcare Holdings,
Inc., a Nevada corporation with a principal place of business located at 695
Town Center Drive, Suite 260, Costa Mesa, California 92626 (the "COMPANY").

                                 R E C I T A L S

      A. Pursuant to a Secured Convertible Note Purchase Agreement ("PURCHASE
AGREEMENT") dated as of September 29, 2004, by and between the Company and
Purchaser, Purchaser has agreed, among other things, to purchase from the
Company (i) a 5% Secured Convertible Promissory Note in the original principal
amount of $500,000 and (ii) a 7.25% Secured Promissory Note in the original
principal amount of $10,000,000.

      B. The Company will derive substantial direct and indirect benefit from
the consummation of the transactions contemplated by the Purchase Agreement.

      C. Purchaser is willing to execute the Purchase Agreement only upon, among
other things, the condition that the Company has executed and delivered this
Agreement in favor of Purchaser.

                                A G R E E M E N T

      In consideration of the promises and of the mutual covenants herein
contained and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, and to induce Purchaser to enter into
the Purchase Agreement and the Related Agreements (as defined below) to which it
is a party, the parties, intending to be legally bound, agree as follows:

1. DEFINITIONS. Unless otherwise defined herein, (a) any terms used in this
Agreement that are defined in the Code shall be construed as set forth in the
Code, (b) capitalized terms or matters of construction defined or established in
the Purchase Agreement shall be applied herein as defined or established
therein, and (c) the following terms shall have the respective meanings set
forth below:

      "AGREEMENTS" means all contracts, undertakings or agreements (other than
rights evidenced by chattel paper, documents or instruments) in or under which
the Company may now or hereafter have any right, title or interest, including,
but not limited to, any agreements relating to the terms of payment or the terms
of performance of any account.

      "CASH EQUIVALENTS" means (a) direct obligations of the United States of
America (including, but not limited to, obligations issued or held in book-entry
form on the books of the Department of the Treasury of the United States of
America) or obligations the timely payment of the principal of and interest on
which are fully guaranteed by the United States of America, all of which mature
within three months from the date of acquisition thereof; (b) interest-bearing
demand or time deposits that mature no more than 30 days from the date of
creation thereof and that are either (i) insured by the Federal Deposit
Insurance Corporation, or (ii) held in any United States commercial bank having
general obligations rated at least "AA" or equivalent by Standard & Poor's
Corporation or Moody's Investors Service and having capital and surplus of at
least $500,000,000 or the equivalent; and (c) certificates of deposit that
mature no more than 30 days from the date of creation thereof and that are
either (i) insured by the Federal Deposit Insurance Corporation, or (ii) held in
any United States bank having general obligations rated at least "AA" or
equivalent by Standard & Poor's Corporation or Moody's Investors Service and
having capital and surplus of at least $500,000,000 or the equivalent.
<PAGE>

      "CHARGE" means any federal, state, county, city, municipal, local, foreign
or other governmental tax at the time due and payable, levy, assessment, charge,
lien, claim or encumbrance upon or relating to: (i) the Collateral; (ii) the
Obligations; (iii) the employees, payroll, income or gross receipts of the
Company; (iv) the ownership or use of any of the assets of the Company; or (v)
any other aspect of the business of the Company.

      "CODE" means the Uniform Commercial Code as it may, from time to time, be
in effect in the State of California; provided, that if, by reason of mandatory
provisions of law, any or all of the attachment, perfection or priority of, or
the remedies with respect to, Purchaser's security interest in any Collateral,
by virtue of California Commercial Code Section 9306 or otherwise, is governed
by the Uniform Commercial Code as in effect in a jurisdiction other than the
State of California, the term "CODE" means the Uniform Commercial Code as in
effect in those other jurisdiction for purposes of the provisions of this
Agreement or any other Related Agreements, relating to the attachment,
perfection, priority or remedies and for purposes of the definitions related to
those provisions.

      "COLLATERAL" has the meaning specified in Section 2.1.

      "COMMISSION" means the United States Securities and Exchange Commission.

      "DEFAULT" means any failure to pay any amount of principal or interest on
the Notes when due.

      "GOODWILL" means all goodwill, trade secrets, proprietary or confidential
information, technical information, proprietary software and computer source
code, procedures, formulae, quality control standards, designs, operating and
training manuals, customer lists, client databases, candidate databases,
distribution agreements and general intangibles now owned or hereafter acquired
by the Company.

      "GOVERNMENTAL AUTHORITY" means any nation or government, any state or
other political subdivision thereof, and any agency, department or other entity
exercising executive, legislative, judicial, regulatory or administrative
functions of or pertaining to government.

      "LEASES" means all of those leasehold estates in real property now owned
or hereafter acquired by the Company, as lessee.

                                      -2-
<PAGE>

      "LIEN" and "LIENS" means any mortgage or deed of trust, pledge,
hypothecation, assignment, deposit arrangement, lien (including, but not limited
to, judgment liens, liens of mechanics, suppliers and other Persons for the
provision of goods or services, and all other liens arising under statute,
common law or judicial interpretation), liens securing any Charge, claim
(including, but not limited to, reclamation claims), security interest, easement
or encumbrance, preference, priority or other security agreement or other
preferential arrangement of any kind or nature whatsoever intended or having the
effect of providing security for an obligation (including, but not limited to,
any lease or title retention agreement, any financing lease having substantially
the same economic effect as any of the foregoing, and the filing of, or
agreement to give, any financing statement perfecting a security interest under
the Code or comparable law of any jurisdiction).

      "NOTES" means, collectively, the 5% Secured Convertible Promissory Note in
the original principal amount of $500,000 and the 7.25% Secured Promissory Note
in the original principal amount of $10,000,000 issued by the Company and sold
and delivered to Purchaser.

      "OBLIGATIONS" means all loans, advances, debts, guarantees, liabilities,
and obligations, for monetary amounts (whether or not such amounts are
liquidated or determinable) owing by the Company to Purchaser, and all covenants
and duties regarding those amounts, of any kind or nature, present or future,
contingent or liquidated, whether or not evidenced by any note, agreement or
other instrument, the payment or performance of which is provided for or arises
now or hereafter under the Purchase Agreement or any Related Agreement,
including, but not limited to, all interest, fees, charges, expenses, attorneys'
fees and any other sum chargeable to the Company thereunder.

      "PURCHASE AGREEMENT" has the meaning set forth in Recital A.

      "PURCHASER" means Kali Chaudhuri, M.D., and, in if all or any part of the
Obligations is transferred, endorsed or assigned by Purchaser to any Person or
Persons, "PURCHASER" shall be deemed to refer equally to that Person or Persons.

      "RELATED AGREEMENT" means the Notes, this Agreement and the Employment
Side Bar Agreement attached as Exhibit C to the Purchase Agreement.

      "STOCK" means all shares, options, warrants, general or limited
partnership interests, membership interests, participations or other equivalents
(regardless of how designated) of or in a corporation, partnership, limited
liability company or equivalent entity, whether voting or nonvoting, including,
but not limited to, common stock, preferred stock, or any other "equity
security" (as that term is defined in Rule 3a11-1 of the General Rules and
Regulations promulgated by the Commission under the Securities Exchange Act of
1934).

2. COLLATERAL.

      2.1 GRANT; DESCRIPTION OF COLLATERAL. To secure the prompt and complete
payment, performance and observance of all of the Obligations, and to induce
Purchaser to enter into the Purchase Agreement and to purchase the Notes as
provided for therein in accordance with the respective terms thereof, the
Company hereby pledges and grants to Purchaser a security interest in all of the
Company's right, title and interest in, to and under all of its assets, whether
now owned or hereafter acquired or arising (including, but not limited to, under
any trade names, styles or divisions thereof), and whether owned or consigned by
or to or leased by or to the Company, and regardless of where located (all of
which being hereinafter collectively referred to as the "COLLATERAL"),
including, without limitation, the following:

                                      -3-
<PAGE>

            (a)   accounts;

            (b)   agreements;

            (c)   chattel paper;

            (d)   documents;

            (e)   equipment;

            (f)   fixtures;

            (g)   general intangibles;

            (h)   instruments;

            (i)   inventory;

            (j)   leases;

            (k)   shares of Stock;

            (l)   goods, cash, Cash Equivalents, and personal property, whether
                  tangible or intangible;

            (m)   all books and records (including, but not limited to, customer
                  lists, credit files, computer programs, printouts,
                  manufacturing processes and other computer materials and
                  records) pertaining to any of the foregoing; and

            (n)   to the extent not otherwise included, all proceeds of the
                  items set forth in (a) through (m) above, inclusive, and all
                  accessions to, substitutions and replacements for, and rents,
                  profits and products of, each of the items set forth in (a)
                  through (m) above, inclusive.

      2.2 COLLATERAL HELD BY PURCHASER. The Collateral includes any of the
Company's property held by Purchaser, including, but not limited to, all
property of every description now or hereafter in the possession or custody of,
or in transit to, Purchaser, for any purpose, including, but not limited to, for
safekeeping, collection or pledge, for the account of the Company, or as to
which the Company may have any right or power.

                                      -4-
<PAGE>

      2.3 SECURITY INTEREST ABSOLUTE. All rights and security interests of
Purchaser in the Collateral shall be absolute and unconditional, irrespective
of: (i) any lack of validity or enforceability of any of the Obligations or any
other agreement or instrument relating thereto; (ii) any change in the time,
manner or place of payment of, or in any other term of, all or any of the
Obligations, or any other amendment or waiver of or any consent to any departure
from terms of the Notes; (iii) any exchange, release or non-perfection of any
Collateral for all or any of the Obligations; or (iv) any other circumstance
which might otherwise constitute a defense available to the Company, or a
discharge of the Company's obligations, with respect to the validity or
enforceability of a security interest to the Collateral.

      2.4 AUTHORIZATION. The Company hereby authorizes Purchaser to file
financing statements describing the Collateral in the State of California and in
any other jurisdictions Purchaser deems necessary in order to perfect its
security interest in the Collateral, and agrees that a carbon, photographic,
photostatic or electronic or other reproduction of this Agreement or of a
financing statement is sufficient as a financing statement.

      2.5 NEGOTIABLE COLLATERAL. To the extent not already in Purchaser's
possession, the Company shall, immediately upon written request therefor from
Purchaser, endorse and chattel paper and negotiable instruments over to
Purchaser and deliver actual physical possession of the chattel paper and
negotiable instruments to Purchaser.

      2.6 COOPERATION AND CONTROL. The Company shall cooperate with Purchaser in
(a) notifying any third parties who are in possession of any Collateral of
Purchaser's security interest, (b) obtaining an acknowledgment from the third
party that it is holding the Collateral for the benefit of Purchaser and (c)
obtaining control with respect to collateral consisting of (i) deposit accounts,
(ii) investment property, (iii) letter of credit rights and (iv) electronic
chattel paper.

3. PURCHASER'S RIGHTS; LIMITATIONS ON PURCHASER'S OBLIGATIONS.

      3.1 THIRD PARTY NOTIFICATION. Upon the occurrence and during the
continuation of a Default, Purchaser may notify (and the Company shall, if
requested by Purchaser, notify) account debtors, parties to the Agreements,
obligors in respect of instruments, and obligors in respect of chattel paper,
that the accounts and the right, title and interest of the Company in and under
the Agreements, instruments, and chattel paper have been assigned to Purchaser
and that payments shall be made directly to Purchaser.

      3.2 ACCOUNT VERIFICATION. Subject to the following sentence, upon prior
notice to the Company (unless a Default has occurred and is continuing in which
case no notice is necessary), Purchaser shall have the right, at the Company's
expense, no more than twice in any 12-month period (unless a Default has
occurred and is continuing in which case no such limitation shall be in effect)
to make test verifications of the accounts and physical verifications and
appraisals of any other Collateral in any manner and through any medium that
Purchaser considers advisable, and the Company agrees to furnish all such
assistance and information as Purchaser may require in connection therewith.
Purchaser may at any time in Purchaser's own name communicate with account
debtors, parties to Agreements, obligors in respect of instruments and obligors
in respect of chattel paper to verify with those Persons, to Purchaser's
satisfaction, the existence, amount and terms of any accounts, agreements,
instruments or chattel paper. The Company, at its own expense, shall cause its
independent certified public accountants to deliver to Purchaser the results of
any confirmation of all or any portion of the accounts and any physical
verifications and reconciliations of all or any portion of the other Collateral
made or observed by the accountants when and if any confirmation, verification
or reconciliation is conducted in connection with annual audit procedures. Upon
the occurrence of a Default, the Company, promptly upon Purchaser's request, at
the Company's own expense, shall prepare and deliver to Purchaser the following
reports: (a) an aged receivable trial balance; (b) test verifications of such
accounts as Purchaser may request; (c) a schedule of all inventory; (d) a
schedule of all equipment; (e) a schedule of all Leases; and (f) a schedule of
all Indebtedness, including, but not limited to, purchase money indebtedness.

                                      -5-
<PAGE>

4. REPRESENTATIONS AND WARRANTIES. The Company hereby represents and warrants to
Purchaser that:

      4.1 OWNERSHIP OF COLLATERAL. Except for the Lien granted to Purchaser
under this Agreement, the Company is the sole owner of its interest in each item
of the Collateral in which it purports to grant a security interest hereunder,
having good and marketable title thereto free and clear of any and all Liens.

      4.2 FILINGS. Except with respect to the Lien granted to Purchaser under
this Agreement, no effective security agreement, financing statement, equivalent
security or lien instrument or continuation statement covering all or any part
of the Collateral is on file or of record in any public office.

      4.3 LIENS. Purchaser has a valid and continuing Lien upon the Collateral,
which Lien (a) is a first priority Lien, and (b) is enforceable as such as
against creditors of, and purchasers from, the Company and as against any
purchaser of real property where any of the fixtures or equipment are located
and any future creditor obtaining a Lien on such real property. All necessary
legal action has been taken to (i) establish and perfect Purchaser's Lien in
each item of the Collateral (other than items of Collateral for which
Purchaser's Lien may be perfected only by possession thereof and which are in
the possession of the Senior Lender or which the Senior Lender requires the
Company to retain possession), and (ii) entitle Purchaser to exercise the rights
and remedies provided in each of this Agreement, the Intellectual Property
Assignment, the Purchase Agreement, any Related Agreements and the Code. The
Company shall not at any time take any action which shall cause this Section 4.3
to become not true and correct, and the Company shall at all times take all
action necessary to cause this Section 4.3 to remain true and correct. If, at
any time, there are Liens on any Collateral, the Company shall use its best
efforts to remove the conflicting Liens within 60 days thereafter and, in any
event, shall remove the conflicting Liens within 90 days thereafter.

      4.4 NAME; LOCATIONS OF COLLATERAL. The Company's exact legal name is
"Integrated Healthcare Holdings, Inc." The Company's chief executive office,
principal place of business, other offices, and premises within which any
Collateral is stored or located, and the location of all of its records
concerning the Collateral are at the address set forth on the first page hereof.
The Company shall not change the state where it is located (as that term is used
in Section 9307 of the Code), its chief executive office, principal place of
business, any of its other offices, or the location of its records concerning
the Collateral, without giving 30 days' prior written notice thereof to
Purchaser and taking all actions which Purchaser instructs the Company are
necessary or appropriate to continuously protect and perfect Purchaser's Lien
upon the Collateral.

                                      -6-
<PAGE>

      4.5 INSTRUMENTS. All action necessary to protect and perfect the Lien of
Purchaser in each instrument which is part of the Collarteral has been duly
taken. The Lien of Purchaser in the instruments which are part of the Collateral
is a first priority Lien and is enforceable as such against creditors of and
purchasers from the Company. The Company shall not at any time take any action
which shall cause this Section 4.5 to become not true and correct, and the
Company shall at all times take all action necessary to cause this Section 4.5
to remain true and correct.

      4.6 SURVIVAL OF REPRESENTATIONS AND WARRANTIES. The representations and
warranties set forth in this Section 4 shall survive the execution and delivery
of this Agreement.

5. COVENANTS. The Company covenants and agrees with Purchaser that, from and
after the date of this Agreement and until the date on which all Obligations
shall have been indefeasibly paid in full:

      5.1 FURTHER ASSURANCES. At any time and from time to time, upon the
request of Purchaser and at the sole expense of the Company, the Company shall
promptly and duly execute and deliver any and all such further instruments and
documents and take such further action as Purchaser may reasonably deem
necessary to obtain the full benefits of this Agreement and of the rights and
powers herein granted, including, but not limited to: (a) securing all consents
and approvals necessary or appropriate for the assignment to or for the benefit
of Purchaser of any Agreement held by the Company or in which the Company has
any rights not heretofore assigned; (b) filing any financing or continuation
statements under the Code with respect to the Lien granted hereunder; (c)
transferring Collateral to Purchaser's possession (if the Collateral consists of
chattel paper or if a Lien on the Collateral can be perfected only by
possession, or if otherwise requested by Purchaser); (d) placing the interest of
Purchaser as lienholder on the certificate of title of any vehicle owned by the
Company; and (e) obtaining waivers, in form and substance satisfactory to
Purchaser, of Liens from landlords and mortgagees. The Company also hereby
authorizes Purchaser to file any such financing or continuation statement
without the signature of the Company to the extent permitted by applicable law.
Purchaser shall, upon request, provide the Company with photocopies of all such
filings at the Company's expense. If any amount payable under or in connection
with any of the Collateral is or shall become evidenced by any Instrument, such
Instrument, other than checks received in the ordinary course of business, shall
be duly endorsed in a manner satisfactory to Purchaser immediately upon the
Company's receipt thereof and promptly delivered to Purchaser.

      5.2 BOOKS AND RECORDS. The Company shall keep and maintain, at its own
cost and expense, satisfactory and complete records of the Collateral,
including, but not limited to, a record of any and all payments received and any
and all credits granted with respect to the Collateral and all other dealings
with the Collateral. The Company shall mark its books and records pertaining to
the Collateral to evidence this Agreement and the Lien granted hereby. All
chattel paper (including any chattel paper created by the Company or any of its
Subsidiaries after the date hereof) shall be marked with the following legend:

            "This writing and the obligations evidenced or secured hereby are
      subject to the security interest of Kali Chaudhuri, M.D."

                                      -7-
<PAGE>

Upon the occurrence and during the continuation of a Default, the Company shall
deliver and turn over all of its books and records pertaining to the Collateral
to Purchaser or to Purchaser's representatives at any time on demand of
Purchaser. Prior to the occurrence of a Default, upon prior notice from
Purchaser, the Company shall permit any representative of Purchaser to inspect
the books and records and shall provide photocopies thereof to Purchaser at the
Company's expense.

      5.3 CORPORATE IDENTITY. The Company shall not change its name, identity or
corporate structure in any manner that might make any financing or continuation
statement filed in connection herewith seriously misleading within the meaning
of Section 9506 of the Code or any other applicable provision of the Code unless
it has given Purchaser at least 30 days' prior written notice thereof and has
taken all action (or made arrangements satisfactory to Purchaser, at the
Company's expense, to take the action substantially simultaneously with the
change if it is impossible to take the action in advance) necessary or requested
by Purchaser to amend the financing statement or continuation statement so that
it is not seriously misleading.

      5.4 FIXTURES AND EQUIPMENT. The Company shall keep and maintain the
fixtures and equipment in good operating condition sufficient for the
continuation of the business conducted by it on a basis consistent with past
practices, and the Company shall provide or arrange for all maintenance and
service and all repairs necessary for such purpose.

      5.5 COLLATERAL TRANSFER, REMOVAL OR SALE. The Company shall not, without
the prior written consent of Purchaser, sell, assign, transfer or otherwise
dispose of any Collateral, other than in the ordinary course of business,
consistent with past practices and in a manner consistent with the best
interests of the Company and its shareholders.

6. PURCHASER'S APPOINTMENT AS ATTORNEY-IN-FACT.

      6.1 APPOINTMENT; POWERS. The Company hereby irrevocably constitutes and
appoints Purchaser and any officer or agent thereof, with full power of
substitution, as its true and lawful attorney-in-fact with full irrevocable
power and authority in the place and stead of the Company and in the name of the
Company or in its own name, from time to time in Purchaser's discretion, for the
purpose of carrying out the terms of this Agreement, to take any and all
appropriate action and to execute and deliver any and all documents and
instruments which may be necessary to accomplish the purposes of this Agreement
and, without limiting the generality of the foregoing, hereby grants to
Purchaser the power and right, on behalf of the Company, without notice to or
assent by the Company, upon the occurrence and during the continuation of a
Default (except as otherwise provided below), to do the following, all at the
Company's expense:

            (a) regardless of whether a Default has occurred or is continuing,
      continue any insurance policies existing pursuant to the terms of this
      Agreement or maintained pursuant to the terms of the Purchase Agreement
      and pay all or any part of the premiums therefor and the costs thereof;

                                      -8-
<PAGE>

            (b) in the name of the Company, in its own name or otherwise, take
      possession of, endorse and receive payment of any checks, drafts, notes,
      acceptances, or other Instruments for the payment of monies due under any
      Collateral;

            (c) receive payment of any and all monies, claims and other amounts
      due or to become due at any time arising out of or in respect of any
      Collateral;

            (d) ask, demand, collect, receive and give acquittances and receipts
      for any and all money due or to become due under any Collateral;

            (e) pay or discharge any charges or Liens levied or placed on or
      threatened against the Collateral;

            (f) effect any repairs or obtain any insurance called for by the
      terms of the Purchase Agreement and pay all or any part of the premiums
      therefor and costs thereof;

            (g) direct any party liable for any payment under or in respect of
      any of the Collateral to make payment of any and all monies due or to
      become due thereunder, directly to Purchaser or as Purchaser shall direct;

            (h) sign and endorse any invoices, freight or express bills, bills
      of lading, storage or warehouse receipts, drafts against account debtors,
      assignments, verifications and notices in connection with accounts and
      other documents constituting or related to the Collateral;

            (i) settle, compromise or adjust any suit, action or proceeding
      described in this Section 6.1 and, in connection therewith, give
      discharges or releases as Purchaser deems appropriate;

            (j) file any claim or take or commence any other action or
      proceeding in any court of law or equity or otherwise deemed appropriate
      by Purchaser for the purpose of collecting any and all such monies due
      under any Collateral whenever payable;

            (k) commence and prosecute any suits, actions or proceedings at law
      or in equity in any court to collect the Collateral or any part thereof
      and to enforce any other right in respect of any Collateral;

            (l) defend any suit, action or proceeding brought against the
      Company with respect to any Collateral if the Company does not defend the
      suit, action or proceeding or if Purchaser believes that the Company is
      not pursuing the defense in a manner that will minimize the loss with
      respect to the Collateral and Purchaser's security interest therein; and

            (m) sell, transfer, pledge, make any agreement with respect to, or
      otherwise deal with any of the Collateral as fully and completely as
      though Purchaser were the absolute owner thereof for all purposes, and to
      do, at Purchaser's option, at any time or from time to time, all acts and
      other things that Purchaser deems necessary to perfect, preserve or
      realize upon the Collateral and Purchaser's Lien therein in order to
      effect the intent of this Agreement, all as fully and effectively as the
      Company might do.

                                      -9-
<PAGE>

      6.2 RATIFICATION. The Company hereby ratifies, to the extent permitted by
law, all that said attorneys shall lawfully do or cause to be done by virtue
hereof. The power of attorney granted pursuant to this Section 6 is a power
coupled with an interest and shall be irrevocable until all Obligations shall
have been indefeasibly paid in full.

      6.3 DUTIES AND LIABILITIES. The powers conferred on Purchaser hereunder
are solely to protect Purchaser's interests in the Collateral and shall not
impose any duty upon it to exercise any such powers. Purchaser shall be
accountable only for amounts that it actually receives as a result of the
exercise of those powers and neither Purchaser nor any of its officers,
directors, partners, employees, agents or representatives shall be responsible
or liable to the Company for any act or failure to act.

      6.4 COMMUNICATION WITH THIRD PARTIES; SALE OF COLLATERAL. The Company also
authorizes Purchaser, at any time and from time to time, upon prior written
notice and receipt of the Company's consent (unless a Default or an Event of
Default has occurred and is continuing, in which case no notice or consent shall
be necessary) to (a) communicate in Purchaser's own name with any party to any
Agreement or account with regard to the assignment of the right, title and
interest of the Company in and under the Agreement or account and other matters
relating thereto, and (b) execute, in connection with the sale provided for in
Section 8, any endorsements, assignments or other instruments of conveyance or
transfer with respect to the Collateral.

7. PERFORMANCE BY PURCHASER OF THE COMPANY'S OBLIGATIONS. If the Company fails
to perform or comply with any of its agreements contained herein or in the
Purchase Agreement or any Related Agreement and Purchaser, as provided for by
the terms of this Agreement or the Purchase Agreement or any Related Agreement,
shall itself perform or comply, or otherwise cause performance of or compliance
with that agreement, then the expenses (including, but not limited to,
attorneys' fees) of Purchaser incurred in connection with that performance or
compliance, together with applicable interest thereon at the rate then in effect
in accordance with the terms of the Notes, shall be payable by the Company to
Purchaser on demand and shall constitute Obligations secured hereby.

8. REMEDIES; RIGHTS UPON DEFAULT.

      8.1 RIGHTS REGARDING COLLATERAL. If any Default occurs and continues,
Purchaser may exercise, in addition to all other rights and remedies granted to
him under the Purchase Agreement, this Agreement, any other Related Agreement or
any other instrument or agreement securing, evidencing or relating to the
Obligations, all rights and remedies of a secured party under the Code. Without
limiting the generality of the foregoing, the Company expressly agrees that in
that event Purchaser may, without demand of performance or other demand,
advertisement or notice of any kind (except the notice specified below of time
and place of public or private sale) to or upon the Company or any other Person
(all and each of which demands, advertisements and notices are hereby expressly
waived to the maximum extent permitted by the Code and other applicable law),
enter upon the premises of the Company where any Collateral is located through
self-help, without judicial process, without first obtaining a final judgment or
giving the Company notice and opportunity for a hearing on Purchaser's claim or
action, and without paying rent to the Company, and collect, receive, assemble,
process, appropriate and realize upon the Collateral, or any part thereof, and
may immediately sell, lease, assign, give an option or options to purchase, or
sell or otherwise dispose of and deliver the Collateral (or contract to do so),
or any part thereof, in one or more parcels at public or private sale or sales
or at any exchange, at prices it deems best, for cash or on credit or for future
delivery without assumption of any credit risk. Purchaser shall have the right
at any public sale or sales and, to the extent permitted by law, at any private
sale or sales, to purchase for the benefit of Purchaser the whole or any part of
the Collateral so sold, free of any right or equity of redemption, which equity
of redemption the Company hereby releases. The sales may be adjourned or
continued from time to time with or without notice. Purchaser shall have the
right to conduct the sales on the Company's premises or elsewhere and shall have
the right to use the Company's premises without charge for the sales for such
time or times as Purchaser deems necessary or advisable. Purchaser shall give
notice of any disposition of the Collateral in accordance with the provisions of
Sections 9610 through 9613 of the Code.

                                      -10-
<PAGE>

         The Company further agrees, if a Default has occurred and continues, at
Purchaser's request, to assemble the Collateral and make it available to
Purchaser at places which Purchaser shall select, whether at the Company's
premises or elsewhere. Until Purchaser is able to effect a sale, lease, or other
disposition of any Collateral, Purchaser shall have the right to use or operate
the Collateral, or any part thereof, to the extent that it deems appropriate for
the purpose of preserving the Collateral or its value or for any other purpose
deemed appropriate by Purchaser. Purchaser shall have no obligation to the
Company to take any action to maintain or preserve the rights of the Company as
against third parties with respect to any Collateral while the Collateral is in
the possession of Purchaser. Purchaser may, if it so elects, seek the
appointment of a receiver or keeper to take possession of Collateral and to
enforce any of Purchaser's remedies with respect to such appointment without
prior notice or hearing. Purchaser shall apply the net proceeds of any
collection, recovery, receipt, appropriation, realization or sale, as provided
in Section 9. The Company shall remain liable for any deficiency remaining
unpaid after the application, and only after so paying over the net proceeds and
after the payment by Purchaser of any other amount required by any provision of
law, including, but not limited to, Section 9608 of the Code (but only after
Purchaser has received what Purchaser considers reasonable proof of a
subordinate party's Lien), need Purchaser account for the surplus, if any, to
the Company. To the maximum extent permitted by applicable law, the Company
waives all claims, damages, and demands against Purchaser arising out of the
repossession, retention or sale of the Collateral. The Company agrees that five
days' prior notice by Purchaser to it of the time and place of any public sale
or of the time after which a private sale may take place is reasonable
notification. The Company shall remain liable for (a) any deficiency if the
proceeds of any sale or disposition of the Collateral are insufficient to pay
all amounts to which Purchaser is entitled, and (b) any and all costs and
expenses incurred by Purchaser, including, but not limited to, attorneys' fees,
to collect the deficiency.

      8.2 FEES. The Company agrees to pay any and all expenses of Purchaser
(including, but not limited to, attorneys' fees and appraisal costs) incurred in
connection with the enforcement of any of its rights and remedies hereunder.

                                      -11-
<PAGE>

      8.3 WAIVER. Except as otherwise specifically provided herein, (to the
maximum extent permitted by applicable law), the Company hereby waives
presentment, demand, protest or any notice of any kind in connection with this
Agreement or any Collateral.

9. APPLICATION OF PROCEEDS. The Proceeds of any sale, disposition or other
realization upon all or any part of the Collateral shall be distributed by
Purchaser upon receipt, in the following order of priorities:

            (a) first, to Purchaser in an amount sufficient to pay in full the
      expenses of Purchaser in connection with such sale, disposition or other
      realization, including, but not limited to, all expenses, liabilities and
      advances incurred or made by Purchaser in connection therewith, including,
      but not limited to, attorneys' fees;

            (b) second, to Purchaser to be applied, first, to all accrued but
      unpaid interest on, and, second, to all principal of, the Notes;

            (c) third, to all other Obligations; and

            (d) finally, upon payment in full of all of the Obligations, to the
      Company or its representatives or to whomsoever may be lawfully entitled
      to receive the same, or as a court of competent jurisdiction may direct.

10. LIMITATION ON PURCHASER'S DUTY IN RESPECT OF COLLATERAL. Purchaser shall use
reasonable care with respect to the Collateral in its possession or under its
control. Purchaser shall not have any other duty as to any Collateral in its
possession or control or in the possession or control of any agent or nominee of
Purchaser, or any income thereon or as to the preservation of rights against
prior parties or any other rights pertaining thereto. Upon request of the
Company, Purchaser shall account for any monies received by Purchaser in respect
of any foreclosure on or disposition of the Collateral.

11. REINSTATEMENT. This Agreement shall remain in full force and effect and
continue to be effective should any petition be filed by or against the Company
for liquidation or reorganization, should the Company become insolvent or make
an assignment for the benefit of creditors, or should a receiver or trustee be
appointed for all or any significant part of the Company's assets, and shall
continue to be effective or be reinstated, as the case may be, if at any time
payment and performance of the Obligations, or any part thereof, is, pursuant to
applicable law, rescinded or reduced in amount, or must otherwise be restored or
returned by any obligee of the Obligations, whether as a "voidable preference,"
"fraudulent transfer" or otherwise, all as though the payment or performance had
not been made. If any payment, or any part thereof, is rescinded, reduced,
restored or returned, the Obligations shall be reinstated and deemed reduced
only by the amount paid and not so rescinded, reduced, restored or returned.

12. NOTICES. Except as otherwise provided herein, whenever it is provided herein
that any notice, demand, request, consent, approval, declaration or other
communication shall or may be given to or served upon any of the parties by any
other party, or whenever either of the parties desires to give or serve upon any
other party any communication with respect to this Agreement, each notice,
demand, request, consent, approval, declaration or other communication shall be
in writing and given in the manner provided for in Section 6.12 of the Purchase
Agreement.

                                      -12-
<PAGE>

13. SEVERABILITY. Any provision of this Agreement which is prohibited or
unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective
to the extent of the prohibition or unenforceability without invalidating the
remaining provisions hereof, and any prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable the provision in any
other jurisdiction. This Agreement is to be read, construed and applied together
with the Purchase Agreement and the Related Agreements which, taken together,
set forth the complete understanding and agreement of Purchaser and the Company
with respect to the matters referred to herein and therein.

14. NO WAIVER; CUMULATIVE REMEDIES. Purchaser shall not, by any act, delay,
omission or otherwise, be deemed to have waived any of its rights or remedies
hereunder, and no waiver shall be valid unless in writing, signed by Purchaser
and then only to the extent therein set forth. A waiver by Purchaser of any
right or remedy hereunder on any one occasion shall not be construed as a bar to
any right or remedy which Purchaser would otherwise have on any future occasion.
Neither Purchaser's failure to exercise, nor any delay in exercising, any right,
power or privilege hereunder, shall operate as a waiver thereof, nor shall any
single or partial exercise of any right, power or privilege hereunder preclude
any other or future exercise thereof or the exercise of any other right, power
or privilege. The rights and remedies hereunder provided are cumulative and may
be exercised singly or concurrently, and are not exclusive of any rights and
remedies provided by law. None of the terms or provisions of this Agreement may
be waived, altered, modified or amended except by a written instrument duly
executed by Purchaser and the Company.

15. LIMITATION BY LAW. All rights, remedies and powers provided in this
Agreement may be exercised only to the extent that the exercise thereof does not
violate any applicable provision of law, and all the provisions of this
Agreement are intended to be (i) subject to all applicable mandatory provisions
of law that may be controlling and (ii) limited to the extent necessary so that
they do not render this Agreement invalid or unenforceable, in whole or in part,
or not entitled to be recorded, registered, or filed under the provisions of any
applicable law.

16. TERMINATION OF THIS AGREEMENT. Subject to Section 11, this Agreement shall
terminate upon the date on which all Obligations have been paid in full. For
purposes of this Section 16, all Obligations shall be deemed to have been paid
in full when (i) the Company has fully satisfied its obligations with respect to
the payment of all principal, premium, interest and other amounts which are or
may become due and payable under the Notes; and (ii) the Company has fully
satisfied its obligations with respect to the payment of all accrued and unpaid
expenses (including expense reimbursements) and fees then payable by the Company
to Purchaser under the Purchase Agreement and this Agreement. Once Purchaser is
satisfied that all Obligations have been paid in full and Purchaser does not
believe that reinstatement of the Obligations pursuant to Section 11 is
possible, Purchaser shall prepare, execute and deliver Code termination
statement(s) to the Company to be filed with the Secretary of State of the State
of Nevada.

                                      -13-
<PAGE>

17. SUCCESSORS AND ASSIGNS. This Agreement and all obligations of the Company
hereunder shall be binding upon the successors and assigns of the Company and,
together with the rights and remedies of Purchaser hereunder, shall inure to the
benefit of Purchaser, all future holders of any instrument evidencing any of the
Obligations, and their respective successors and assigns. No sales of
participations, other sales, assignments, transfers or other dispositions of any
agreement governing or instrument evidencing any of the Obligations or any
portion thereof or interest therein shall in any manner affect the Lien granted
to Purchaser hereunder.

18. ENFORCEMENT. If the Company fails to observe or perform any covenant or
agreement to be observed or performed under this Agreement, Purchaser may
proceed to protect and enforce its rights by suit in equity or action at law,
whether for specific performance of any term contained in this Agreement or for
an injunction against the breach of any term or in aid of the exercise of any
power granted in this Agreement or to enforce any other legal or equitable right
of Purchaser, or to take any one or more actions. The Company shall pay all
fees, costs, and expenses, including without limitation, fees and expenses of
attorneys, accountants and other experts retained by Purchaser, and all fees,
costs and expenses of appeals incurred or expended by Purchaser in connection
with the enforcement of this Agreement or the collection of any sums due
hereunder, whether or not suit is commenced, unless and to the extent that the
Company prevails in any action, suit or proceeding initiated by Purchaser which
a court of competent jurisdiction determines was initiated or maintained by
Purchaser in bad faith. None of the rights, powers or remedies conferred under
this Agreement shall be mutually exclusive, and each right, power or remedy
shall be cumulative and in addition to any other right, power or remedy whether
conferred by this Agreement or now or hereafter available at law, in equity, by
statute or otherwise.

19. DESCRIPTIVE HEADINGS. The descriptive headings of the several paragraphs of
this Agreement are for convenience of reference only and do not constitute a
part of this Agreement and are not to be considered in construing or
interpreting this Agreement.

20. GOVERNING LAW. In all respects, including all matters of construction,
validity and performance, this Agreement and the rights and obligations arising
hereunder shall be governed by, and construed and enforced in accordance with,
the laws of the State of California applicable to contracts made and performed
in such state, without regard to principles thereof regarding conflicts.

21. WAIVER OF JURY TRIAL. BECAUSE DISPUTES ARISING IN CONNECTION WITH COMPLEX
FINANCIAL TRANSACTIONS ARE MOST QUICKLY AND ECONOMICALLY RESOLVED BY AN
EXPERIENCED AND EXPERT PERSON AND THE PARTIES WISH APPLICABLE STATE AND FEDERAL
LAWS TO APPLY (RATHER THAN ARBITRATION RULES), THE PARTIES DESIRE THAT THEIR
DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH APPLICABLE LAWS. THEREFORE, TO
ACHIEVE THE BEST COMBINATION OF THE BENEFITS OF THE JUDICIAL SYSTEM AND OF
ARBITRATION, AND UNDERSTANDING THEY ARE WAIVING A CONSTITUTIONAL RIGHT, THE
PARTIES HERETO WAIVE ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, OR
PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE, WHETHER IN CONTRACT, TORT, OR
OTHERWISE, ARISING OUT OF, CONNECTED WITH, RELATED TO, OR INCIDENTAL TO, THIS
AGREEMENT, THE PURCHASE AGREEMENT AND/OR ANY RELATED AGREEMENT OR THE
TRANSACTIONS COMPLETED HEREBY OR THEREBY.

                                      -14-
<PAGE>

      IN WITNESS WHEREOF, each of the parties hereto has caused this Security
Agreement to be executed and delivered by its duly authorized officer on the
date first set forth above.

                                        INTEGRATED HEALTHCARE HOLDINGS, INC.,
                                        a California corporation

                                        By: /s/ Larry Anderson
                                           -------------------------------------
                                           Larry B. Anderson, President

                                        /s/ Kali Chaudhuri
                                        ----------------------------------------
                                        Kali Chaudhuri, M.D.

                                      -15-
<PAGE>

                                    EXHIBIT C
                          EMPLOYMENT SIDE BAR AGREEMENT
<PAGE>

                                    EXHIBIT D
                            FORM OF OPTION AGREEMENT
<PAGE>

THIS OPTION SHALL NOT BECOME EFFECTIVE UNTIL EXECUTED BY OPTIONOR AND DELIVERED
TO OPTIONEE AND OPTIONEE'S COMPLIANCE WITH ALL CONDITIONS THERETO. THE
SUBMISSION OF THIS FORM OF OPTION TO OPTIONEE BY OPTIONOR OR OPTIONOR'S AGENT
DOES NOT CONSTITUTE AN OFFER TO OPTION. NO EMPLOYEE OR AGENT OF OPTIONOR OR ANY
PERSON WITH WHOM OPTIONEE MAY HAVE NEGOTIATED THIS OPTION HAS ANY AUTHORITY TO
MODIFY THE TERMS HEREOF OR TO MAKE ANY AGREEMENTS, REPRESENTATIONS OR PROMISES
UNLESS SAME ARE CONTAINED HEREIN OR ADDED HERETO IN WRITING.

                                OPTION AGREEMENT

      THIS OPTION AGREEMENT (this "Agreement") is made this 28th day of
September, 2004, ("Grant Date") by and between INTEGRATED HEALTHCARE HOLDINGS,
INC., a Nevada corporation ("Optionor") and KALI CHAUDHURI, M.D. (or his
assignee or designee) ("Optionee").

                                R E C I T A L S:

      A. Optionor expects to acquire title to that certain real property located
in the cities of Santa Ana and Anaheim, County of Orange, State of California,
more particularly described in Exhibit A attached hereto (the "Property")

      B. Optionor is willing to grant Optionee an option to purchase the
Property subject to all of the terms, conditions and provisions of this
Agreement.

                                   ARTICLE I

                               OPTION TO PURCHASE

      1.1 Grant of Option. Optionor hereby grants to Optionee an option to
purchase the Property ("Option") for a purchase price consideration of
$5,000,000 ("Purchase Price") upon all of the terms, covenants and conditions
contained in the form of escrow instructions ("Escrow Instructions") attached
hereto as Exhibit B. The Option shall commence on the Grant Date and continue
for a period ending at 4:00 p.m. on the fifth anniversary of the closing of the
purchase of the Property by Optionor ("Option Period").

      1.2 Automatic Termination. If Optionee has not exercised the Option
pursuant to Article II, on or before 4:00 p.m. on the date of expiration of the
Option Period, this Option shall automatically terminate without notice to
Optionee, and all rights of Optionee under this Agreement shall then and there
cease.
<PAGE>

                                   ARTICLE II

                         EXERCISE OF OPTION TO PURCHASE

      If Optionee desires to exercise this Option and has performed all acts in
the time and manner as required by the terms hereof and this Option has not
otherwise terminated or expired, Optionee shall do so by delivering to Optionor
in accordance with Section 4.3 on or before the day which is 10 days prior to
the date on which the Option or any extension previously granted hereunder would
otherwise expire, three duplicate originals of the Escrow Instructions each
executed by Optionee. Optionor shall thereupon promptly execute the Escrow
Instructions and deposit one executed copy with the escrow holder named therein,
return one executed copy to Optionee and retain one executed copy for Optionor's
records. The date that the Escrow Instructions are executed and delivered by
Optionee to Optionor shall be the date inserted on the first page of the Escrow
Instructions.

                                  ARTICLE III

                        ENTRY AND IMPROVEMENT OF PROPERTY

      3.1 Entry for Investigation. Optionor hereby grants to Optionee a license
to enter upon any portion of the Property for the purpose of conducting
engineering surveys, investigations, soil tests and other studies. Optionee
agrees to indemnify and hold Optionor and the Property free from any and all
liability, claims, damage and expense (including but not limited to attorney's
fees) caused by or resulting from the exercise of said license. Such undertaking
of indemnity shall survive the exercise of the Option or the expiration thereof.
The limited license herein granted shall be co-extensive with the term of this
Option or any extension thereof.

                                   ARTICLE IV

                            MISCELLANEOUS PROVISIONS

      4.1 Memorandum of Option. Immediately following execution of this Option,
Optionor shall execute and file with the Orange County Recorder's office a
Memorandum of Option in form satisfactory to Optionee reflecting this Option and
Optionee's interest therein.

      4.2 Attorneys' Fees. In the event of any dispute between the parties
hereto involving the covenants or conditions contained in this Option or arising
out of the subject matter of this Option, the prevailing party shall be entitled
to recover reasonable expenses, attorneys' fees and costs.

      4.3 Notices. Unless otherwise provided for herein, any notice to be given
or other document to be delivered by either party to the other hereunder shall
be delivered in person to either party or may be deposited in the United States
mail in the State of California, by registered or certified mail, with postage
prepaid and addressed to the party to whom intended as follows:

                                      -2-
<PAGE>

         To Optionor:               Integrated Healthcare Holdings, Inc.
                                    695 Town Center Drive, Suite 260
                                    Costa Mesa, CA  92626
                                    Attention:  Chief Executive Officer

         To Optionee:               Kali Chaudhuri, M.D.
                                    c/o Strategic Global Management, Inc.
                                    6800 Indiana Avenue, Suite 130
                                    Riverside, CA  92506

      Either party hereto may from time to time, by written notice to the other,
designate a different address which shall be substituted for the one above.

      Notwithstanding anything to the contrary herein contained, any notices or
documents which may be delivered by mail pursuant to this Section 4.3 must be
actually received by the other party on the last business day immediately
preceding any deadline date specified in this Agreement.

      4.4 Entire Agreement and Inurement. This Agreement and other documents
incorporated herein by reference contain the entire agreement of the parties,
and all negotiations and agreements between the parties hereto or their agents
with respect to this transaction are merged in such instruments, which alone
express the parties' rights and obligations. All obligations herein contained
shall be binding upon and inure to the benefit of the parties hereto and their
respective successors, heirs, and assigns.

      4.5 Time of the Essence. It is understood and agreed that time is of the
essence for all performances herein contained.

      4.6 Modification. Any amendments or modifications to this Option or
attached Escrow Instructions must be in writing and executed by all of the
parties to this Agreement.

      4.7 Assignment. Optionee may not assign this Option, or any rights
hereunder, in whole or in part, without the prior written consent of Optionor,
which consent may be withheld at the sole discretion of Optionor. Optionor's
consent to an assignment by Optionee shall not relieve Optionee from its
obligations under this Agreement.

      4.8 Optionor's Cooperation and Delivery. Optionor agrees to reasonably
cooperate with Optionee in providing access to all documents in Optionor's
possession concerning the Property. All documents made available or provided by
Optionor to Optionee shall be delivered without representation or responsibility
of Optionor for the truth, accuracy or quality of material contained in such
documents. Such cooperation shall not, however, require Optionor to: (i) obtain
any documents not already in its possession, (ii) provide technical assistance
from persons, or (iii) expend any funds with respect to its cooperation with
Optionee.

      4.9 Authority to Execute. Each individual executing this Agreement on
behalf of a corporation represents and warrants that he or she is duly
authorized to execute and deliver this Agreement on behalf of such corporation,
in accordance with a duly adopted resolution of the board of directors of such
corporation, or in accordance with the by-laws of such corporation, and that
this Agreement is binding upon such corporation in accordance with its terms.

                                      -3-
<PAGE>

      4.10 Interpretation. This Agreement shall be construed according to its
fair meaning and as if prepared by both parties hereto. Titles and captions are
for convenience only and shall not constitute a portion of this Agreement. As
used in this Agreement, masculine, feminine or neuter gender and the singular or
plural number shall each be deemed to include the others wherever and whenever
the context so dictates.

      4.11 Governing Law. This Agreement shall be construed in accordance with
the laws of the State of California in effect at the time of the execution of
this Agreement. Any action brought in connection with this Agreement shall be
brought in a court of competent jurisdiction located in Orange County,
California.

      4.12 Condemnation. If all or any portion of the Property is taken or
designated to be taken by condemnation proceedings, or proceedings in lieu
thereof, prior to the exercise of the Option and if Optionee subsequently
exercises the Option pursuant to Article II, Optionee shall be entitled to all
condemnation proceeds upon consummation of the transaction, and the terms of
this Agreement shall remain unmodified. Optionor shall hold any such proceeds
until the close of the escrow contemplated by this Agreement for the Property.
Notwithstanding the foregoing, if Optionee does not exercise the Option pursuant
to Article II, Optionee shall have no claim or right to any such condemnation
proceeds or be entitled to any compensation whatsoever for any of Optionee's
rights under this Agreement.

      4.13 Severability. If any term, provision, condition or covenant of this
Agreement or the application thereof to any party or circumstances shall, to any
extent, be held invalid or unenforceable, the remainder of this Agreement, or
the application of such term, provision, condition or covenant to persons or
circumstances other than those as to whom or which it is held invalid or
unenforceable, shall not be affected thereby, and each term and provision of
this Agreement shall be valid and enforceable to the fullest extent permitted by
law.

      4.14 No Withholding Because Non-Foreign Seller. Optionor represents and
warrants to Optionee that Optionor is not, and as of any closing date for the
purchase of the Property, will not be a foreign person or entity within the
meaning of Section 1445 of the Internal Revenue Code and that it will deliver
through the escrow at closing a non-foreign affidavit in the form specified in
the Escrow Instructions pursuant to Section 1445(b)(2) of the Internal Revenue
Code and the Regulations promulgated thereunder

      4.15 No Waiver. No delay or omission by either party hereto in exercising
any right or power accruing upon the compliance or failure of performance by the
other party hereto under the provisions of this Agreement shall impair any such
right or power or be construed to be a waiver thereof. A waiver by either party
hereto of a breach of any of the covenants, conditions or agreements hereof to
be performed by the other party shall not be construed as a waiver of any
succeeding breach of the same or other covenants, agreements, restrictions or
conditions hereof.

      4.16 Exhibits. Exhibits A and B, attached hereto, are incorporated herein
by reference.

                                      -4-
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have executed this Option Agreement
the day and year first above written.

Signed by Optionor on:

September 29, 2004                        INTEGRATED HEALTHCARE HOLDINGS, INC.

                                          By:
                                             -----------------------------------
                                             Larry B. Anderson, President

                                                                      "Optionor"

Signed by Optionee on:
September 29, 2004                        --------------------------------------
                                          KALI CHAUDHURI, M.D.

                                                                      "Optionee"

                                      -5-
<PAGE>

                                    EXHIBIT A

                          LEGAL DESCRIPTION OF PROPERTY

                                    EXHIBIT A
                              TO OPTION AGREEMENT
<PAGE>

                                    EXHIBIT B

                         AGREEMENT FOR PURCHASE AND SALE
                    OF REAL PROPERTY AND ESCROW INSTRUCTIONS

                                                Escrow No. ___________

                                                Date of Opening
                                                of Escrow:  ______________, 200_

To:   TITLE INSURANCE COMPANY
      ("Escrow Holder")

      [ADDRESS]

      THIS AGREEMENT FOR PURCHASE AND SALE OF REAL PROPERTY AND ESCROW
INSTRUCTIONS (this "Agreement") is made this _____ day of _______________, 200_,
by and between INTEGRATED HEALTHCARE HOLDINGS, INC. ("Seller"), and
_____________________________________________ ("Buyer").

                                R E C I T A L S:

      A. Seller is the owner of that certain real property located in the cities
of Santa Ana and Anaheim, County of Orange, State of California, more
particularly described on Exhibit A (the "Property").

      B. Seller and Buyer have previously executed that certain Option Agreement
("Option Agreement") dated September 28, 2004, the terms of which are
incorporated herein by this reference. A copy of the Option Agreement shall be
delivered to ("Escrow Holder") on request. By execution of this Agreement and
delivery of other specified performances, Buyer has exercised its option to
purchase the Property.

      NOW, THEREFORE, the parties hereto agree as follows:

TERMS AND CONDITIONS

1.    PURCHASE AND SALE OF PROPERTY.

      Buyer hereby agrees to purchase from Seller, and Seller agrees to sell to
Buyer the Property, upon the terms and conditions hereinafter set forth.

2.    OPENING OF ESCROW.

      Within one business day after the execution of this Agreement by Seller,
the parties shall open an escrow ("Escrow") with the Escrow Holder by causing an
executed copy of this Agreement to be deposited with Escrow Holder. Escrow shall
be deemed open on the date that Seller delivers this executed Agreement to
Escrow Holder.

                                   EXHIBIT B
                              TO OPTION AGREEMENT
<PAGE>

3.    PAYMENT OF PURCHASE PRICE.

      3.1 Amount of Purchase Price. The purchase price for the Property shall be
$5,000,000 ("Purchase Price").

      3.2 Payment of Purchase Price. On the day preceding Close of Escrow, Buyer
shall deposit with Escrow Holder in "good funds" payable to Seller or order the
sum of $5,000,000,

      "Good funds" shall mean a wire transfer of funds, cashier's or certified
check drawn on or issued by the offices of a financial institution located in
the State of California, or cash.

4.    ADDITIONAL FUNDS AND DOCUMENTS REQUIRED FROM BUYER AND SELLER.

      4.1 Buyer. Buyer agrees that on or before 12:00 noon on the date preceding
the Closing Date, Buyer will deposit with Escrow Holder all additional funds
and/or documents (executed and acknowledged, if appropriate) which are necessary
to comply with the terms of this Agreement.

      4.2 Seller. Seller agrees that within three days following the date that
Escrow is opened hereunder, Seller will deposit with Escrow Holder an executed
and recordable grant deed ("Grant Deed") conveying the Property to Buyer,
together with such funds and other items and instruments as may be necessary in
order for the Escrow Holder to comply with this Agreement.

      Escrow Holder will cause the Grant Deed to be recorded when (but in no
event after the date specified in Section 5.1) it can issue the Title Policy in
the form described in Section 6, and holds for the account of Seller the items
described above to be delivered to Seller through Escrow, less costs, expenses
and disbursements chargeable to Seller pursuant to the terms hereof.

5.    CLOSING DATE; TIME OF ESSENCE.

      5.1 Closing Date. Escrow shall close on or before the date which is 30
days after the date of opening of escrow ("Closing Date"). The terms "the Close
of Escrow," and/or the "Closing" are used herein to mean the time Seller's Grant
Deed is filed for record by the Escrow Holder in the Office of the County
Recorder of Orange County, California.

      5.2 Time of Essence. Buyer and Seller specifically understand that time is
of the essence and Buyer and Seller specifically agrees to strictly comply and
perform its obligations herein in the time and manner specified and waives any
and all rights to claim such compliance by mere substantial compliance with the
terms of this Agreement.

6.    TITLE POLICY.

      When Escrow Holder holds for Buyer the Grant Deed in favor of Buyer
executed and acknowledged by Seller covering the Property, Escrow Holder shall
cause to be issued and delivered to Buyer and Seller as of the Closing a
C.L.T.A. standard coverage policy of title insurance ("Title Policy") issued by
a title insurance company acceptable to Buyer ("Title Company"), with liability
in the amount of the Purchase Price, covering the Property and showing title
vested in Buyer free of encumbrances, except:

                                      B-2
<PAGE>

            (a) Nondelinquent general and special real property taxes and
      assessments;

            (b) Easements, encumbrances, covenants, conditions, restrictions,
      reservations, rights-of-way and other matters of record of whatever kind
      or nature, including but not limited to, Exceptions _ through __,
      inclusive, as shown on that certain Preliminary Title Report No.
      ___________ dated as of September __, 2004, previously approved by Buyer
      (the "Preliminary Title Report");

            (c) The standard printed exceptions and exclusions contained in the
      CLTA form policy;

            (d) Any exceptions created or consented to by Buyer, including
      without limitation, any exceptions arising by reason of Buyer's possession
      of or entry on the Property.

7.    CONDITIONS PRECEDENT TO CLOSE OF ESCROW.

      7.1 Conditions to Buyer's Obligations. The obligations of Buyer under this
Agreement shall be subject to the satisfaction or written waiver, in whole or in
part, by Buyer of each of the following conditions precedent:

            (a) Title Company will issue the Title Policy as required by Section
      6 of this Agreement insuring title to the Property vested in Buyer.

            (b) Escrow Holder holds and will deliver to Buyer the instruments
      and funds, if any, accruing to Buyer pursuant to this Agreement.

      7.2 Conditions to Seller's Obligations. The obligations of Seller under
this Agreement shall be subject to the satisfaction or written waiver, in whole
or in part, by Seller of each of the following conditions precedent:

            (a) Escrow Holder holds and will deliver to Seller the instruments
      and funds accruing to Seller pursuant to this Agreement.

8.    ESCROW PROVISIONS.

      8.1 Escrow Instructions. This Agreement, when signed by Buyer and Seller,
shall also constitute escrow instructions to Title Company. If required by
Escrow Holder, Buyer and Seller agree to execute Escrow Holder's standard escrow
instructions, provided that the same are consistent with and do not conflict
with the provisions of this Agreement. In the event of any such conflict, the
provisions of this Agreement shall prevail.

                                      B-3
<PAGE>

      8.2 General Escrow Provisions. Escrow Holder shall deliver the Title
Policy to Buyer and instruct the County Recorder of Orange County, California,
to mail the Grant Deed to Buyer at the address set forth in Section 13.3 after
recordation. All funds received in this Escrow shall be deposited in one or more
general escrow accounts of the Escrow Holder with any bank doing business in
Orange County, California, and may be disbursed to any other general escrow
account or accounts. All disbursements shall be made by Escrow Holder's check.
This Agreement and any modifications, amendments, or supplements thereto may be
executed in counterparts and shall be valid and binding as if all of the
parties' signatures were on one document.

      8.3 Prorations Through Escrow. All nondelinquent general and special real
property taxes and assessments, income and expenses of leases to which Buyer
takes subject, if any, and insurance premiums (unless Buyer obtains new
insurance coverage) shall be prorated to the Close of Escrow on the basis of a
30-day month and a 360-day year. Seller may terminate utility service, if any,
as of Close of Escrow, and, if Buyer obtains new insurance on the Property,
shall cancel the existing insurance as of Close of Escrow.

      8.4 Payment of Costs. Seller shall pay one-half (1/2) of the Escrow fee,
documentary transfer taxes (affixed after recordation), premium charges for the
Title Policy, and the charge for drawing the Grant Deed. Buyer shall pay the
one-half (1/2) of the Escrow fee and charges for recording the Grant Deed. All
other costs of escrow not otherwise specifically allocated by this Agreement
shall be apportioned between the parties in a manner consistent with the custom
and usage of Escrow Holder.

      8.5 Termination and Cancellation of Escrow. If Escrow fails to close as
provided above, Escrow shall terminate automatically without further action by
Escrow Holder or any party, and Escrow Holder is instructed to return all funds
and documents then in Escrow to the respective depositor of the same with Escrow
Holder. Cancellation of Escrow, as provided herein, shall be without prejudice
to whatever legal rights Buyer or Seller may have against each other arising
from the Escrow or this Agreement.

9.    BROKERAGE COMMISSIONS.

      Each party agrees to indemnify and hold the other harmless from and
against all liabilities, costs, damages and expenses, including, without
limitation, attorneys' fees, resulting from any claims or fees or commissions,
based upon agreements by it, if any, to pay a broker's commission and/or
finder's fee.

10.   POSSESSION.

      Possession of the Property shall be delivered to Buyer as of Close of
Escrow.

11.   MISCELLANEOUS.

      11.1 Assignment. Buyer shall have the right to assign this Agreement and
any interest or right hereunder or under the Escrow without the prior written
consent and approval of Seller. Subject to the foregoing, this Agreement shall
be binding upon and shall inure to the benefit of Buyer and Seller and their
respective heirs, personal representatives, successors and assigns.

                                      B-4
<PAGE>

      11.2 Attorneys' Fees. In any action between the parties hereto, seeking
enforcement of any of the terms and provisions of this Agreement or the Escrow,
or in connection with the Property, the prevailing party in such action shall be
entitled, to have and to recover from the other party its reasonable attorney's
fees and other reasonable expenses in connection with such action or proceeding,
in addition to its recoverable court costs.

      11.3 Notices. Any notice which either party may desire to give to the
other party or to the Escrow Holder must be in writing and may be given by
personal delivery or by mailing the same by registered or certified mail, return
receipt requested, postage prepaid, to the party to whom the notice is directed
at the address of such party hereinafter set forth, or such other address and to
such other persons as the parties may hereafter designate:

         To Seller:                 Integrated Healthcare Holdings, Inc.
                                    695 Town Center Drive, Suite 260
                                    Costa Mesa, CA 92626
                                    Attention:  Chief Executive Officer

         To Buyer:                  Kali Chaudhuri, M.D.
                                    c/o Strategic Global Management, Inc.
                                    6800 Indiana Avenue, Suite 130
                                    Riverside, CA 92506

         To Escrow Holder:          ____________________________________________
                                    ____________________________________________
                                    ____________________________________________
                                    ____________________________________________

      Any notice given by mail shall be deemed received 48 hours after such
notice is deposited in the United States mail, addressed as provided above, with
postage fully prepaid.

      11.4 Interpretation; Governing Law. This Agreement shall be construed
according to its fair meaning and as if prepared by both parties hereto. This
Agreement shall be construed in accordance with the laws of the State of
California in effect at the time of the execution of this Agreement. Any action
brought in connection with this Agreement shall be brought in a court of
competent jurisdiction located in Orange County, California. Titles and captions
are for convenience only and shall not constitute a portion of this Agreement.
As used in this Agreement, masculine, feminine or neuter gender and the singular
or plural number shall each be deemed to include the others wherever and
whenever the context so dictates.

      11.5 No Waiver. No delay or omission by either party hereto in exercising
any right or power accruing upon the compliance or failure of performance by the
other party hereto under the provisions of this Agreement shall impair any such
right or power or be construed to be a waiver thereof. A waiver by either party
hereto of a breach of any of the covenants, conditions or agreements hereof to
be performed by the other party shall not be construed as a waiver of any
succeeding breach of the same or other covenants, agreements, restrictions or
conditions hereof.

                                      B-5
<PAGE>

      11.6 Modifications. Any alteration, change or modification of or to this
Agreement, in order to become effective, shall be made by written instrument or
endorsement thereon and in each such instance executed on behalf of each party
hereto.

      11.7 Severability. If any term, provision, condition or covenant of this
Agreement or the application thereof to any party or circumstances shall, to any
extent, be held invalid or unenforceable, the remainder of this instrument, or
the application of such term, provision, condition or covenant to persons or
circumstances other than those as to whom or which it is held invalid or
unenforceable, shall not be affected thereby, and each term and provision of
this Agreement shall be valid and enforceable to the fullest extent permitted by
law.

      11.8 Merger of Prior Agreements and Understandings. This Agreement, the
Option Agreement and other documents incorporated herein by reference contain
the entire understanding between the parties relating to the transaction
contemplated hereby and all prior or contemporaneous agreements, understandings,
representations and statements, oral or written, are merged herein and shall be
of no further force or effect.

      11.9 Covenants to Survive Escrow. The covenants and agreements contained
herein shall survive the Close of Escrow and shall be binding upon and inure to
the benefit of the parties hereto and their representatives, heirs, successors
and assigns.

      11.10 Time is of the Essence. Time is hereby expressly made of the essence
of this Agreement.

      11.11 Execution in Counterpart. This Agreement may be executed in several
counterparts, and all so executed shall constitute one agreement binding on all
parties hereto, notwithstanding that all parties are not signatories to the
original or the same counterpart.

      11.12 No Withholding Because Non-Foreign Seller. Seller represents and
warrants to Buyer that Seller is not, and as of the Closing Date for the
purchase of the property, will not be a foreign person or entity within the
meaning of Section 1445 of the Internal Revenue Code and that it will deliver
through Escrow, on or before the Closing Date, a non-foreign affidavit in the
form attached hereto as Exhibit B or if requested by Escrow Holder on Escrow
Holder's standard form pursuant to Section 1445(b)(2) of the Internal Revenue
Code and the Regulations promulgated thereunder.

                                      B-6
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have executed this Agreement of
Purchase and Sale of Real Property and Escrow Instructions as of the date first
above written.

                                     INTEGRATED HEALTHCARE HOLDINGS, INC.

                                     By:
                                        ----------------------------------------
                                        Larry B. Anderson, President

                                                                        "SELLER"

                                     -------------------------------------------
                                     KALI CHAUDHURI, M.D.
                                                                         "BUYER"

                                      B-7
<PAGE>

                                    EXHIBIT E
                         FORM OF TEN MILLION DOLLAR NOTE
<PAGE>

$10,000,000.00                                            Costa Mesa, California
                                                              September 28, 2004

                             SECURED PROMISSORY NOTE

      FOR VALUE RECEIVED, the undersigned, INTEGRATED HEALTHCARE HOLDINGS, INC.,
a Nevada corporation (the "COMPANY"), promises to pay to Kali Chaudhuri, M.D.
("HOLDER"), at c/o 6800 Indiana Avenue, Suite 130, Riverside, California 92506,
or at such other location as is designated by Holder in writing hereunder, the
aggregate sum of Ten Million Dollars ($10,000,000), bearing simple interest on
the unpaid principal balance of this Note, from the date of this Note until this
Note is paid in full at a rate of seven and one quarter percent (7.25%) per
annum. Accrued interest shall be computed based on the actual number of days
elapsed. Interest only shall be payable on the first Business Day of each
calendar quarter beginning January 2, 2005. All principal and accrued but unpaid
interest will be due and payable in full at the earlier to occur of (a) closing
of the Tenet Transaction or (b) the terminate, for any reason, of the letter of
intent or purchase agreement between the Company and Tenet Healthcare
Corporation and/or its affiliates relating to the Tenet Transaction (the "DUE
DATE"). All payments shall be made in lawful money of the United States, without
offset, deduction, or counterclaim of any kind.

      1. TERMS. Capitalized terms used herein without definition have the
meanings ascribed to them in the Secured Convertible Note Purchase Agreement of
even date herewith (as amended from time to time in accordance with the terms
thereof, the "AGREEMENT"), by and between the Company and Holder.

      2 PAYMENTS AND COMPUTATIONS. All payments on account of indebtedness
evidenced by this Note shall be made not later than 11:00 A.M. (California time)
on the day when due in lawful money of the United States and shall be first
applied to interest due on the unpaid principal balance and the remainder to any
principal due (it being understood that unless otherwise specified in writing by
the Company, any payment which is applied to reduce the principal balance
outstanding shall be applied to the last Advance evidenced by this Note first).
Payments are to be made at such place as Holder or the legal holders of this
Note may, from time to time, in writing specify, and in the absence of a
specification, at the principal place of business of Holder as set forth in the
first paragraph of this Note.

      3. SECURITY. Repayment of this Note is secured pursuant to the terms of a
Security Agreement dated the date of this Note by and between the Company and
Holder.

      4. ATTORNEYS' FEES. If any action is instituted on this Note, the
successful or prevailing party or parties shall be entitled to recover
reasonable attorneys' fees and other costs incurred in that action or
proceeding, in addition to any other relief to which the party or parties may be
entitled. Diligence, demand, presentment, notice of dishonor, and protest are
waived by the Company, and any and all makers, sureties, guarantors, and
endorsers of this Note, and their successors and assigns. Time is of the essence
for every obligation under this Note.
<PAGE>

      5. LAW. This Note shall be construed under the laws of the State of
California, as such laws are applied to contracts entered into and performed
entirely within that state by residents thereof.

      6. RULES OF CONSTRUCTION/REPRESENTATION. The parties hereto agree that
they are sophisticated business persons or entities who have had the opportunity
to be represented by counsel during the negotiation and execution of this Note
and, therefore, waive the application of any law, regulation, holding or rule of
construction providing that ambiguities in an agreement or other document will
be construed against the party drafting such agreement or document.

      IN WITNESS WHEREOF, the Company has executed and delivered this Note as of
the day and year and at the place first above written.

                                            INTEGRATED HEALTHCARE HOLDINGS, INC.

                                            By: /s/ Larry Anderson
                                               ---------------------------------
                                            Larry B. Anderson, President
<PAGE>

                                    EXHIBIT F
                            ARTICLES OF INCORPORATION
<PAGE>

                                    EXHIBIT G
                                     BYLAWS
<PAGE>

                                    EXHIBIT H
                             TENET LETTER OF INTENTASSET SALE AGREEMENT

      This Asset Sale Agreement (the "Agreement") is made and entered into as of
the 29th day of September, 2004 (the "Effective Date") by and among AHM CGH,
Inc., a California corporation ("AHM"), Health Resources Corporation of America
- California, a Delaware corporation ("HRC"), SHL/O Corp., a Delaware
corporation ("SHL/O") and UWMC Hospital Corporation, a California corporation
("UWMC") (AHM, HRC, SHL/O and UWMC are collectively referred to herein as
"Seller") and Integrated Healthcare Holdings, Inc., a Nevada corporation
("Purchaser"). Purchaser and Seller are sometimes referred to herein
collectively as the "Parties" or individually as a "Party," in either capital or
lower case.

                                R E C I T A L S:

      A. Seller (I) engages in the business of delivering acute care services to
the public through the acute care hospitals identified on Schedule A-1 (the
"Acute Care Hospitals"), (II) owns and operates certain medical office buildings
incident to the operation of the Acute Care Hospitals as specifically identified
on Schedule A-2 (the "MOBs"), and (III) owns and operates other healthcare
businesses incident to the operation of the Acute Care Hospitals as specifically
identified on Schedule A-3 (the "Other Businesses") (the Acute Care Hospitals,
MOBs and the Other Businesses are referred to in this Agreement collectively as
the "Hospitals").

      B. Purchaser desires to purchase from Seller, and Seller desires to sell
to Purchaser, substantially all of the assets with respect to the operation of
the Hospitals, for the consideration and upon the terms and conditions contained
in this Agreement.

      NOW, THEREFORE, in consideration of the foregoing premises and the mutual
promises and covenants contained in this Agreement, and for their mutual
reliance, the parties hereto agree as follows:

                                   ARTICLE I

                    DEFINITIONS; SALE AND TRANSFER OF ASSETS;
                             CONSIDERATION; CLOSING

      1.1 Definitions. The terms listed below are defined elsewhere in this
Agreement and, for ease of reference, the section containing the definition of
each such term is set forth opposite such term.

         TERM                                               SECTION
         ----                                               -------
         2002 & 2003 Financials                             ss.2.10
         2004 Financials                                    ss.2.10
         Accounts Receivable                                ss.1.2.1
         Accrued Paid Time Off Amount                       ss.1.2.1
         Acute Care Hospitals                               Recitals
         affiliate                                          ss.4.6(b)
         Agency Settlements                                 ss.11.2(a)
         Aggregate Amount                                   ss.10.2.2(a)(viii)
         Aggregate Damage                                   ss.1.14(a)
<PAGE>

         Agreement                                          Preamble
         AHM                                                Preamble
         Assets                                             ss.1.9
         Assumed Obligations                                ss.1.11
         Audit Periods                                      ss.2.8(d)
         Bills of Sale                                      ss.1.6.1
         Business Services Agreement                        ss.1.6.10
         Cash Purchase Price                                ss.1.2
         Casualty Termination Notice                        ss.1.14(a)
         Casualty Termination Notice Period                 ss.1.14(a)
         CEOs                                               ss.2.10
         CFOs                                               ss.2.10
         Claim Notice                                       ss.10.4(a)
         Closing                                            ss.1.5
         Closing Date                                       ss.1.5
         Closing of Financials                              ss.9.4
         CNA                                                ss.4.3
         CNOs                                               ss.2.10
         COBRA Coverage                                     ss.5.3(e)
         Code                                               ss.2.12(b)
         Competing Business                                 ss.4.13
         Confidential Information                           ss.5.6
         Confidentiality Agreement                          ss.5.6
         Consequential Damages                              ss.10.2.2(a)(vii)
         Consultant                                         ss.4.12
         Contract and Lease Consents                        ss.2.6(d)
         Contracts                                          ss.1.9(f)
         control                                            ss.4.6(b)
         COOs                                               ss.2.10
         Damages                                            ss.10.2.1
         Decision Date                                      ss.1.14(d)
         Disclosure Schedule                                ss.2
         Document Retention Period                          ss.9.2(a)
         DOJ                                                ss.4.11
         Effective Date                                     Preamble
         Effective Time                                     ss.1.5
         Employee Loan Liabilities                          ss.1.2.1
         Employee on Disability                             ss.5.3(a)
         Employee Settle-Up Payments                        ss.9.5
         Encumbrances                                       ss.2.7(b)
         Environmental Laws                                 ss.2.6(c)
         Environmental Permits                              ss.2.6(b)
         Environmental Survey                               ss.4.12
         EPAs                                               ss.5.3(g)
         ERISA                                              ss.2.10
         Estimated Payment Amount                           ss.9.5

                                      -2-
<PAGE>

         Excluded Asset Due Date                            ss.9.1
         Excluded Assets                                    ss.1.10
         Excluded Liabilities                               ss.1.12
         Excluded Multi-Facility Contracts                  ss.1.9(f)
         Final Balance Sheet                                ss.1.3
         Financial Statements                               ss.2.10
         FMLA                                               ss.5.3(a)
         FTC                                                ss.4.11
         Good Faith Deposit                                 ss.1.4(a)
         Government Program Transition Patients             ss.11.3(a)
         Group Purchasing Contract                          ss.1.6.8
         Hazardous Substances                               ss.2.6(c)
         Hired Employees                                    ss.5.3(a)
         Hospitals                                          Recitals
         Hospitals' Employees                               ss.5.3(b)
         HRC                                                Preamble
         HSR Act                                            ss.4.11
         Indemnified Party                                  ss.10.4
         Indemnifying Party                                 ss.10.4(a)
         Indemnity Notice                                   ss.10.4(b)
         Independent Auditor                                ss.1.3
         Independent Consultant                             ss.1.14(a)
         Interim Balance Sheet                              ss.1.2
         Interim Financials                                 ss.2.10
         Inventory                                          ss.1.9(h)
         JCAHO                                              ss.2.8(b)
         Leadership Team                                    ss.4.3(b)
         Leased Real Property                               ss.1.9(b)
         Leasehold Title Policy                             ss.4.8
         Leases                                             ss.1.9(e)
         Lender's Title Policy                              ss.4.8
         Licenses                                           ss.1.9(d)
         Material Contracts                                 ss.2.4(b)
         Material Leases                                    ss.2.4(a)
         Medicare Assignment Agreement                      ss.1.6.15
         MOBs                                               Recitals
         Multi-Facility Contracts                           ss.1.9(f)
         Notice Period                                      ss.10.4(a)
         Offering Circular                                  ss.5.6
         Original Closing Date                              ss.1.14(a)
         Other Businesses                                   Recitals
         Other Excluded Contracts                           ss.1.9(f)
         Owned Real Property                                ss.1.9(a)
         Owners' Title Policy                               ss.4.8
         Permitted Exceptions                               ss.7.7
         Person                                             ss.4.6(b)

                                      -3-
<PAGE>

         Personal Property                                  ss.1.9(c)
         Post-Closing Adjustment Date                       ss.1.3
         Power of Attorney                                  ss.1.6.12
         Prepaids                                           ss.1.9(g)
         Prime Rate                                         ss.1.3
         Purchase Price                                     ss.1.2
         Purchaser                                          Preamble
         Purchaser Confidential Information                 ss.4.17
         Purchaser Parties                                  ss.10.2.1
         Purchaser's Information                            ss.4.17
         Real Estate Assignments                            ss.1.6.2
         Real Property                                      ss.1.9(b)
         Receivable Records                                 ss.1.10(l)
         Records                                            ss.1.9(i)
         Relevant Claim                                     ss.10.2.2(a)(viii)
         Retained Management Employees                      ss.5.3(a)
         SEIU                                               ss.4.3
         Seller                                             Preamble
         Seller Business Service Area                       ss.4.13
         Seller Cost Reports                                ss.11.2(a)
         Seller Payment Due Date                            ss.9.1
         Seller Plans                                       ss.2.12(a)
         Seller Tax Claims                                  ss.10.2.1(e)
         Settlement Due Date                                ss.11.2(a)
         Sick Pay Amount                                    ss.1.2.1
         Submittal Date                                     ss.1.14(d)
         Superseded Agreements                              ss.12.14
         Surveys                                            ss.4.8
         Tangible Personal Property                         ss.1.9
         Tax                                                ss.2.16
         Taxes                                              ss.2.16
         Tax Return                                         ss.2.16
         Tenet Affiliate Contracts                          ss.1.9(f)
         Termination Date                                   ss.8.1(g)
         THC                                                ss.1.6.14
         Third Party Claim                                  ss.10.4(a)
         Title Commitment                                   ss.4.8
         Title Company                                      ss.1.4(a)
         Title Instruments                                  ss.4.8
         Title Policy                                       ss.4.8
         Transferred Information                            ss.4.17
         Transferred Transition Patients                    ss.11.3(c)
         Transition Patients                                ss.11.3
         Transition Services                                ss.11.3
         Transitional Services Agreements                   ss.1.6.9
         UNAC                                               ss.5.3(g)

                                      -4-
<PAGE>

         UWMC                                               Preamble
         WARN                                               ss.1.12(e)

      1.2 Purchase Price. Subject to the terms and conditions of this Agreement,
the aggregate purchase price to be paid by Purchaser to Seller for the purchase
of all of the Assets shall be (a) Seventy Million Dollars ($70,000,000) (the
"Purchase Price"), minus (b) the amount of Seller's capital lease obligations
with respect to the Hospitals on the Closing Date, if any, that are assumed by
Purchaser pursuant to Section 1.11 of this Agreement, minus (c) the net present
value on the Closing Date of the Employee Loan Liabilities, minus (d) Seven
Hundred Fifty Thousand ($750,000), reflecting the credit made available to
Purchaser hereunder for assuming the Sick Pay Amount at Closing; minus (e) the
Accrued Paid Time Off Amount on the Closing Date (the sum of (a), (b), (c), (d)
and (e) being referred to for purposes of this Agreement as the "Cash Purchase
Price"). The payment of the Cash Purchase Price at Closing shall be governed by
Section 1.7.

            1.2.1 Definitions. For purposes of this Agreement, the following
terms shall have the meaning set forth below:

                  (i) "Accounts Receivable" shall be defined as all accounts,
notes, interest and other receivables of Seller, including accounts, notes or
other amounts receivable from physicians, and all claims, rights, interests and
proceeds related thereto, including all accounts and other receivables,
disproportionate share payments and cost report settlements related thereto,
arising from the rendering of services to inpatients and outpatients at any
Hospital, billed and unbilled, recorded and unrecorded, for services provided by
Seller while owner of the Assets whether payable by private pay patients,
private insurance, third party payors, Medicare, Medi-Cal, TRICARE, Blue Cross,
or by any other source.

                  (ii) "Accrued Paid Time Off Amount" shall mean the accrued
paid time off and management time off (excluding the Sick Pay Amount), including
CashPlus, liabilities of Seller and Seller's affiliates, as of the Closing Date,
with respect to the Hospital Employees subject to the Employee Lease Agreement
on the day immediately following the Closing Date.

                  (iii) "Employee Loan Liabilities" shall be defined as the
aggregate of all liabilities and obligations of Seller to certain Hired
Employees under Seller's Employee Student Loan Repayment Program for the period
commencing as of the Effective Time and continuing until such liabilities and
obligations are fully satisfied.

                  (iv) "Sick Pay Amount" shall be defined as the amount of the
extended sick pay (Reserve Sick) obligations of Seller and/or its affiliates to
the Hired Employees.

            1.2.2 Interim Balance Sheet. At least three (3) calendar days, but
no more than ten (10) calendar days, prior to the Closing Date, Seller shall
prepare and deliver to Purchaser the latest available unaudited balance sheet of
Seller with respect to the operation of the Hospitals (the "Interim Balance
Sheet"). The Interim Balance Sheet shall include a calculation (including
supporting documentation which details the applicable general ledger items used
in the calculation) of the amount of Seller's capital lease obligations with
respect to the Hospitals on the Closing Date, if any, that are assumed by
Purchaser pursuant to Section 1.11 of this Agreement, the Sick Pay Amount, the
Accrued Paid Time Off Amount and the Employee Loan Liabilities on the Closing
Date (as well as the net present value of the Employee Loan Liabilities on the
Closing Date), all of which amounts shall, unless otherwise mutually agreed by
the parties, be used to determine the Cash Purchase Price under Section 1.2. The
final, pre-closing Interim Balance Sheet shall be attached hereto as Schedule
1.2-b The amounts set forth in the final pre-closing Interim Balance Sheet shall
be subject to adjustment as provided below.

                                      -5-
<PAGE>

      1.3 Post-Closing Adjustment of Certain Items. Within one hundred twenty
(120) calendar days after the Closing Date, the final unaudited balance sheet of
the Hospitals as of the Closing Date (the "Final Balance Sheet"), which shall
include a calculation (including supporting documentation which details the
applicable general ledger items used in the calculation) of the amount of
Seller's capital lease obligations with respect to the Hospitals on the Closing
Date, if any, that are assumed by Purchaser pursuant to Section 1.11 of this
Agreement, the Sick Pay Amount, the Accrued Paid Time Off Amount and the
Employee Loan Liabilities on the Closing Date (as well as the net present value
of the Employee Loan Liabilities on the Closing Date), shall be prepared by
Seller and delivered to Purchaser. The Interim Balance Sheet and the Final
Balance Sheet shall be prepared in a manner consistent with the terms of Section
2.10. If Purchaser disputes any entry on the Final Balance Sheet that affects
the calculation of capital lease obligations assumed by Purchaser, the Sick Pay
Amount, the Accrued Paid Time Off Amount or the net present value of the
Employee Loan Liabilities, Purchaser shall notify Seller in writing (which
writing shall contain Purchaser's determination of the amount of the disputed
entry, unless Purchaser reasonably requires additional information from Seller
for such calculation) within twenty (20) business days after Purchaser's receipt
of the Final Balance Sheet from Seller. In the event of such dispute, Seller
shall provide Purchaser with such additional information and documents, if any,
as Purchaser may reasonably request in order to review the accuracy and fairness
of the amounts presented in the Interim Balance Sheet. After Purchaser's review
of all such materials, if the difference between Seller's and Purchaser's
respective aggregate calculations of capital lease obligations assumed by
Purchaser, the Sick Pay Amount, the Accrued Paid Time Off Amount and the net
present value of the Employee Loan Liabilities is equal to or less than five
percent (5%) of the respective amount of Seller's aggregate calculation,
Seller's aggregate calculation shall be conclusive and binding as between
Purchaser and Seller. If the difference between Seller's and Purchaser's
respective aggregate calculations is greater than five percent (5%) of Seller's
aggregate calculation, and Purchaser and Seller cannot resolve such dispute
within thirty (30) business days after Purchaser notifies Seller in writing of
such dispute, then Ernst & Young independent certified public accountants (the
"Independent Auditor"), shall review the matter in dispute and, solely as to
disputes relating to accounting issues and acting as an expert and not as an
arbitrator, shall promptly decide the proper amounts of such disputed entries
(which decision shall also include a final recalculation of the Cash Purchase
Price). In the event that all or a portion of the dispute at issue involves a
legal issue or an interpretation of this Agreement, such legal or interpretative
dispute shall first be subject to adjudication by a court or similar tribunal,
with any necessary review by the Independent Auditor under this Section 1.3
occurring following the resolution of such legal dispute. Such decision of the
Independent Auditor shall be conclusive and binding as between Purchaser and
Seller, and the costs of such review shall be borne by each of Seller and
Purchaser in the ratio equal to (i) the dollar amount that such party's
determination varies from the determination of the Independent Auditor, divided
by (ii) the sum of the variances of each party's determination from the
determination of the Independent Auditor.

                                      -6-
<PAGE>

         Within twenty-five (25) business days after Purchaser's receipt of the
Final Balance Sheet from Seller or, if disputed by Purchaser, within five (5)
business days after the earlier of (a) the date Purchaser and Seller finally
resolve such dispute and recalculate the Cash Purchase Price accordingly, or (b)
the date of receipt of a decision from the Independent Auditor (the
"Post-Closing Adjustment Date"), either (i) Seller shall pay Purchaser in cash
or in other immediately available funds the amount of any decrease in the Cash
Purchase Price, or (ii) Purchaser shall pay Seller in cash or in other
immediately available funds the amount of any increase in the Cash Purchase
Price, as the case may be. If Purchaser or Seller, as the case may be, shall
fail to make such payment to the other within ten (10) days after the
Post-Closing Adjustment Date, then the party failing to receive such amount due
to it shall be entitled to receive interest on such unpaid amount at a per annum
rate equal to the prime rate reported by the Wall Street Journal under "Money
Rates" (the "Prime Rate") on the Post-Closing Adjustment Date plus two percent
(2%) (or the maximum rate allowed by law, whichever is less) from such
defaulting party, such interest accruing on each calendar day after the
Post-Closing Adjustment Date until payment of such amount and all interest
thereon is made.

      1.4 Good Faith Deposit/Personal Guaranty.

            (a) Good Faith Deposit. Purchaser shall deliver to Chicago Title
Insurance Company (the "Title Company"), for earnest money, a good faith deposit
in the amount of Ten Million Dollars ($10,000,000), payable as of the Effective
Date (the "Good Faith Deposit"). The Title Company shall hold the Good Faith
Deposit in an interest bearing account (which interest shall be accrued to
Purchaser) pursuant to the terms of the Escrow Agreement attached as Exhibit
1.4-a which Seller, Purchaser and the Title Company shall execute concurrent
with the execution of this Agreement. The Good Faith Deposit is non-refundable
regardless of the termination of this Agreement pursuant to Section 8.1 below,
except that Purchaser shall be entitled to the return of the Good Faith Deposit,
with all interest accrued thereon, in the event that (i) Purchaser terminates
this Agreement pursuant to Section 8.1(c), 8.1(d), 8.1(f), 8.1(g) or 8.1(h)
(provided the failure of the applicable event or condition(s) giving rise to
Purchaser's right to terminate under such subsections is not in any manner due
to Purchaser's fault, as provided therein, including without limitation an
inability of Purchaser to obtain financing or funding for the payment of the
Cash Purchase Price) or (ii) Seller terminates this Agreement pursuant to 8.1(e)
or 8.1(g) based upon the failure of a condition or a failure to close,
respectively, that is not in any manner due to Purchaser's failure to perform,
including without limitation an inability of Purchaser to obtain financing or
funding for the payment of the Cash Purchase Price. In the event the Closing
occurs, however, the Good Faith Deposit shall be applied as a credit against the
Purchase Price, payable at Closing pursuant to Section 1.7.2.

            (b) Personal Guaranty. As an inducement to Seller to execute this
Agreement, Kali Chaudhuri, M.D., one of Purchaser's lender, has delivered to
Seller, as of the Effective Date, a personal guaranty in the form of Exhibit
1.4-b hereto pursuant to which Dr. Chaudhuri will guaranty Purchaser's
indemnification obligation under Section 10.3.1(d) of this Agreement with
respect to the (i) Lease between Chapman Investment Associates, as Lessor, and
Chapman General Hospital, Inc., as Lessee, dated as of December 31, 1984, as
amended or assigned, and (ii) Lease between Jess Watkins, as Trustee under the
Cayuga Land Trust, Lawrence Johnson and James Kirby, as lessors, and Greatwest
Medical Management, Inc., as lessee, dated as of December 31, 1984, as amended
or assigned, both with respect to Chapman Medical Center (the "Chapman Medical
Center Leases").

                                      -7-
<PAGE>

      1.5 Closing Date. The consummation of the transactions contemplated by
this Agreement (the "Closing") shall take place at 9:00 a.m. on November 30,
2004 (the "Closing Date"), at the offices of McDermott Will & Emery LLP, 2049
Century Park East, Suite 3400, Los Angeles, California 90067 or such other date,
time and place as the parties shall mutually agree; provided that all conditions
precedent and other matters required to be completed as of the Closing Date have
been or will be completed on such date, and if they are not, such Closing Date
shall automatically be changed to December 31, 2004. The Closing with respect to
each Hospital shall be deemed to have occurred and to be effective as between
the parties as of 12:01 a.m. Pacific time on the next day after the Closing Date
(the "Effective Time").

      1.6 Items to be Delivered by Seller at Closing. At or before the Closing,
Seller shall deliver to Purchaser, the following, duly executed by Seller where
appropriate:

            1.6.1 General Assignment, Bill of Sale and Assumption of Liabilities
in the form of Exhibit 1.6.1 attached hereto (the "Bills of Sale");

            1.6.2 Assignment and Assumption of Real Estate Leases in the form of
Exhibit 1.6.2 attached hereto with respect to each Leased Real Property (the
"Real Estate Assignments");

            1.6.3 Grant Deed(s) (or such other deed comparable to grant deed(s)
as is applicable to the jurisdiction at issue) in the form of Exhibit 1.6.3
attached hereto;

            1.6.4 favorable original certificates of good standing, or
comparable status, of Seller, issued by the respective states of incorporation
of each Seller, dated no earlier than a date which is seven (7) calendar days
prior to the Closing Date;

            1.6.5 an opinion of Seller's or Seller's affiliates' in-house
counsel in substantially the form attached hereto as Exhibit 7.6;

            1.6.6 a certificate of the President or any Vice President of each
Seller certifying to Purchaser (a) compliance with Seller's covenants set forth
in this Agreement and (b) that all of the conditions contained in Article VI
have been satisfied except those, if any, waived in writing by Seller;

            1.6.7 a certificate of the corporate Secretary of each Seller
certifying to Purchaser (a) the incumbency of the officers of Seller on the
Effective Date and on the Closing Date and bearing the authentic signatures of
all such officers who shall execute this Agreement and any additional documents
contemplated by this Agreement and (b) the due adoption and text of the
resolutions of the sole director of each Seller authorizing (i) the transfer of
the Assets and Assumed Obligations by each Seller to Purchaser and (ii) the
execution, delivery and performance of this Agreement and all ancillary
documents and instruments by each Seller, and that such resolutions have not
been amended or rescinded and remain in full force and effect on the Closing
Date;

                                      -8-
<PAGE>

            1.6.8 the Group Purchasing Contract in the form of Exhibit 5.15
attached hereto (the "Group Purchasing Contract"), which Group Purchasing
Contract shall include, without limitation, making available to Purchaser
Seller's current and future Broadlane GPO pricing for capital equipment,
medical/surgical supplies and overall purchasing power for a period of not less
than five (5) years following the Closing Date;

            1.6.9 the Transitional Services Agreements, which shall be
substantially in the form of Exhibit 1.6.9 attached hereto (the "Transitional
Services Agreements"), which Transitional Services Agreements shall include,
without limitation, (a) leaving in place and making available to Purchaser
Seller's information technology systems with respect to the operation of the
Hospitals, including, but not limited to, Seller's existing Perot Systems
information technology infrastructure with respect to the operation of the
Hospitals and pricing to the Hospitals for the period of not less than three (3)
years following the Closing Date to the extent Seller has the authority to do so
pursuant to its agreements with third parties in effect as of the Effective
Date, (b) a license of Seller's clinical policy and procedure manuals with
respect to the operation of the Hospitals for no longer than six (6) months
following the Closing Date, and (c) a license of Seller's proprietary employee
and operating manuals (other than clinical policies and clinical manuals) for
six (6) months following the Closing Date;

            1.6.10 the Business Services Agreement, which shall be in the form
of Exhibit 1.6.10 attached hereto (the "Business Services Agreement"), pursuant
to which Purchaser will bill Seller's accounts receivable for sixty (60) days
following the Closing Date;

            1.6.11 UCC termination statements for any and all financing
statements (which do not correspond to an Assumed Obligation) filed with respect
to the Assets;

            1.6.12 Limited Power of Attorney for use of Pharmacy License, DEA
and Other Registration Numbers, and DEA Order Forms, in the form of Exhibit
1.6.12 attached hereto (the "Power of Attorney");

            1.6.13 copies of the third party consents obtained by Seller in
connection with the assignment of the Material Contracts and Material Leases;

            1.6.14 Guaranty Agreement of Tenet Healthcare Corporation, a Nevada
corporation ("THC"), in the form of Exhibit 1.6.14 attached hereto, pursuant to
which THC will agree to guaranty all of the obligations of Seller under this
Agreement, including without limitation, Seller's obligations under Section 10.2
(indemnification) hereof;

            1.6.15 an assignment and assumption agreement in the form of Exhibit
1.6.15 for the assignment of those certain Medicare provider numbers and
Medicare provider agreements set forth on Schedule 1.6.15 (the "Medicare
Assignment Agreement");

            1.6.16 the Employee Leasing Agreement, which shall be in the form of
Exhibit 1.6.16 attached hereto (the "Employee Leasing Agreement"), which shall
bear a term expiring, with respect to each Hospital, as of the end of the pay
period with respect to such Hospital ending immediately prior to June 30, 2005;
and

                                      -9-
<PAGE>

            1.6.17 such other customary instruments, certificates, consents or
other documents which are reasonably necessary to carry out the transactions
contemplated by this Agreement and to comply with the terms hereof, in all cases
consistent with the terms of this Agreement.

      1.7 Items to be Delivered by Purchaser at Closing. At or before the
Closing, Purchaser shall execute and deliver or cause to be delivered to Seller
the following, duly executed by Purchaser where appropriate:

            1.7.1 payment of the Cash Purchase Price based upon the Interim
Balance Sheet (subject to adjustment as described in Section 1.3), plus any
amount which Purchaser is required to reimburse Seller pursuant to Section
1.11(d), less the Good Faith Deposit (including any and all interest accrued
thereon), as adjusted to reflect the prorations provided in Section 1.8 and any
adjustments to the Cash Purchase Price pursuant to Section 1.14. Such amounts
shall be payable by wire transfer of immediately available funds to Seller to
the account(s) specified by Seller to Purchaser in writing;

            1.7.2 instructions to the Title Company to distribute the Good Faith
Deposit to Seller on the Closing Date;

            1.7.3 a certificate of the President or any Vice President of
Purchaser certifying to Seller (a) compliance with Purchaser's covenants set
forth in this Agreement, (b) that Purchaser has obtained all material licenses,
permits, certificates of need and authorizations from governmental agencies or
governmental bodies that are necessary or required for completion of the
transactions contemplated by this Agreement (except for the hospital or other
licenses, Medicare and Medi-Cal provider numbers and agreements, and the
approvals that generally are not issued until after the change of ownership is
complete) and (c) that all of the conditions contained in Article VII have been
satisfied except those, if any, waived in writing by Purchaser

            1.7.4 a certificate of the corporate Secretary of Purchaser
certifying to Seller (a) the incumbency of the officers of Purchaser on the
Effective Date and on the Closing Date and bearing the authentic signatures of
all such officers who shall execute this Agreement and any additional documents
contemplated by this Agreement and (b) the due adoption and text of the
resolutions of the Board of Directors of Purchaser authorizing the execution,
delivery and performance of this Agreement and all ancillary documents and
instruments by Purchaser, and that such resolutions have not been amended or
rescinded and remain in full force and effect on the Closing Date;

            1.7.5 an opinion of Purchaser's counsel in substantially the form
attached hereto as Exhibit 6.4;

            1.7.6 favorable original certificate of good standing, or comparable
status, of Purchaser, issued by the Nevada Secretary of State dated no earlier
than a date which is seven (7) calendar days prior to the Closing Date;

            1.7.7 the Bills of Sale;

            1.7.8 the Real Estate Assignments;

                                      -10-
<PAGE>

            1.7.9 the Group Purchasing Contract;

            1.7.10 if requested by Purchaser, the Transitional Services
Agreements (along with the payment to Seller by wire transfer of immediately
available funds of any amounts which must be made by Purchaser to Seller or any
affiliate of Seller concurrent with the execution thereof);

            1.7.11 the Business Services Agreement;

            1.7.12 the Power of Attorney;

            1.7.13 copies of all third party consents obtained by Purchaser in
connection with the assignment of the Contracts and Leases to Purchaser;

            1.7.14 the Medicare Assignment Agreement;

            1.7.15 intentionally omitted;

            1.7.16 the Employee Leasing Agreement; and

            1.7.17 such other customary instruments, certificates, consents or
other documents which are reasonably necessary to carry out the transactions
contemplated by this Agreement and to comply with the terms hereof, in all cases
consistent with the terms of this Agreement.

      1.8 Prorations and Utilities. To the extent not otherwise prorated
pursuant to this Agreement, or as reflected in the Interim Balance Sheet or the
Final Balance Sheet, Purchaser and Seller shall prorate (as of the Effective
Time), if applicable, the following as they relate to the Assets: real estate
and personal property lease payments, real estate and personal property taxes,
assessments and other similar charges against real estate, plus all other income
and expenses which are normally prorated upon the sale of assets of a going
concern (a "Prorated Item"). As to power and utility charges, "final readings"
as of the Closing Date shall be ordered from the utilities; the cost of
obtaining such "final readings," if any, to be paid for by Purchaser. If any
party delivers to the other party any amount required by this Section 1.8 in
respect of any Prorated Item, the receiving party shall use such amount to pay
such Prorated Item and the delivering party shall no longer have any liability
in respect of such Prorated Item.

      1.9 Transfer of Seller Assets. On the Closing Date, Seller shall assign,
transfer, convey and deliver to Purchaser, free and clear of any Encumbrances
except for the Permitted Exceptions, and Purchaser shall acquire, all of each
Seller's right, title and interest in and to only the following assets and
properties, as such assets shall exist on the Closing Date with respect to the
operation of any Hospital, such transfer being deemed to be effective at the
Effective Time (collectively, the "Assets"):

            (a) all of the real property that is owned by such Seller or its
affiliates and used with respect to the operation of any Hospital, including,
without limitation, the real property that is described in Schedule 1.9(a) (such
description to include a legal description and address), together with all
buildings, improvements and, structures, residences, fixtures located thereupon,
and all landscaping, utility lines, roads, driveways, fences, parking areas,
contiguous and adjacent entry rights, construction in progress, and all other
improvements located thereon and all rights, privileges and easements
appurtenant to the foregoing (collectively, the "Owned Real Property");

                                      -11-
<PAGE>

            (b) all of the real property that is leased by such Seller or its
affiliates and used with respect to the operation of any Hospital including,
without limitation, the leased real property described in Schedule 1.9(b) (the
"Leased Real Property") (the Owned Real Property and the Leased Real Property
are collectively referred to in this Agreement as the "Real Property");

            (c) all of the Tangible Personal Property owned by such Seller with
respect to the operation of any Hospital (the "Personal Property"), including,
without limitation, the Personal Property described in Schedule 1.9(c);

            (d) all of such Seller's rights, to the extent assignable or
transferable, to all licenses, permits, approvals, certificates of need,
authorizations, provider agreements (other than Medicare provider agreements),
provider numbers (other than Medicare provider numbers), Medicare provider
agreements and Medicare provider numbers set forth on Schedule 1.6.15,
applications, certificates of exemption, franchises, accreditations and
registrations and other governmental licenses, permits or approvals issued to
such Seller with respect to the operation, development or expansion of any
Hospital (the "Licenses"), including, without limitation, the Licenses described
in Schedule 1.9(d) except to the extent Purchaser elects, in its discretion, not
to take assignment of any such Licenses;

            (e) all of such Seller's interest, to the extent assignable or
transferable, in and to all real property and personal property leases with
respect to the operation of any Hospital (the "Leases"), including, without
limitation, those leases described in Schedule 1.9(e);

            (f) all of such Seller's interest, to the extent assignable or
transferable, in and to all contracts and agreements (including, but not limited
to, purchase orders) with respect to the operation of any Hospital (the
"Contracts"), including, without limitation, those Contracts described in
Schedule 1.9(f); provided, however, the term Contracts as used in this Agreement
shall exclude, subject to Section 9.3, (i) multi-hospital contracts as to which
one of the Hospitals and one or more of Seller's or Seller's affiliates' other
acute care hospitals (which are not among the Hospitals) participate (the
"Multi-Facility Contracts"), (ii) all national or regional contracts of Seller
or any affiliate thereof which are made available to any of the Hospitals by
virtue of such Hospital being an affiliate of Tenet Healthcare Corporation
("THC") or its affiliates (the "Tenet Affiliate Contracts") (the Multi-Facility
Contracts and the Tenet Affiliate Contracts collectively are referred to as the
"Excluded Multi-Facility Contracts") and (iii) any contracts specifically
identified on Schedule 1.9(f) as being excluded (the "Other Excluded
Contracts");

            (g) all of those advance payments, prepayments, prepaid expenses,
deposits and the like which exist as of the Closing Date, subject to the
prorations provided in Section 1.8 of this Agreement, which were made with
respect to the operation of any Hospital or Asset (the "Prepaids"), the current
categories and amounts of which are set forth on Schedule 1.9(g);

                                      -12-
<PAGE>

            (h) except as excluded by Sections 1.10(d) and 1.10(i), all
inventories of supplies, drugs, food, janitorial and office supplies and other
disposables and consumables located at any of the Hospitals, or used with
respect to the operation of any of the Hospitals (the "Inventory");

            (i) all data, documents, records, operating manuals, files and
computer software with respect to the operation of any of the Hospitals,
including, without limitation, all patient records, medical records, employee
records, financial and accounting records with respect to the operation of any
of the Hospitals, equipment records, maintenance records, construction plans and
specifications, warranty records, advertising and promotional materials,
studies, reports and medical and administrative libraries (collectively, the
"Records");

            (j) to the extent assignable, all rights in all warranties of any
manufacturer or vendor in connection with the Personal Property or Real
Property;

            (k) all goodwill of the businesses evidenced by the Assets and
associated with the businesses of the Hospitals;

            (l) all insurance proceeds arising in connection with property
damage to the Assets occurring after the Effective Date and prior to the
Effective Time, to the extent not expended on the repair or restoration of the
Assets;

            (m) the names, symbols, telephone numbers and telephone directory
listings used with respect to the operation of the Hospitals, including, without
limitation, the names of the Hospitals set forth on Schedule 1.9(m) and all
variants thereof;

            (n) the domain names, "www.chapmanmedicalcenter.com",
"www.coastalcommhospital.com", "www.westernmedicalcenter.com", and
"www.westernmedanaheim.com";

            (o) any of such Assets as are owned by any affiliate of Seller; and

            (p) those (and only those) marketing materials and marketing
brochures specifically described in Schedule 1.9(p); it being understood that
Purchaser's use of such materials shall be subject to Section 5.4 (that is, any
of Seller's affiliates' business names, such as, without limitation, Tenet
Healthcare Corporation, shall be removed from such marketing materials and
brochures prior to the use thereof by Purchaser);

provided, however, that the Assets shall not include the Excluded Assets as
defined in Section 1.10 below.

      For purposes of this Agreement, "Tangible Personal Property" shall be
defined as all machinery, equipment, tools, furniture, office equipment, medical
equipment, computer hardware and software, supplies, materials, vehicles,
leasehold improvements and other items of tangible personal property (other than
Inventory) of every kind owned or leased by Seller (wherever located and whether
or not carried on Seller's books), together with any express or implied warranty
by the manufacturers or sellers or lessors of any item or component part thereof
and all maintenance records and other documents relating thereto.

                                      -13-
<PAGE>

      In support of Section 1.9(o) above, Seller agrees that to the extent any
affiliates of Seller own any interest in any property that, if owned by Seller,
would constitute an Asset being transferred hereunder, Seller shall cause such
affiliates to transfer, without further charge to Purchaser, all such interests
in such property to Purchaser at Closing.

      1.10 Excluded Assets. Notwithstanding anything to the contrary in Section
1.9, Seller shall retain all assets owned directly or indirectly by it (or any
of Seller's affiliates) which are not among the Assets, including, without
limitation, the following assets of Seller (collectively, the "Excluded
Assets"):

            (a) cash, cash equivalents and short-term investments;

            (b) those categories of current assets of Seller with respect to the
operation of any of the Hospitals which are set forth on Schedule 1.10(b);

            (c) such computer software, programs and hardware or data processing
equipment which is (i) proprietary to Seller and/or Seller's affiliates, data
processing system manuals and licensed software materials or (ii) used in
connection with the operation of one or more of Seller's or Seller's affiliates'
acute care hospitals other than any of the Hospitals (and not located at any of
the Hospitals), as more particularly described in Schedule 1.10(c);

            (d) except as expressly set forth in Section 1.9(p), all of Seller's
or any affiliate of Seller's proprietary manuals, marketing materials, policy
and procedure manuals, standard operating procedures and marketing brochures,
data and studies or analyses not developed or used exclusively for one or more
of the Hospitals;

            (e) any asset which would revert to the employer upon the
termination of any Seller Plan, including assets representing a surplus or
overfunding of any Seller Plan;

            (f) the Excluded Multi-Facility Contracts and Other Excluded
Contracts;

            (g) the names "Tenet Healthcare Corporation", "Tenet", "Tenet
HealthSystem", "OrNda HealthCorp", and any other names, symbols or world-wide
web addresses (including, without limitation, any world-wide web address
containing "tenethealth.com") not used exclusively at any of the Hospitals, all
abbreviations and variations thereof, and trademarks, trade names, service
marks, copyrights and any applications therefor, symbols and logos related
thereto, together with any promotional material, stationery, supplies or other
items of inventory bearing such names or symbols or abbreviations or variations
thereof;

            (h) all current contracts between Seller and any affiliate of Seller
with respect to the operation of any Hospital, except those approved in writing
by Seller and Purchaser to be assigned to Purchaser on or after the Effective
Time;

            (i) the portions of Inventory, Prepaids and other Assets disposed
of, expended or canceled, as the case may be, by any Seller after the Effective
Date and prior to the Effective Time in the ordinary course of business;

                                      -14-
<PAGE>

            (j) assets owned and provided by vendors of services or goods to any
of the Hospitals;

            (k) the Accounts Receivable;

            (l) all documents, records, correspondence, work papers and other
documents relating to the Accounts Receivable, the Seller Cost Reports or the
Agency Settlements (the "Receivable Records");

            (m) all claims, rights, interests and proceeds with respect to state
or local tax refunds (including but not limited to property tax) resulting from
periods prior to the Effective Time, and the right to pursue appeals of same;

            (n) all of Seller's corporate record books and minute books;

            (o) any Owned Real Property not purchased by, or any Leased Real
Property not assigned to, Purchaser pursuant to Sections 1.14(a)(ii) or
1.14(c)(ii), as set forth in Schedule 2.7(e);

            (p) all insurance proceeds arising in connection with property
damage to any Owned Real Property not purchased by, or any Leased Real Property
not assigned to, Purchaser pursuant to Sections 1.14(a)(ii) or 1.14(c)(ii), as
set forth in Schedule 2.7(e);

            (q) all unclaimed property of any third party, including, without
limitation, property which is subject to applicable escheat laws;

            (r) all claims, rights, interests and proceeds (whether received in
cash or by credit to amounts otherwise due to a third party) with respect to
amounts overpaid by Seller to any third party with respect to periods prior to
the Effective Time (e.g. such overpaid amounts may be determined by billing
audits undertaken by Seller or Seller's consultants);

            (s) all bank accounts of Seller;

            (t) all rights, claims and choses in action of Seller and its
affiliates with respect to periods prior to the Effective Time, and any
payments, awards or other proceeds resulting therefrom;

            (u) all writings and other items that are protected from discovery
by the attorney-client privilege, the attorney work product doctrine or any
other cognizable privilege or protection, which are further described by way of
example, rather than limitation, on Schedule 1.10(u);

            (v) Seller's current Medicare and Medi-Cal provider agreements and
provider numbers, but excluding those Medicare provider agreements and Medicare
provider numbers set forth on Schedule 1.6.15, unless Purchaser affirmatively
elects to revise Schedule 1.6.15 on or before October 14, 2004;

                                      -15-
<PAGE>

            (w) certain content of each Hospital's website, as more particularly
described on Schedule 1.10(w);

            (x) all intercompany receivables of Seller with any of Seller's
affiliates; and

            (y) any assets identified in Schedule 1.10(y).

      1.11 Assumed Obligations. On the Closing Date, Seller shall assign, and
Purchaser shall assume and agree to discharge on and after the Effective Time,
the following liabilities and obligations of Seller and only the following
liabilities and obligations (collectively, the "Assumed Obligations"):

            (a) the Contracts, but only to the extent of the obligations arising
thereunder with respect to events or periods on and after the Effective Time;

            (b) the Leases, including the capital lease obligations of Seller
listed on Schedule 1.11(b) with respect to the Hospitals, but only to the extent
of the obligations arising thereunder with respect to events or periods on and
after the Effective Time;

            (c) Intentionally omitted;

            (d) the Accrued Paid Time Off with respect to the Hired Employees
(but only to the extent Purchaser receives a credit towards the Purchase Price
as described in Section 1.2(e), as such credit is initially determined pursuant
to Section 1.2.2 and such credit is finally determined pursuant to Section 1.3);
provided, however, if Seller or any affiliate of Seller satisfies any portion of
such obligations and liabilities existing as of the Closing Date by payment to a
Hired Employee (which satisfaction of such obligations and liabilities may only
occur if Seller has obtained Purchaser's express consent, unless otherwise
required by law, contract or the terms of the Seller Plans), then Purchaser
shall reimburse Seller the amount of such payment at Closing;

            (e) the Sick Pay Amount as of the Closing Date;

            (f) all unpaid real and personal property taxes for the current
property tax year, if any, that are attributable to the Assets prior to the
Effective Time, subject to the prorations provided in Section 1.8;

            (g) all utilities being furnished to the Assets on and after the
Effective Time, subject to the prorations provided in Section 1.8; and

            (h) any other obligations and liabilities identified in Schedule
1.11(h).

It is expressly understood and agreed that Purchaser shall not assume nor shall
Purchaser be liable for any liability, obligation, governmental overpayment,
claim against or contract of any Seller, any affiliate of any Seller or any
Hospital of any kind or nature, whether or not accrued, whether fixed,
contingent or otherwise, whether known or unknown, and whether or not recorded
on the books and records of any Seller or any affiliate of any Seller, arising
out of any event occurring prior to the Effective Time, unless such liability,
obligation, claim or contract is expressly assumed by Purchaser pursuant to the
terms of this Agreement.

                                      -16-
<PAGE>

      1.12 Excluded Liabilities. Notwithstanding anything to the contrary in
Section 1.11, Purchaser shall not assume or become responsible for any of
Seller's duties, obligations or liabilities, whether known or unknown, direct or
indirect, foreseen or unforeseen, that are not expressly assumed by Purchaser
pursuant to the terms of this Agreement, the Bills of Sale or the Real Estate
Assignments (the "Excluded Liabilities"), and Seller shall remain fully and
solely responsible for all of Seller's debts, liabilities, contract obligations,
expenses, obligations and claims of any nature whatsoever related to Seller, the
Assets or the Hospitals unless expressly assumed by Purchaser under this
Agreement, in the Bills of Sale or in the Real Estate Assignments. The Excluded
Liabilities shall include, without limitation:

            (a) any current liabilities of Seller with respect to the operation
of any of the Hospitals prior to the Effective Time which are not specifically
included in the Assumed Obligations;

            (b) all liabilities of Seller arising out of or relating to any act,
omission, event or occurrence connected with the Seller, the Assets or Seller's
operations, including without limitation Seller's use, ownership or operation of
any of the Hospitals or any of the Assets, prior to the Effective Time, other
than as specifically included in the Assumed Obligations;

            (c) all liabilities in connection with claims of professional
malpractice or other tortious conduct to the extent arising out of or relating
to acts, omissions, events or occurrences prior to the Effective Time;

            (d) except as otherwise subject to reimbursement pursuant to the
Employee Leasing Agreement, all liabilities of each Seller for its respective
shares of matching contributions for eligible beneficiaries' 401(k) plans,
Section 125 plans and other Seller Plans, all liabilities and responsibilities
under all defined benefit pension plans sponsored by any Seller, and all
administrative costs associated with such welfare benefit plans or defined
benefit pension plans;

            (e) any and all obligations of Seller under the Worker Adjustment
and Retraining Notification Act (and California Assembly Bill AB 2957, as
codified at California Labor Code Sections 1400 through 1408) (collectively,
"WARN") with respect to the operation of the Hospitals as a result of the
consummation of the transactions contemplated by this Agreement;

            (f) all liabilities of Seller relating to cost reports (and all
claims with respect thereto) relating to each Seller (including home office cost
reports) with respect to Medicare, Medi-Cal, TRICARE or Blue Cross programs or
any other third-party payor for all periods prior to the Effective Time;

            (g) all liabilities of Seller relating to the Seller Cost Reports
with respect to periods ending prior to the Effective Time;

                                      -17-
<PAGE>

            (h) all liabilities of Seller for violations of any law, regulation
or rule to the extent arising from acts, omissions, events or occurrences prior
to the Effective Time, including, without limitation, those federal and state
laws pertaining to Medicare, Medi-Cal and other fraud and abuse laws;

            (i) all liabilities of Seller under the Excluded Multi-Facility
Contracts and Other Excluded Contracts; and

            (j) any tax liability of Seller (including income taxes) incurred as
a result of the consummation of the transaction contemplated by this Agreement;

            (k) all liabilities and obligations of Seller with respect to any
and all agreements, leases and other contracts not assigned to Purchaser
hereunder, whether arising before or after the Effective Time;

            (l) to the extent accrued prior to Closing, all liabilities and
obligations arising out of any breach by Seller prior to Closing of any Lease or
Contract;

            (m) all liabilities of Seller and its affiliates arising under or
relating in any way to the requirements of federal or state securities laws and
related disclosure requirements; provided, however, this Section 1.12(m) shall
not apply to any Offering Circular and the terms of this Section 1.12(m) shall
be subject to Purchaser's obligations under Section 10.3.1(j);

            (n) all liabilities of Seller for commissions or fees owed to any
finder or broker in connection with the transactions contemplated hereunder,
including without limitation any fees owing to Citigroup or Bank of America or
any of their respective affiliated companies; and

            (o) all liabilities of Seller and/or Seller's affiliates for
employee bonus programs at the Hospitals (including sign-on bonus and referral
bonus programs), tuition reimbursement programs, and career advancement
programs, and any other similar employee benefit program as to which, as of the
Closing Date, there are determinable amounts to be paid after the Closing Date
have arisen based on events on or prior to the Closing Date and which amounts
have not been accrued for financial reporting purposes by the Hospitals based
on, among other factors, the fact that such amounts to be paid in the future are
contingent on one or more future events (including without limitation the
continued employment of the employee entitled to such payment on the date of
payment); and

            (p) all liabilities of Seller and/or Seller's affiliates for any
Accrued Paid Time Off in excess of the amount treated as an Assumed Obligation
under Section 1.11(d).

      1.13 Disclaimer of Warranties. Except as expressly set forth in Article II
hereof, the Assets transferred to Purchaser will be sold by Seller and purchased
by Purchaser in their physical condition at the Effective Time, "AS IS, WHERE IS
AND WITH ALL FAULTS AND NONCOMPLIANCE WITH LAWS" WITH NO WARRANTY OF
HABITABILITY OR FITNESS FOR HABITATION, with respect to the Real Property, land,
buildings and improvements, and WITH NO WARRANTIES, INCLUDING, WITHOUT
LIMITATION, THE WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE, with respect to the physical condition of the Personal Property and
Inventory, any and all of which warranties (both express and implied) Seller
hereby disclaims. All of the foregoing real and personal property shall be
further subject to normal wear and tear on the land, buildings, improvements and
equipment and normal and customary use of the inventory and supplies in the
ordinary course of business up to the Effective Time.

                                      -18-
<PAGE>

      1.14 Risk of Loss. The risk of loss or damage to any of the Assets,
Personal Property, Real Property, the Hospitals and all other property, transfer
of which is contemplated by this Agreement, shall remain with Seller until the
Effective Time and Seller shall maintain its insurance policies covering the
Assets, Personal Property, Real Property, the Hospitals and all other property
through the Effective Time.

            (a) With respect to the Real Property, if prior to the Closing, all
or any part of the Real Property is destroyed or damaged by fire or the elements
or by any other cause where such damage or destruction is in the aggregate (the
"Aggregate Damage") less than twenty percent (20%) of the Purchase Price, the
parties' duties and obligations under this Agreement shall not be affected and
the Closing shall proceed as scheduled; provided, however, Seller shall assign,
transfer and set over to Purchaser all of Seller's right, title and interest in
and to any insurance proceeds on account of such damage or destruction and, if
such insurance policy proceeds are insufficient to repair, restore and/or
replace the Real Property, the difference between the cost to repair, restore
and/or replace and the amount of such proceeds shall be deducted from the Cash
Purchase Price. If prior to the Closing, all or any part of the Real Property is
destroyed or damaged by fire or the elements or by any other cause where the
Aggregate Damage exceeds twenty percent (20%) of the Purchase Price, Purchaser
may elect to (i) purchase such Owned Real Property, or take assignment of such
Leased Real Property, and the Closing shall proceed as scheduled (provided,
however, at the Closing Seller shall assign, transfer and set over to Purchaser
all of Seller's right, title and interest in and to any insurance proceeds on
account of such damage or destruction loss plus the amount of any deductibles
under such insurance policies) or (ii) not purchase such Owned Real Property, or
not take assignment of such Leased Real Property, and, in such event, an
appropriate adjustment to the Cash Purchase Price shall be made by Purchaser and
Seller. If prior to the Closing, all or any part of the Real Property is
destroyed or damaged by fire or the elements or by other cause where the
Aggregate Damage exceeds twenty percent (20%) of the Purchase Price, Purchaser
may elect to terminate this Agreement by written notice to Seller (the "Casualty
Termination Notice") after the date which is fifteen (15) days after the
occurrence of such damage or destruction but no later than the date which is
thirty (30) days after the occurrence of such damage or destruction (the
"Casualty Termination Notice Period"); provided, however, that in no event shall
the Casualty Termination Notice be provided (A) after the Closing or (B) if
Seller and Purchaser are unable to agree prior to the inception of the Casualty
Termination Notice Period that the amount of the Aggregate Damage exceeds twenty
percent (20%) of the Purchase Price. If Purchaser and Seller are unable to agree
upon the amount of the Aggregate Damage by the earlier to occur of (I) the
originally scheduled Closing Date (the "Original Closing Date") or (II) the
inception of the Casualty Termination Notice Period, the amount of the Aggregate
Damage shall be determined by Centex Rodgers (the "Independent Consultant")
pursuant to Section 1.14(d).

            (b) With respect to any Assets other than Real Property which are
destroyed or damaged by fire or the elements or by any other cause prior to the
Closing, Seller shall assign, transfer and set over to Purchaser all of Seller's
right, title and interest to any insurance proceeds on account of such damage or
destruction and shall reimburse Purchaser for any deductible Purchaser is
required to pay in connection with the receipt of such insurance proceeds.

                                      -19-
<PAGE>

            (c) If prior to the Closing, all or any part of a parcel of the Real
Property is made subject to an eminent domain proceeding which would in
Purchaser's reasonable judgment materially adversely (whether individually or in
the aggregate) impair access to the Real Property or be materially adverse
(whether individually or in the aggregate) to the operation of the Hospitals,
Purchaser may elect to (i) purchase such affected Owned Real Property, or take
assignment of such Leased Real Property, and the Closing shall proceed as
scheduled (provided, however, at the Closing Seller shall assign, transfer and
set over to Purchaser all of Seller's right, title and interest in and to any
award in such eminent domain proceeding) or (ii) not purchase the affected Owned
Real Property, or not take assignment of such Leased Real Property, and, in such
event, an appropriate adjustment to the Cash Purchase Price shall be made by
Purchaser and Seller. If Purchaser and Seller are unable to agree upon the
amount of the adjustment described in subsection (ii) of the preceding sentence
by the Original Closing Date, the adjustment shall be resolved by the
Independent Consultant pursuant to Section 1.14(d).

            (d) If pursuant to either Section 1.14(a) or 1.14(c), the amount of
the Aggregate Damage (and any applicable Cash Purchase Price adjustment) is to
be determined by the Independent Consultant, within five (5) calendar days after
the earlier to occur of the Original Closing Date or the inception of the
Casualty Termination Notice Period (the "Submittal Date"), each party shall
submit to the other party and to the Independent Consultant its proposed
Aggregate Damage (and any applicable Cash Purchase Price adjustment) as a result
of the event(s) contemplated by either Section 1.14(a) or 1.14(c), along with a
detailed description of the basis for such amount and any applicable adjustment.
Within ten (10) calendar days after the Submittal Date (the "Decision Date"),
the Independent Consultant, acting as an expert and not as an arbitrator, shall
select either the Aggregate Damage (and any applicable Cash Purchase Price
adjustment) proposal of Seller or the Aggregate Damage (and any applicable Cash
Purchase Price adjustment) proposal of Purchaser as the definitive amount of the
Aggregate Damage (and any applicable adjustment to the Cash Purchase Price) and
Purchaser shall thereafter have the right to provide a Casualty Termination
Notice provided that the Aggregate Damage exceeds twenty percent (20%) of the
Purchase Price. If either Purchaser or Seller fails to timely provide its
proposed Aggregate Damage (and any applicable Cash Purchase Price adjustment) to
the Independent Consultant, the Aggregate Damage (and any applicable Cash
Purchase Price adjustment) shall be the amount proposed by the submitting party
and Purchaser shall thereafter have the right to provide a Casualty Termination
Notice provided that the Aggregate Damage exceeds twenty percent (20%) of the
Purchase Price. If neither party submits its proposed Aggregate Damage (and any
applicable Cash Purchase Price adjustment) to the Independent Consultant, no
adjustment to the Cash Purchase Price shall be made and Purchaser shall not have
the right to provide a Casualty Termination Notice. The decision of the
Independent Consultant shall be conclusive and binding as between Purchaser and
Seller, and the costs of such review shall be borne by the party whose proposed
Aggregate Damage (and any applicable Cash Purchase Price adjustment) is not
selected by the Independent Consultant. Upon any such determination of the
adjustment to the Cash Purchase Price in accordance with this Section 1.14, the
parties shall, subject to the terms and conditions of this Agreement, consummate
the transactions contemplated by this Agreement at a mutually agreeable time and
place, in accordance with the provisions of this Agreement. If pursuant to
either Section 1.14(a) or 1.14(c), the amount of the Aggregate Damage (and any
applicable Cash Purchase Price adjustment) is to be determined by the
Independent Consultant and either the Submittal Date or the Decision Date falls
on a day which is on or after the Termination Date, then the Termination Date
shall be extended to the date which is ten (10) calendar days after the Decision
Date.

                                      -20-
<PAGE>

                                   ARTICLE II

                    REPRESENTATIONS AND WARRANTIES OF SELLER

      As an inducement to Purchaser to enter into this Agreement and to
consummate the transactions contemplated by this Agreement, each Seller, jointly
and severally, hereby represents, warrants and covenants to Purchaser as to the
following matters, except as disclosed in the disclosure schedule as of the
Effective Date, as may be amended pursuant to the terms of this Agreement (the
"Disclosure Schedule") hereby delivered by Seller to Purchaser. Except as
otherwise provided herein, Seller shall be deemed to remake all of the following
representations, warranties and covenants as of the Closing Date:

      2.1 Authorization. Seller has full corporate power and authority to enter
into this Agreement and full power and authority to carry out the transactions
contemplated hereby.

      2.2 Binding Agreement. All corporate and other actions required to be
taken by each Seller to authorize the execution, delivery and performance of
this Agreement, all documents executed by each Seller which are necessary to
give effect to this Agreement, and all transactions contemplated hereby, have
been duly and properly taken or obtained by such Seller. No other corporate or
other action on the part of each Seller is necessary to authorize the execution,
delivery and performance of this Agreement, all documents necessary to give
effect to this Agreement and all transactions contemplated hereby. This
Agreement has been duly and validly authorized, executed and delivered by each
Seller and, assuming due and valid execution by Purchaser, this Agreement
constitutes a valid and binding obligation of each Seller enforceable in
accordance with its terms subject to (a) applicable bankruptcy, reorganization,
insolvency, moratorium and other laws affecting creditors' rights generally from
time to time in effect and (b) limitations on the enforcement of equitable
remedies..

      2.3 Organization and Good Standing; No Violation.

            (a) Each Seller is a corporation duly organized, validly existing
and in good standing under the laws of the state of its incorporation. Each
Seller has full power and authority to own, operate and lease its properties and
to carry on its businesses as now conducted. Each Seller is duly qualified and
licensed to do business under the laws of the State of California.

            (b) Neither the execution and delivery by Seller of this Agreement
nor the consummation of the transactions contemplated hereby by Seller nor
compliance with any of the material provisions hereof by Seller, will violate,
conflict with or result in a breach of any material provision of Seller's
articles of incorporation or bylaws, respectively.

            (c) Seller, as applicable, has previously provided to Purchaser true
and complete copies of its articles of incorporation and bylaws as in effect as
of the Effective Date. Seller, as applicable, will provide to Purchaser true and
complete copies of its articles of incorporation and bylaws as in effect as of
the Closing Date, if different from those in effect as of the Effective Date.

                                      -21-
<PAGE>

            (d) Seller does not have any Subsidiaries. As used in this
Agreement, "Subsidiary" means any corporation, partnership, trust, limited
liability company or other non-corporate business enterprise in which Seller (or
another Subsidiary of Seller) holds stock or other ownership or equity interests
representing (a) more than 50% of the voting power of all outstanding stock or
ownership interests of such entity or (b) the right to receive more than 50% of
the net assets of such entity available for distribution to the holders of
outstanding stock or ownership interests upon a liquidation or dissolution of
such entity.

      2.4 Contracts and Leases.

            (a) With the exception of the Excluded Multi-Facility Contracts,
Schedule 1.9(e) includes a list of all Leases in respect of Real Property or
Personal Property (i) which (A) require lease payments by Seller with respect to
the operation of any Hospital during the remaining term of such Lease in excess
of Twenty Five Thousand Dollars ($25,000), and (B) either have a remaining term
in excess of twelve (12) months or cannot be terminated by Seller upon notice of
ninety (90) calendar days or less, or (ii) which are with each Hospital's
referral sources (as determined by applicable health care laws, rules and
regulations) ("Referral Sources"), including, without limitation, any physicians
on each Hospital's medical staff. Prior to the Effective Date, Seller has made
available to Purchaser true and correct copies of all of the Leases set forth in
Schedule 1.9(e). The Leases set forth on Schedule 1.9(e) are referred to herein
as the "Material Leases".

            (b) With the exception of the Excluded Multi-Facility Contracts,
Schedule 1.9(f) includes a list of all Contracts (i) which (A) require the
payment by Seller with respect to the operation of any Hospital during the
remaining term of such instrument in excess of Twenty Five Thousand Dollars
($25,000), and (B) either have a remaining term in excess of twelve (12) months
or cannot be terminated by Seller upon notice of ninety (90) calendar days or
less, or (ii) which are with each Hospital's Referral Sources, including,
without limitation, any physicians on each Hospital's medical staff. Prior to
the Effective Date, Seller has made available to Purchaser true and correct
copies of all of the Contracts set forth in Schedule 1.9(f). The Contracts set
forth on Schedule 1.9(f) are referred to herein as the "Material Contracts".

            (c) Each Material Lease and each Material Contract, respectively, is
in full force and effect and is the valid and binding obligation of Seller and,
to the knowledge of Seller, of each other party thereto.

            (d) Schedule 2.4(d) sets forth a list of the Excluded Multi-Facility
Contracts which are material to the operation of the Hospitals.

            (e) In all material respects, (i) all obligations required to be
performed under the terms of the Material Leases and the Material Contracts by
Seller have been performed, (ii) no act or omission by Seller (including,
without limitation, entering into this Agreement or the consummation of the
transactions contemplated herein) has occurred or failed to occur which, with
the giving of notice, the lapse of time or both would constitute a default under
the Material Leases or the Material Contracts, and (iii) each of such Material
Leases and Material Contracts is now and will be upon the Closing Date in full
force and effect without default on the part of Seller. No provision of this
Section 2.4(e) shall apply to any failure to obtain consents to the assignment
of the Material Leases and Material Contracts from the third parties to the
Material Leases and Material Contracts in which consent is required to assign
the Material Leases and Material Contracts to Purchaser.

                                      -22-
<PAGE>

      2.5 Required Consents. Except as set forth on Schedule 2.5, Seller is not
a party to or bound by, nor are any of the Assets subject to, any mortgage,
material lien, deed of trust, any Material Lease or any Material Contract, or
any material order, judgment or decree which (a) requires the consent of another
to the execution of this Agreement or (b) requires the consent of another to
consummate the transactions contemplated by this Agreement.

      2.6 Compliance With Laws and Contracts.

            (a) Except as set forth in Schedule 2.6(a), Seller, with respect to
the operation of the Hospitals, including, without limitation, with respect to
any Contracts and Leases with each Hospital's Referral Sources, is in compliance
with all applicable laws, statutes, ordinances, orders, rules, regulations,
policies, guidelines, licenses, certificates, certificates of need, judgments or
decrees of all judicial or governmental authorities (federal, state, local,
foreign or otherwise), including, without limitation, those relating to
Medicare, Medi-Cal and the Hospitals' cost reports, except where the failure to
be in such compliance would not have a material adverse effect on the Assets or
the businesses of the Hospitals. Except as set forth in Schedule 2.6(a), Seller,
with respect to the operation of the Hospitals, has not been charged with or
given notice of, and to the best knowledge of Seller, Seller, with respect to
the operation of the Hospitals, is not under investigation with respect to, any
violation of, or any obligation to take remedial action under, any applicable
(i) material law, statute, ordinance, rule, regulation, policy or guideline
promulgated, (ii) material license, certificate or certificate of need issued,
or (iii) order, judgment or decree entered, by any federal, state, local or
foreign court or governmental authority relating to the Hospitals or the
businesses of any of the Hospitals. Notwithstanding the foregoing, no provision
of this Section 2.6(a) shall be deemed a representation or warranty by Seller as
to compliance with any Environmental Laws (as defined in Section 2.6(c) below).

            (b) Seller's ownership and operation of each of the Hospitals and
the Assets are and have been in compliance with all Environmental Laws, except
where the failure to be in such compliance would not have a material adverse
effect on the Assets or the businesses of the Hospitals. Seller has obtained all
licenses, permits and approvals necessary or required under all applicable
Environmental Laws (the "Environmental Permits") for the ownership and operation
each of the Hospitals and the Assets. All such Environmental Permits are in
effect and, to Seller's knowledge, no action to revoke or modify any of such
Environmental Permits is pending. There is not now pending or, to Seller's
knowledge, threatened, any claim, investigation or enforcement action by any
governmental authority (whether judicial, executive or administrative)
concerning Seller's potential liability under Environmental Laws in connection
with the ownership or operation of the Hospitals or the Assets. To Seller's
knowledge, there has not been a release or threatened release of any Hazardous
Substance at, upon, in, under or from the Hospitals or the Assets at any time.
Seller has arranged any disposal of Hazardous Substances from the Hospitals with
licensed contractors in accordance with applicable Environmental Laws.

                                      -23-
<PAGE>

            (c) For the purposes of this Agreement, the term "Environmental
Laws" shall mean all state, federal or local laws, ordinances, codes or
regulations relating to Hazardous Substances or to the protection of the
environment, including, without limitation, laws and regulations relating to the
storage, treatment and disposal of medical and biological waste. For purposes of
this Agreement, the term "Hazardous Substances" shall mean (i) any hazardous or
toxic waste, substance, or material defined as such in (or for the purposes of)
any Environmental Laws, (ii) asbestos-containing material, (iii) medical and
biological waste, (iv) polychlorinated biphenyls, (v) petroleum products,
including gasoline, fuel oil, crude oil and other various constituents of such
products, and (vi) any other chemicals, materials or substances, exposure to
which is prohibited, limited or regulated by any Environmental Laws.

            (d) To Seller's knowledge, Seller has performed all material
obligations relating to the Assets and the businesses of the Hospitals, and is
not in breach or default, nor do any circumstances exist which with or without
notice or lapse of time, or both, would result in breach or default, nor is
there any claim of such breach or default with respect to any obligation to be
performed, under any Material Contract, Material Lease, guaranty, indenture or
loan agreement relating to the Assets or the businesses of the Hospitals, which
breach or default or its consequences might materially adversely affect the
Assets or the businesses of the Hospitals. No provision of this Section 2.6(d)
shall apply to any failure to obtain consents to the assignment of the Contracts
and Leases from the third parties to the Contracts and Leases in which consent
is required to assign the Contracts and Leases to Purchaser (the "Contract and
Lease Consents").

      2.7 Title; Sufficiency.

            (a) Each Seller has good and marketable fee simple or leasehold
title, as the case may be, to its respective Real Property. Each Seller has good
and valid title to its respective Personal Property, which individually or in
the aggregate is material to the condition (financial or otherwise), operations
or the business of any particular Hospital. Schedule 1.9(a) contains a complete
list of all of the real property owned by each Seller that is used in connection
with the conduct of the Hospitals' businesses. Schedule 1.9(e), Schedule 1.9(f)
and/or Schedule 2.7(b) includes a list of all Contracts or Leases in respect of
Real Property or Personal Property which contain a grant to any third party of a
right or option to purchase any of the Real Property or any of the Personal
Property.

            (b) The Real Property and the Personal Property is held by each
respective Seller free and clear of all liens, pledges, claims, charges,
security interests or other encumbrances ("Encumbrances"), and is not, in the
case of the Real Property, subject to any rights-of-way, building or use
restrictions, exceptions, variances, reservations or limitations of any nature
whatsoever except, with respect to such properties, (i) liens for current real
property taxes and assessments, (ii) mechanics', carriers', workmen's,
repairmen's and other statutory liens, rights of way, building or use
restrictions, exceptions, easements, covenants, variances, reservations and
other limitations of any kind, if any, which would not have a material adverse
effect on the Assets or the businesses of the Hospitals or for which, in respect
of matters affecting title to the Real Property, title insurance coverage has
been obtained, (iii) those standard printed exceptions customarily set forth in
ALTA Extended Coverage title reports or ALTA Extended Coverage title policies
(other than exceptions for matters identified in the Surveys with respect to the
Real Property), and (iv) other such encumbrances as are set forth in Schedules
2.7(b) and 7.7. None of the Real Property is subject to a pending, or to
Seller's knowledge threatened, condemnation or similar proceeding.

                                      -24-
<PAGE>

            (c) Seller has not received notice of, nor, to Seller's knowledge,
is there any action, proceeding or litigation pending (or overtly contemplated
or threatened) (i) to modify the zoning of, or other governmental rules or
restrictions applicable to the Real Property or the use or development thereof,
or (ii) for any street widening or changes in highway or traffic lanes or
patterns in the immediate vicinity of the Real Property, which in each case
would be reasonably likely to interfere with the use, ownership and/or operation
of the Real Property. Except as set forth in Schedule 2.7(c), to Seller's
knowledge, there are no material defects in the physical condition of the HVAC
or electrical systems, or the plumbing at any of the Hospitals.

            (d) The Inventory with respect to each Hospital is, and at the
Closing Date will be, maintained in such quality and quantities as is consistent
with such Hospital's historical practices.

            (e) The Assets and the Excluded Assets comprise substantially all of
the property and assets used in the conduct of the businesses and operation of
the Hospitals. The Assets and the Excluded Assets comprise all property and
assets owned by the Sellers, except as set forth in Schedule 2.7(e).

      2.8 Certain Representations With Respect to the Hospitals.

            (a) All licenses, certifications and certificates of need which are
necessary to operate the business of each respective Hospital by each respective
Seller are valid and in good standing, except where the failure to have such
licenses, certifications and certificates of need would not have a material
adverse effect on the Assets or the businesses of the Hospitals. Each of the
Acute Care Hospitals is duly licensed by the State of California to operate as a
general acute care hospital having that number and type of beds as set forth on
such Acute Care Hospital's current general acute care hospital license.

            (b) Each Acute Care Hospital is duly accredited by the Joint
Commission on Accreditation of Healthcare Organizations ("JCAHO") for the period
set forth in Schedule 2.8(b). Except as set forth in Schedule 2.8(b), (i) Seller
has not received any notices of deficiency from JCAHO with respect to the
Hospitals' current accreditation period which require or request any action or
response by Seller or the Hospitals and (ii) any such deficiencies have been
corrected or otherwise remedied.

            (c) Each Acute Care Hospital is certified for participation in the
Medicare, Medi-Cal and TRICARE programs, and has current and valid provider
contracts with each of such programs, except where the failure to have such
contracts would not have a material adverse effect on the businesses of the
Hospitals. Except as set forth in Schedule 2.8(c), Seller has not received
notices from the regulatory authorities which enforce the statutory or
regulatory provisions in respect of any of the Medicare, Medi-Cal or TRICARE
programs of any pending or threatened investigations with respect to the
operation of the Hospitals.

                                      -25-
<PAGE>

            (d) Notices of Program Reimbursement have been issued by the
applicable fiscal intermediary with respect to the cost reports of the Hospitals
for Medicare, Medi-Cal (if required) and Blue Cross (if required) through the
periods set forth in Schedule 2.8(d) (the "Audit Periods"). Each of such reports
was timely filed. Seller has not received notice of any material dispute between
any Hospital and the applicable governmental agency or private entity, or their
intermediaries or representatives, regarding such cost reports for periods
subsequent to the periods specified in Schedule 2.8(d). Except as set forth in
Schedule 2.8(d), there are no pending or, to Seller's knowledge, threatened
material claims or investigations by any of such programs against any Hospital
with respect to the Audit Periods or any period thereafter.

            (e) With respect to the operation of the Hospitals, no Seller has
any outstanding loan, grant or loan guarantee pursuant to the Hill-Burton Act
(42 USC Section 291a, et seq.).

            (f) Except as disclosed on Schedule 2.8(f), there are no pending or,
to the knowledge of Seller, threatened disciplinary or corrective actions or
appeals therefrom involving physician applicants, active medical staff members
or affiliated health professionals under the medical staff bylaws at each
Hospital. Seller has provided to Purchaser a true, correct and complete copy of
the bylaws, rules and regulations of the medical staff at each Hospital and its
executive committee. Notwithstanding the foregoing provisions of this Section
2.8(f), Seller shall not be required to disclose any information pursuant to
this Section 2.8(f) where such disclosure is prohibited by state law or such
disclosure would, or could reasonably be expected to, jeopardize any applicable
privilege or protection described in Section 1.10(u), including, without
limitation, peer review or any other privilege which is available under
applicable law.

            (g) Seller has submitted a plan and compliance schedule ("Seismic
Plan") for each Hospital to the California Office of Statewide Health Planning
and Development ("OSHPD"). Each Seismic Plan reflects Seller's good faith
evaluation of the seismic condition of the Hospital for which such Seismic Plan
was submitted as of the date of such submission, and Seller's plan to bring such
Hospital into substantial compliance with the regulations and standards
developed by OSHPD pursuant to the Alfred E. Alquist Hospital Facilities Seismic
Safety Act of 1983, as amended, including by SB 1953 in 1994 (the "Alquist Act")
as then in effect. Seller's estimate of the cost for each Hospital to comply
with the regulations and standards as in effect on the date of the submission of
the Seismic Plan with respect thereto, as previously provided to Purchaser, was
made in good faith and based upon assumptions that Seller believed to be
reasonable as of the date of such submission. Seller has been granted extensions
until 2013 by OSHPD with respect to each Hospital. Seller has delivered or
otherwise made available, or will deliver or otherwise make available prior to
Closing, to Purchaser copies of the Seismic Plans.

      2.9 Brokers and Finders. Other than Citigroup and Bank of America, neither
Seller nor any affiliate thereof, nor any officer or director thereof, has
engaged any finder or broker in connection with the transactions contemplated
hereunder. Seller shall be solely responsible for, and hereby indemnifies
Purchaser against, any payments to Citigroup or Bank of America required to be
made in connection with the negotiation or consummation of this Agreement or any
of the transactions contemplated hereby.

                                      -26-
<PAGE>

      2.10 Financial Statements. The following have been or will be prepared
from the books and records of Seller (a) the unaudited financial statements of
each Seller with respect to the operation of the Hospitals as of December 31,
2003 and December 31, 2002, and for the years ended December 31, 2003 and
December 31, 2002 (the "2002 & 2003 Financials"), (b) the unaudited financial
statements of each Seller with respect to the operation of the Hospitals as of
July 31, 2004 and for the seven (7) months then ended (the "2004 Financials"),
(c) the unaudited financial statements of each Seller with respect to the
operation of the Hospitals for months subsequent to July 2004 as made available
pursuant to Section 4.5 (the ("Interim Financials") (d) the Interim Balance
Sheet and (e) the Final Balance Sheet (the 2002 & 2003 Financials, the 2004
Financials, the Interim Financials, the Interim Balance Sheet and the Final
Balance Sheet are collectively referred to herein as the "Financial
Statements"). The 2002 & 2003 Financials and the 2004 Financials are attached as
Schedule 2.10. The Financial Statements fairly present, or will fairly present,
the financial position and results of operations, as applicable, of each Seller
with respect to the operation of the Hospitals as of and for the periods then
ended. The Financial Statements are in conformity with generally accepted
accounting principles consistently applied during such periods, except that the
Financial Statements: (i) do not reflect all cost report adjustments,
allocations or adjustments of overhead, intercompany interest or income taxes,
and other year-end adjustments, (ii) do not contain footnotes, (iii) were
prepared without physical inventories, (iv) do not contain an unaudited
statement of cash flow, (v) omit substantially all the disclosures required by
generally accepted accounting principles, (vi) are not restated for subsequent
events, (vii) may not reflect any adjustments for impairment of long-lived
assets or goodwill, or restructuring charges or the reclassification of assets
held for sale on the balance sheet, (viii) do not reflect accounts receivable
sale transactions with an affiliate and (ix) may not fully reflect the following
liabilities: (A) vacation, holiday and similar accruals and accruals in respect
of Seller's or any affiliate of Seller's self-insured employee health benefits,
(B) liabilities payable in connection with workers' compensation claims, (C)
liabilities payable pursuant to any employee welfare benefit plan (within the
meaning of Section 3(1) of the Employee Retirement Income Security Act of 1974,
as amended ("ERISA")), maintained by Seller or any affiliate of Seller on
account of any of the Hospitals' employees, the chief executive officers of the
Hospitals ("CEOs"), the chief financial officers of the Hospitals ("CFOs"), the
chief operating officers of the Hospitals ("COOs") and the chief nursing
officers of the Hospitals ("CNOs"), (D) federal, state and local income or
franchise taxes and (E) payroll and bonuses payable and vacation, holiday and
similar accruals with respect to the CEOs, CFOs, COOs and CNOs.

      2.11 Legal Proceedings. Except as set forth on Schedule 2.11, there are no
claims, proceedings or investigations pending or, to the best knowledge of
Seller, threatened relating to or affecting Seller with respect to the operation
of the Hospitals or any of the Assets before any court or governmental body
(whether judicial, executive or administrative) in which an adverse
determination would have a material adverse effect on the Assets or the business
condition of the Hospitals. Seller, with respect to the operation of the
Hospitals, is not subject to any judgment, order, decree or other governmental
restriction specifically (as distinct from generically) applicable to it or its
assets, including the Assets, which would have a material adverse effect on the
Assets or the business condition (financial or otherwise) of the Hospitals.
There is no claim, proceeding, or investigation pending or, to the best
knowledge of Seller, threatened, relating to or affecting Seller with respect to
the operation of the Hospitals before any court or governmental body (whether
judicial, executive or administrative) which: (a) materially adversely affects
or seeks to prohibit, restrain or enjoin the execution and delivery of this
Agreement; (b) materially adversely affects or questions the validity or
enforceability of this Agreement; (c) questions the power or authority of any
Seller to carry out the transactions contemplated by, or to perform its
obligations under, this Agreement; or (d) would result in any change which would
materially adversely affect the ability of any Seller to perform any of its
obligations hereunder.

                                      -27-
<PAGE>

      2.12 Employee Benefits.

            (a) Schedule 2.12 contains a list of (i) each pension, profit
sharing, bonus, deferred compensation, or other retirement plan or arrangement
of Seller with respect to the operation of the Hospitals, whether oral or
written, which constitutes an "employee pension benefit plan" as defined in
Section 3(2) of ERISA, (ii) each medical, health, disability, insurance or other
plan or arrangement of Seller with respect to the operation of the Hospitals,
whether oral or written, which constitutes an "employee welfare benefit plan" as
defined in Section 3(1) of ERISA, and (iii) each other employee benefit,
program, plan or perquisite provided by Seller with respect to the operation of
the Hospitals, in which any employee of Seller participates in his capacity as
such (collectively, the "Seller Plans"). Copies of the summary plan descriptions
and brochures with respect to the Seller Plans have previously been, or will
promptly be, furnished to Purchaser.

            (b) With respect to each Seller Plan, to Seller's knowledge, Seller
does not have any direct or indirect, actual or contingent liability, other than
to make payments for contributions, premiums or benefits when due in the
ordinary course, all of which payments that are due having been made. Neither
the Hospitals nor any of the Assets are subject to any lien under ERISA or the
Internal Revenue Code of 1986, as amended (the "Code").

            (c) All of the Seller Plans have been administered in material
compliance with ERISA and the applicable provisions of the Code. There are no
"accumulated funding deficiencies" within the meaning of ERISA or the Code or
any federal excise tax or other liability on account of any deficient fundings
in respect of the Seller Plans. No reportable event(s) (within the meaning of
ERISA) or prohibited transaction(s) (within the meaning of the Code), has
occurred in respect of any of the Seller Plans that would result in any material
liability to Seller. Other than claims for benefits, there are not pending or,
to Seller's knowledge, threatened any claims relating to the Seller Plans by any
employee of Seller with respect to the operation of the Hospitals, alleging a
breach or breaches of fiduciary duties or violations of other applicable state
or federal law which could result in liability on the part of Seller or any of
the Seller Plans under ERISA or any other law that would have a material adverse
effect on Seller. To Seller's knowledge, none of the Seller Plans discriminates
in operation in favor of employees who are officers or who are highly
compensated, except as permitted under the Code and ERISA. To Seller's
knowledge, all returns, reports, disclosure statements and premium payments
required to be made under ERISA and the Code with respect to any of the Seller
Plans have been timely filed or delivered, except where any such failure to file
or deliver would not have a material adverse effect on Seller. Except as set
forth on Schedule 2.12(c) and except for routine random audits or submissions by
Seller to the Voluntary Compliance Resolution Program, none of the Seller Plans
have been audited or investigated by either the Internal Revenue Service, the
Department of Labor or the Pension Benefit Guaranty Corporation within the last
five (5) years, and there are no outstanding issues with reference to any of the
Seller Plans pending before such governmental agencies. Seller currently and for
the past five years has neither (i) sponsored nor contributed to a defined
benefit pension plan as defined in ERISA ss. 3(2)A nor (ii) contributed to any
multi-employer plan as defined in ERISA ss. 3(37)A.

                                      -28-
<PAGE>

            (d) With respect to the Seller Plans, except as otherwise contained
in the Assumed Obligations or as set forth in Sections 5.3 (employee matters)
and 5.16 (collective bargaining obligations) of this Agreement, to the best of
Seller's knowledge, there is no liability, direct or indirect, absolute or
contingent, which the Purchaser shall assume, or could reasonably be expected to
assume, as part of the transactions contemplated by this Agreement or otherwise.

      2.13 Personnel.

            (a) Schedule 2.13(a) sets forth a complete list (as of the date set
forth therein) of names, positions and current annual salaries or wage rates,
bonus and other compensation and/or benefit arrangements, the paid time off pay,
including CashPlus and Reserve Sick, and period of service credited for vesting
as of the date thereof of all full-time and part-time employees of Seller with
respect to the operation of the Hospitals and indicating whether such employee
is a part-time or full-time employee.

            (b) Except as set forth on Schedule 2.13(b), there are no labor
union or collective bargaining agreements in effect with respect to the
employees of Seller with respect to the operation of the Hospitals. Seller has
provided Purchaser with copies of all agreements and contracts described in
Schedule 2.13(b). There is no unfair labor practice complaint against Seller
pending, or to the best knowledge of Seller threatened, before the National
Labor Relations Board with respect to the operation of the Hospitals. There is
no labor strike, arbitration, dispute, slowdown or stoppage, and no union
organizing campaign, pending, or to the best knowledge of Seller threatened by
or involving the employees of Seller with respect to the operation of the
Hospitals.

      2.14 Insurance. Seller maintains, and has maintained, without
interruption, at all times during each Seller's respective ownership of the
Hospitals, self-insurance or policies or binders of insurance covering such
risks and events, including personal injury, property damage, malpractice and
general liability, to provide adequate and sufficient insurance coverage for all
the assets and operations of the Hospitals. Schedule 2.14 contains a list of all
such insurance maintained by Seller with respect to the operation of the
Hospitals as of the Effective Date, which insurance is in full force and effect.

      2.15 Solvency. No Seller or THC is insolvent and no Seller or THC will be
rendered insolvent as a result of any of the transactions contemplated by this
Agreement. For purposes hereof, the term "solvency" means that: (a) the fair
salable value of each company's tangible assets is in excess of the total amount
of its respective liabilities (including for purposes of this definition all
liabilities, whether or not reflected on a balance sheet prepared in accordance
with generally accepted accounting principles, and whether direct or indirect,
fixed or contingent, secured or unsecured, and disputed or undisputed); (b) each
company is able to pay its respective debts or obligations in the ordinary
course as they mature; and (c) each company has capital sufficient to carry on
its respective businesses and all businesses which it is respectively about to
engage.

                                      -29-
<PAGE>

      2.16 Taxes. Seller has duly filed all federal, state and local Tax Returns
required to be filed by it (all of which are true and correct in all material
respects) and has duly paid or made provision for the payment of all Taxes
(including any interest or penalties and amounts due state unemployment
authorities) which are due and payable, whether or not in connection with such
returns. Seller (with respect to the operation of the Hospitals) has withheld
proper and accurate amounts from its employees' compensation, and made deposits
of all such withholdings, in material compliance with all withholding and
similar provisions of the Code and any and all other applicable laws. There are
no liens for Taxes upon the Assets, except for statutory liens for current Taxes
not yet due and payable or which may hereafter be paid without penalty or which
are being contested in good faith by appropriate proceedings. No claim by any
taxing authority with respect to the Hospitals (or operation thereof) or the
Assets is pending in a jurisdiction where Seller does not file Tax Returns. For
purposes of this Agreement, (a) the terms "Tax" and "Taxes" mean any and all
federal, state, local and foreign taxes, assessments and other governmental
charges, duties, impositions, levies and liabilities, including, without
limitation, taxes based upon, measured by, or with respect to income, net
income, gross income, earnings, profits, or gross receipts, or any sales, use,
ad valorem, transfer, franchise, license, withholding, payroll, employment,
excise, severance, stamp, occupation, premium, property, windfall profits,
environmental, alternative, add-on minimum, custom duties, capital stock, social
security (or similar), unemployment, disability, gains, recapture, estimate, or
other taxes, fees, assessments, or charges of any kind whatsoever, together with
any interest, penalty, and addition thereto and (b) the term "Tax Return" means
any return, declaration, report, claim, election, notice, or information return
or statement or other document (including, without limitation, any related or
supporting information, schedules, or exhibits) filed or required to be filed
with any federal, state, local or foreign governmental authority or other
authority in connection with any Tax or estimated Tax.

      2.17 No Knowledge of Purchaser's Breach. Neither Seller nor any of its
affiliates has knowledge of any breach of any representation or warranty by
Purchaser or of any other condition or circumstance that would excuse Seller
from its timely performance of its obligations hereunder. If information comes
to Seller's attention on or before the Closing Date (whether through Purchaser
or otherwise and whether before or after the Effective Date) which indicates
that Purchaser has breached any of its representations and warranties under this
Agreement, then Seller must immediately notify Purchaser.

      2.18 Independent Auditor. The Independent Auditor is not, and during the
five (5) years prior to the Effective Date has not been, Seller's or THC's
primary independent auditor for financial reporting purposes.

      2.19 Seller Knowledge. References in this Agreement to "Seller's
knowledge", "knowledge of Seller" or the "best knowledge of Seller" mean the
actual knowledge of the CEOs, CFOs, COOs, and CNOs of the Hospitals, Barry
Wolfman and Ken Westbrook, Senior V.P.s of Regional Operations for Tenet
California, Tenet HealthSystem's Vice President of Regional Finance Operations,
California Region (which as of the Effective Date is William Durham), Paul
O'Neill and Eric Tuckman, without independent investigation. No constructive or
imputed knowledge shall be attributed to any such individual by virtue of any
position held, relationship to any other Person or for any other reason.

                                      -30-
<PAGE>

                                  ARTICLE III

                   REPRESENTATIONS AND WARRANTIES OF PURCHASER

      As an inducement to Seller to enter into this Agreement and to consummate
the transactions contemplated by this Agreement, Purchaser hereby represents,
warrants and covenants to Seller as to the following matters as of the Effective
Date and, except as otherwise provided herein, shall be deemed to remake all of
the following representations, warranties and covenants as of the Closing Date:

      3.1 Authorization. Purchaser has full corporate power and authority to
enter into this Agreement and has full corporate power and authority to carry
out the transactions contemplated hereby.

      3.2 Binding Agreement. All corporate and other actions required to be
taken by Purchaser to authorize the execution, delivery and performance of this
Agreement, all documents executed by Purchaser which are necessary to give
effect to this Agreement, and all transactions contemplated hereby, have been
duly and properly taken or obtained by Purchaser. No other corporate or other
action on the part of Purchaser is necessary to authorize the execution,
delivery and performance of this Agreement, all documents necessary to give
effect to this Agreement and all transactions contemplated hereby. This
Agreement has been duly and validly executed and delivered by Purchaser and,
assuming due and valid execution by Seller, this Agreement constitutes a valid
and binding obligation of Purchaser enforceable in accordance with its terms
subject to (a) applicable bankruptcy, reorganization, insolvency, moratorium and
other laws affecting creditors' rights generally from time to time in effect and
(b) limitations on the enforcement of equitable remedies.

      3.3 Organization and Good Standing. Purchaser is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Nevada, and has full corporate power and authority to own, operate and lease its
properties and to carry on its business as now conducted.

      3.4 No Violation. Neither the execution and delivery by Purchaser of this
Agreement nor the consummation of the transactions contemplated hereby nor
compliance with any of the material provisions hereof byPurchaser will violate,
conflict with or result in a breach of any material provision of the Articles of
Incorporation, Bylaws or other organizational documents of Purchaser.

      3.5 Brokers and Finders. Except as described on Schedule 3.5, neither
Purchaser nor any affiliate thereof nor any officer or director thereof has
engaged any finder or broker in connection with the transactions contemplated
hereunder.

      3.6 Representations of Seller. Purchaser acknowledges that it is
purchasing the Assets that it will be acquiring hereunder on as "AS IS, WHERE
IS" basis (as more particularly described in Section 1.13), and that Purchaser
is not relying on any representation or warranty (expressed or implied, oral or
otherwise) made on behalf of Seller other than as expressly set forth in this
Agreement.

                                      -31-
<PAGE>

      3.7 Legal Proceedings. Except as described on Schedule 3.7, there are no
claims, proceedings or investigations pending or, to the best knowledge of
Purchaser, threatened relating to or affecting Purchaser or any affiliate of
Purchaser before any court or governmental body (whether judicial, executive or
administrative) in which an adverse determination would materially adversely
affect the properties, business condition (financial or otherwise) of Purchaser
or any affiliate of Purchaser. Neither Purchaser nor any affiliate of Purchaser
is subject to any judgment, order, decree or other governmental restriction
specifically (as distinct from generically) applicable to Purchaser or any
affiliate of Purchaser which materially adversely affects the condition
(financial or otherwise), operations or business of Purchaser or any affiliate
of Purchaser.

      3.8 No Knowledge of Seller's Breach. Neither Purchaser nor any of its
affiliates has knowledge of any breach of any representation or warranty by
Seller or of any other condition or circumstance that would excuse Purchaser
from the timely performance of its obligations hereunder. If information comes
to Purchaser's attention on or before the Closing Date (whether through Seller
or otherwise and whether before or after the Effective Date) which indicates
that Seller has breached any of its representations and warranties under this
Agreement, then Purchaser must immediately notify Seller.

      3.9 Ability to Perform. Purchaser has the ability to obtain funds in cash
in amounts equal to the Cash Purchase Price by means of credit facilities or
otherwise and will at the Closing have immediately available funds in cash,
which are sufficient to pay the Cash Purchase Price and to pay any other amounts
payable pursuant to this Agreement and to consummate the transactions
contemplated by this Agreement.

      3.10 Solvency. Purchaser is not insolvent nor will be rendered insolvent
as a result of any of the transactions contemplated by this Agreement. For
purposes hereof, the term "solvency" means that: (a) the fair salable value of
Purchaser's tangible assets is in excess of the total amount of its liabilities
(including for purposes of this definition all liabilities, whether or not
reflected on a balance sheet prepared in accordance with generally accepted
accounting principles, and whether direct or indirect, fixed or contingent,
secured or unsecured, and disputed or undisputed); (b) Purchaser is able to pay
its debts or obligations in the ordinary course as they mature; and (c)
Purchaser has capital sufficient to carry on its businesses and all businesses
which it is about to engage.

      3.11 Independent Auditor. The Independent Auditor is not, and during the
five (5) years prior to the Effective Date has not been, Purchaser's primary
independent auditor for financial reporting purposes.

      3.12 Purchaser Knowledge. References in this Agreement to "Purchaser's
knowledge or "the best knowledge of Purchaser" mean the actual knowledge of the
Chief Executive Officer, Chief Financial Officer and Chief Operating Officer of
Purchaser, without independent investigation. No constructive or imputed
knowledge shall be attributed to any such individual by virtue of any position
held, relationship to any other Person or for any other reason.

                                      -32-
<PAGE>

                                   ARTICLE IV

                               COVENANTS OF SELLER

      4.1 Access and Information; Inspections. From the Effective Date through
the Effective Time, Seller shall afford to the officers and agents of Purchaser
(which shall include accountants, attorneys, bankers and other consultants and
agents of Purchaser) full and complete access during normal business hours to
and the right to inspect the plants, properties, books, accounts, records and
all other relevant documents and information with respect to the assets,
liabilities and businesses of the Hospitals. From the Effective Date through the
Effective Time, Seller shall furnish Purchaser with such additional financial
and operating data and other information in Seller's or an affiliate's
possession as to businesses and properties of the Hospitals as Purchaser or its
representatives may from time to time reasonably request, without regard to
where such information may be located. Purchaser's right of access and
inspection shall be exercised in such a manner as not to interfere unreasonably
with the operations of the Hospitals. Such access may include consultations with
the personnel of Seller; provided, however, that Purchaser shall not consult
with or contact in any manner any physicians on the medical staff at any of the
Hospitals without Seller's prior written consent, which consent shall not be
unreasonably withheld. Further, Purchaser may, at its sole cost and expense
(except as otherwise provided in Section 12.12), undertake environmental,
mechanical and structural surveys of the Hospitals. Notwithstanding the
foregoing, all access and inspection activities contemplated by this Section 4.1
shall be subject to the prior reasonable approval of Seller (which approval may
only be granted by Paul O'Neill or his designee).

      4.2 Conduct of Business. On and after the Effective Date and prior to the
Effective Time, and except as otherwise consented to or approved by an
authorized officer of Purchaser or required by this Agreement, Seller shall,
with respect to the operation of the Hospitals:

            (a) carry on its respective businesses with respect to the operation
of the Hospitals in substantially the same manner as presently conducted and not
make any material change in personnel, operations, finance, accounting policies
(unless Seller is required to adopt such changes under generally accepted
accounting principles or Seller's affiliates adopt such changes on a
company-wide basis), or real or personal property;

            (b) maintain each Hospital and all parts thereof and all other
Assets in operating condition in a manner consistent with past practices,
ordinary wear and tear excepted;

            (c) perform all of its material obligations under agreements
relating to or affecting each Hospital, its respective operations or the Assets;

            (d) keep in full force and effect present insurance policies or
other comparable self-insurance;

            (e) comply with all material legal requirements and contractual
obligations applicable to the Assets or the businesses of the Hospitals;

            (f) continue all construction, renovation, and Hospitals improvement
projects which are physically in progress as of the Effective Date substantially
in accordance with project schedules, budgets, construction plans, designs, and
furnishing plans in effect with respect to such projects as of the Effective
Date; (g) use its reasonable efforts, and cause its affiliates to use their
reasonable efforts, to maintain and preserve Seller's respective business
organizations intact, retain Seller's respective present employees at each
Hospital and maintain Seller's respective relationships with physicians,
suppliers, customers and others having business relationships with each
Hospital.

                                      -33-
<PAGE>

      4.3 Negative Covenants. From the Effective Date until the Effective Time,
with respect to the operation of the Hospitals, Seller shall not, without the
prior written consent of Purchaser or except as may be required by law:

            (a) amend or terminate any of the Contracts, enter into any new
contract or commitment, or incur or agree to incur any liability, except in the
ordinary course of business (which ordinary course of business shall include
renewals of any Contract), and in no event with respect to any such contract,
commitment or liability as to which the total to be paid in the future under the
contract, commitment or liability exceeds Fifty Thousand Dollars ($50,000);

            (b) increase compensation payable or to become payable or make any
bonus payment to or otherwise enter into one or more bonus agreements with any
employee, except in the ordinary course of business in accordance with Seller's
customary personnel policies; provided, however, this Section 4.3(b) shall not
apply to (i) agreements or arrangements with any of the CEOs, CFOs, COOs or CNOs
(collectively, the "Leadership Team") which are consistent with the practices of
the affiliates of Seller, or (ii) any non-recurring payments or proposed
non-recurring payments by Seller or any affiliate of Seller to any of the
Hospitals' Employees (including any member of the Leadership Team) to provide an
incentive to such Hospitals' Employees (or to any member of the Leadership Team)
to remain employed at the Hospitals through the Effective Time, provided that
such non-recurring payments shall not be among the Assumed Obligations or (iii)
any increases in compensation or any bonus payments or any other compensation
arrangements as required by labor union agreements described on Schedule
2.13(b);

            (c) create, assume or permit to exist any new debt, mortgage, deed
of trust, pledge or other lien or encumbrance upon any of the Assets, whether
now owned or hereafter acquired;

            (d) acquire (whether by purchase or lease) or sell, assign, lease,
or otherwise transfer or dispose of any property, plant or equipment, except in
the ordinary course of business with comparable replacement thereof;

            (e) take any action outside the ordinary course of business;

            (f) except with respect to life/safety/emergency or other immediate
patient safety-related expenditures (as to which type of expenditures Seller
shall provide prompt notice), purchase capital assets or incur costs in respect
of construction in progress;

            (g) incur or record trade accounts payable with respect to the
Hospitals other than in the ordinary course of business;

                                      -34-
<PAGE>

            (h) reduce Inventory, or accelerate or delay the purchase of
Inventory or the payment of amounts due to or from any vendor or other
third-party, including any affiliate, except in the ordinary course of business;
or

            (i) except to the extent required by law or by any Governmental
Entity, take any affirmative act, or omit to take any action, that has the
direct effect of reducing the number of licensed beds at any Acute Care Hospital
or eliminating a material service provided at any Acute Care Hospital as of the
Effective Date.

For purposes of this Section 4.3, Seller shall be deemed to have obtained
Purchaser's prior written consent to undertake the actions otherwise prohibited
by this Section 4.3 if Seller gives Purchaser written notice of a proposed
action and Seller does not receive from Purchaser a written notice of objection
to such action within ten (10) business days after Purchaser receives Seller's
written notice. Notwithstanding any provision to the contrary contained in this
Agreement, neither Section 4.2 nor this Section 4.3 shall be construed to
prohibit Seller from engaging in any act which Seller reasonably believes is
required on an emergency basis, or the absence of which would have a material
adverse effect on the ability of any Hospital to operate in accordance with its
historical manner of operations. Seller shall give Purchaser prompt written
notice subsequent to taking any act described in the immediately preceding
sentence. Purchaser acknowledges that the terms of the applicable collective
bargaining agreements provide for "Local Bargaining" (as defined therein) on
certain subjects as more particularly described in such collective bargaining
agreements. Except as consistent with any Board of Inquiry Report or Interest
Arbitration Award under applicable collective bargaining agreements, Seller
shall not without the consent of Purchaser voluntarily agree to economic terms
in such Local Bargaining which are materially more costly to any Hospital than
the result of Local Bargaining at other Tenet facilities in California. Seller
agrees that it shall consult with Purchaser regarding the proposed terms of any
amendments or agreements between Seller or any Seller affiliate and SEIU, CNA or
UNAC with respect to the Hospitals that is proposed to be executed prior to the
Effective Time and would materially affect the working conditions of employees
at the Hospitals; such consultation with Purchaser shall occur prior to the
execution of such amendment or agreement. Purchaser acknowledges and agrees that
Hospital representatives can engage in such Local Bargaining prior to the
Closing Date and that Purchaser shall be bound by the product of such Local
Bargaining. Purchaser further acknowledges and agrees that, prior to the Closing
Date, Seller shall be free to make any wage increases and/or other changes in
the terms and conditions of union represented employees pursuant to the terms of
any collective bargaining agreement in effect between Seller and any labor
organization (including without limitation California Nurses Association ("CNA")
and Service Employees International Union ("SEIU") and/or its affiliated locals)
covering such employees.

      4.4 Cooperation. Between the date of this Agreement and the Closing Date,
Seller will: (i) use its reasonable commercial efforts to obtain, as promptly as
practicable, all material Governmental Authorizations required of Seller to
consummate the transactions contemplated hereby; and (ii) provide such other
information and communications to Governmental Entities as such Governmental
Entities may reasonably request; and (iii) reasonably cooperate with Purchaser
in Purchaser's obtaining, as soon as practicable, all material Governmental
Authorizations required of Purchaser to consummate the transactions contemplated
hereby. For purposes of this Agreement, (a) "Governmental Entities" shall mean
any local, state or federal government, including each of their respective
branches, departments, agencies, commissions, boards, bureaus, courts,
instrumentalities or other subdivisions, including the respective Departments of
Health (or similar departments or agencies) in the State of California, the
Medicare and Medi-Cal programs, TRICARE and fiscal intermediaries, and (b)
"Governmental Authorizations" shall mean all licenses, permits, certificates, no
objection letters, clearances and other authorizations, consents and approvals
of any Governmental Entity which are required to consummate any of the
transactions contemplated hereby or to operate any Hospital as currently
operated under any law, including provider agreements with Medicare and
Medi-Cal.

                                      -35-
<PAGE>

      4.5 Additional Financial Information. Within thirty (30) calendar days
following the end of each calendar month prior to Closing, Seller shall deliver
to Purchaser complete copies of the unaudited balance sheet and related
unaudited statements of income relating to Seller with respect to the operation
of the Hospitals for each month then ended, together with corresponding
year-to-date amounts, which presentation shall be consistent with the provisions
of Section 2.10 which are applicable to the Financial Statements.

      4.6 No-Shop.

            (a) This Section 4.6(a) shall apply from and after the Effective
Date until the earlier to occur of the following events: (i) the Closing Date,
(ii) the termination of this Agreement, (iii) October 15, 2004, if Purchaser has
not filed, on or before such date, all applications, licensing packages and
other similar documents with all applicable Governmental Entities (or other
third parties) which are a prerequisite to obtaining the material licenses,
permits, authorizations and Medicare and Medi-Cal provider numbers which
constitute conditions to closing under Section 7.1 including without limitation
(x) Purchaser's Change of Hospital Ownership ("CHOW") package with the
California Department of Health Services ("DHS") and (y) Purchaser's application
on Form 855 for a new Medicare provider number for the Acute Care Hospitals with
the applicable fiscal intermediary, Mutual of Omaha (the "FI") (but not
including Purchaser's application with the California Department of Pharmacy,
which is addressed in the immediately following subsection), (iv) October 25, if
Purchaser has not filed, on or before such date, Purchaser's application with
the California Department of Pharmacy for a new pharmacy license with respect to
the Acute Care Hospitals, and (v) October 31, 2004, if Purchaser has not
received written confirmation from JCAHO that Purchaser will be entitled to
obtain "deemed status," based on the Acute Care Hospitals' existing
accreditation by JCAHO, sufficient to avoid having to undergo a new survey of
the Acute Care Hospitals as a prerequisite to obtaining approval for its CHOW
application by the California Department of Health Services with respect to any
Medicare provider numbers and agreements for which Purchaser has elected not to
accept assignment; this Section 4.6(a) shall terminate as to being binding on
Seller upon the occurrence (or failure to occur) of any of the foregoing events
without regard to whether such occurrence (or failure to occur) is attributable
to any fault of Purchaser. So long as this Section 4.6(a) remains in effect,
Seller shall not, and shall cause its affiliates, officers, directors,
employees, investment bankers or agents to not, without the prior written
consent of Purchaser: (i) offer for sale or lease the assets of the Hospitals or
the Assets (or any material portion thereof); (ii) solicit, encourage (by way of
furnishing non-public information or otherwise), negotiate or take other action
to facilitate offers to buy all or any material portion of any of the Hospitals
or the Assets; (iii) hold discussions with any party (other than Purchaser)
looking toward such, or in response to, an offer or solicitation; or (iv) enter
into any agreement with any party (other than Purchaser) with respect to the
sale or other disposition of any of the Hospitals or the Assets. Notwithstanding
the foregoing, this Section 4.6 shall not be construed to prohibit Seller or its
affiliates from engaging in corporate transactions involving Seller's or
Seller's affiliates' stock or securities, including macro-level mergers,
reorganizations or other transactions, so long as the terms thereof do not
contemplate the sale or lease or other disposition of the Hospitals or the
Assets.

                                      -36-
<PAGE>

            (b) Any reference in this Agreement to an "affiliate" shall mean any
Person directly or indirectly controlling, controlled by or under common control
with a second Person; provided, however, an "affiliate" shall not include the
stockholders of THC or any officer or director of any Person. The term "control"
(including the terms "controlled by" and "under common control with") means the
possession, direct or indirect, of the power to direct or cause the direction of
the management and policies of a Person, whether through the ownership of voting
securities, by contract or otherwise. A "Person" shall mean any natural person,
partnership, corporation, limited liability company, association, trust or other
legal entity.

      4.7 Seller's Efforts to Close. Seller shall use its reasonable commercial
efforts to satisfy all of the conditions precedent set forth in Articles VI and
VII to its or Purchaser's obligations under this Agreement to the extent that
Seller's action or inaction can control or influence the satisfaction of such
conditions.

      4.8 Title Matters. Prior to the Closing Date and as an express condition
to Closing, Seller shall deliver to Purchaser (a) a pro forma preliminary binder
or title commitment(s) (the "Title Commitment") sufficient to confirm the Title
Company's commitment to the issuance of an ALTA Extended Coverage Owner's Title
Insurance Policy with respect to the Owned Real Property (the "Owner's Title
Policy") and an ALTA Extended Coverage Leasehold Title Policy with respect to
any ground lease(s) or other leases of record specified on Schedule 4.8 (the
"Leasehold Title Policy") (the Owner's Title Policy and the Leasehold Title
Policy are collectively referred to in this Agreement as the "Title Policy"),
issued by the Title Company and naming Purchaser as the insured, together with
true, correct and legible copies of all instruments referred to therein as
conditions or exceptions to title (the "Title Instruments") and subject to no
exceptions to Title except for Permitted Exceptions, and (b) ALTA surveys as
required by the Title Company to issue the Title Policy, which shall, unless
otherwise required by the Title Company in accordance with customary practices,
be made (1) in accordance with "Minimum Standard Detail Requirements for
ALTA/ACSM Land Title Surveys," jointly established and adopted by ALTA and ACSM
in 1999, and (2) pursuant to the Accuracy Standards (as adopted by ALTA and ACSM
and in effect on the date of said certificate) of an "Urban" survey (the
"Surveys"). If Purchaser finances any portion of the Purchase Price, the parties
shall also cooperate in obtaining a Title Commitment for an ALTA Lender's Title
Policy ("Purchaser's Lender Title Policy"), in the amount of the loan being
made, in favor of the lender, and consistent with the requirements set forth
above for the Title Policy and Surveys. In addition, Purchaser may request that
the Title Policy include a zoning endorsement with respect to the Owned Real
Property; any zoning endorsement shall be obtained by Purchaser solely at
Purchaser's expense and shall not (x) constitute a condition precedent to
Purchaser's obligation to consummate the transactions contemplated by this
Agreement or (y) otherwise delay the Closing. Section 12.12 shall govern which
party or parties hereto shall bear the costs and expenses of the Title
Commitment(s), the Title Policy, Purchaser's Lender Title Policy and the
Surveys.

                                      -37-
<PAGE>

      4.9 Termination of Hospitals' Employees. Upon the Transition Time, the
Hospitals' Employees (other than the Retained Management Employees) shall cease
to be employees of Seller and Seller's affiliates, and shall be removed from
such entities' respective payrolls. Seller shall terminate effective as of the
Transition Time the active participation of all of the Hospitals' Employees
(other than the Retained Management Employees) in all of the Seller Plans, and
shall cause each Seller Plan to comply with all applicable laws. After the
Transition Time, Seller shall timely make or cause to be made by Seller's
affiliates appropriate distributions to, or for the benefit of, all of the
Hospitals' Employees (other than the Retained Management Employees) in respect
of the Seller Plans which are in force and effect with respect to the Hospitals'
Employees (other than the Retained Management Employees) at the Hospitals
immediately prior to the Transition Time in accordance with ERISA, the Code and
the terms and conditions of the Seller Plans and subject to the collective
bargaining agreements of Seller and/or Seller's obligations under the National
Labor Relations Act; provided, however, no such distribution shall be required
to the extent it is among the Assumed Obligations. Except as specifically
provided herein, Purchaser is not assuming and shall have no obligation or
responsibility for any benefits payable from Seller Plans. Notwithstanding any
provision to the contrary contained in this Agreement, Seller shall provide a
notice to all of the Hospitals' Employees (as contemplated by WARN) which gives
such employees at least sixty (60) days notice of termination of their
employment concurrent with the Transition Time.

      4.10 Termination Cost Reports. Seller shall file all Medicare, Medi-Cal
and TRICARE termination cost reports required to be filed as a result of the
consummation of (a) the transfer of the Assets to Purchaser and (b) the
transactions contemplated by this Agreement. All such termination cost reports
shall be filed by Seller in a manner that is consistent with current laws, rules
and regulations. Seller will be solely responsible financially and otherwise,
for the contents of all such termination cost reports (and related claims and
documentation). Without limiting the generality of the foregoing, Seller will be
solely obligated for all cost report deficiencies related to periods prior to
the Effective Time.

      4.11 Hart-Scott-Rodino Act Filings. Seller will (a) take promptly all
actions necessary to make the filings required of Seller or Seller's affiliates
under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the rules and
regulations promulgated thereunder (the "HSR Act"), (b) comply at the earliest
practicable date with any request for additional information received by Seller
or Seller's affiliates from the Federal Trade Commission (the "FTC") or
Antitrust Division of the Department of Justice (the "DOJ") pursuant to the HSR
Act, and (c) cooperate with Purchaser in connection with Purchaser's filings
under the HSR Act and in connection with resolving any investigation or other
regulatory inquiry concerning the transactions contemplated by this Agreement
commenced by either the FTC or the DOJ. All fees and expenses of Seller incurred
in connection with Seller's filing under the HSR Act shall be borne by Seller.

      4.12 Environmental Survey. Seller shall promptly obtain from an
environmental consulting firm (the "Consultant") a written environmental survey
of the Owned Real Property (the "Environmental Survey") and shall deliver the
Environmental Survey to Purchaser, which survey shall be identified on Exhibit
4.12 hereto. Section 12.12 shall govern which party or parties hereto shall bear
the costs and expenses of the Environmental Survey.

                                      -38-
<PAGE>

      4.13 Noncompetition; Nonsolicitation. As an inducement to Purchaser to
enter into this Agreement and to consummate the transactions contemplated
hereby, full consideration for which is included as part of the Purchase Price,
neither Seller nor any of Seller's affiliates, shall, for a period of two (2)
years following the Closing Date, without the prior written consent of
Purchaser, directly or indirectly, invest in, own, manage, operate, control or
participate in the ownership, management, operation or control of, any Competing
Business within the Seller Business Service Area. For purposes of this
Agreement, the term "Competing Business" means the business of owning and
operating general acute care hospitals, and the term "Seller Business Service
Area" means the area within a five (5) mile radius of any of the Acute Care
Hospitals. Notwithstanding the foregoing, the following shall be excluded from
the foregoing provisions of this Section 4.13: (a) the general acute care
hospital activities of Seller and Seller's affiliates as of the Closing Date
(other than the activities of the Hospitals) and (b) Seller's or any affiliate
of Seller's acquisition and operation of a general acute care hospital within
the Seller Business Service Area after the Closing Date so long as such hospital
was acquired in a transaction in which the amount of consideration allocated to
such hospital is less than twenty-five percent (25%) of the total consideration
necessary to consummate such transaction. During the period commencing on the
Effective Date and ending on the second anniversary of the Closing Date, neither
Seller nor any of its affiliates shall actively solicit any of the Hospitals'
Employees (other than the Retained Management Employees) to remain or become an
employee of Seller or any affiliate of Seller; provided, however, that at any
time Seller and its affiliates may make general solicitations not directed
specifically at Hospitals' Employees to recruit employees through any means
(including, without limitation through job fairs or advertisements in newspapers
of general circulation) and shall have the right to hire Hospitals' Employees
who respond to such permitted solicitation efforts or seek such employment
unsolicited by Seller or any affiliate of Seller. During the period commencing
on the Effective Date and ending on the Closing Date, neither Seller nor any of
its affiliates shall directly solicit any physician that is on the medical staff
of any of the Acute Care Hospitals to join the medical staff of any acute care
facility owned or operated by Seller or any affiliate of Seller that is not
among the Acute Care Hospitals; provided, however, that this sentence shall not
be construed to prevent Seller or any affiliate of Seller from (i) engaging in
conversations with physicians already on the medical staff of any acute care
facility owned or operated by Seller or any affiliate of Seller that is not
among the Acute Care Hospitals including without limitation to retain such
physicians on such medical staffs, (ii) at any time, making general
solicitations in the ordinary course of business not directed specifically at
physicians on the medical staff of the Acute Care Hospitals to recruit
physicians or (iii) responding to physicians on the medical staff of any of the
Acute Care Hospitals who are the initiators of contact with Seller or any
affiliate of Seller, including without limitation regarding joining the medical
staff of any acute care facility owned or operated by Seller or any affiliate of
Seller that is not among the Acute Care Hospitals. Seller shall cause each of
its affiliates to comply with the obligations imposed by this Section 4.13. In
the event that the provisions contained in this Section 4.13 shall ever be
deemed to exceed the time or geographic limits or any other limitations
permitted by applicable law in any jurisdiction, then such provisions shall be
deemed reformed in such jurisdiction to the maximum extent permitted by
applicable law.

                                      -39-
<PAGE>

      4.14 Enforceability. Seller hereby acknowledges that the restrictions
contained in Section 4.13 are reasonable and necessary to protect the legitimate
interests of Purchaser following the Closing Date. The parties also hereby
acknowledge and agree that any breach of Section 4.13 would result in
irreparable injury to Purchaser and that any remedy at law for any breach of
Section 4.13 would be inadequate. Notwithstanding any provision to the contrary
contained in this Agreement, the parties therefore agree, and Seller hereby
specifically consents that, without necessity of proof of actual damage,
Purchaser may be granted temporary or permanent injunctive relief, that
Purchaser shall be entitled to an equitable accounting of all earnings, profits
and other benefits arising from such breach, and that Purchaser shall be
entitled to recover its reasonable fees and expenses, including attorneys' fees,
incurred by Purchaser in enforcing the restrictions contained in Section 4.13.

      4.15 Material Contract Consents. Seller shall use its reasonable
commercial good faith efforts to obtain the consents from the third parties
under all Material Contracts and Material Leases, which, by the terms of such
Material Contract or Material Lease, require such consent. To the extent any
consents from third parties under any Contracts or Leases (to the assignment
thereof to Purchaser) are not obtained as of the Closing, Seller and Purchaser
shall comply with Section 9.3 and use their reasonable commercial good faith
efforts to mitigate any costs, losses or damages associated with the failure to
obtain such consents prior to Closing. Notwithstanding the foregoing, Seller's
obtaining the consents described in this Section 4.15 (including any consents
from third parties under any Contracts which are not among the Material
Contracts or any Leases which are not among the Material Leases) shall not be a
condition precedent to either party's obligation to close the transaction
contemplated by this Agreement.

      4.16 American with Disabilities Act. Seller shall, prior to Closing, cause
the Hospitals to be released from the terms of the consent decree and nationwide
settlement pertaining to Seller and/or Seller's affiliates regarding the
Americans with Disabilities Act.

      4.17 Confidentiality. Seller shall, and shall cause its employees,
representatives and agents to, hold in strict confidence, unless compelled to
disclose by judicial or administrative process or, in the opinion of Seller's
counsel, by other requirements of law, all Purchaser's Confidential Information
(as hereinafter defined), and Seller shall not disclose the Purchaser
Confidential Information to any Person, except as otherwise may be reasonably
necessary to carry out the transactions contemplated by this Agreement,
including any business or diligence review by or on behalf of Seller. Seller's
obligations set forth in the immediately preceding sentence shall apply (a)
between the Effective Date and the Closing, with respect to Purchaser's
Information, and (b) after the Closing for all Purchaser Confidential
Information. For the purposes hereof, "Purchaser Confidential Information" shall
mean (a) all information of any kind concerning Purchaser or any of its
affiliates or owners or relating to the business or financial resources and
condition of Purchaser or its affiliates and owners provided by Purchaser to
Seller in connection with the transactions contemplated herein ("Purchaser's
Information"), and (b) all Records and other materials and information sold to
Purchaser under this Agreement relating to the Assets or the operation of the
Hospitals, other than Records, material and information relating to the period
prior to the Effective Time and/or which does not relate exclusively to the
Hospitals ("Transferred Information") except information (i) ascertainable or
obtained from public or published information, (ii) with respect to Purchaser's
Information only, received from a third party not known by Seller to be under an
obligation to Purchaser or any affiliate of Purchaser to keep such information
confidential, (iii) which is or becomes known to the public (other than through
a breach of this Agreement), or (iv) with respect to Purchaser's Information
only, which was in Seller's possession prior to disclosure thereof to Purchaser
in connection herewith.

                                      -40-
<PAGE>

      4.18 Seller's Obligation to Maintain Insurance Coverage. For a period of
five (5) years after the Effective Time, at Seller's own expense, Seller shall
either purchase a tail policy or continue to maintain insurance under Tenet
HealthSystem's master insurance program for acts, errors and omissions of
professional liability occurring at the Hospital Businesses during Seller's
ownership of the Hospital Businesses prior to the Effective Time. Such coverage
may be provided via commercial insurance, self-insurance, a captive insurer, or
some combination thereof.

                                   ARTICLE V

                             COVENANTS OF PURCHASER

      5.1 Purchaser's Efforts to Close. Purchaser shall use its reasonable
commercial efforts to satisfy all of the conditions precedent set forth in
Articles VI and VII to its or Seller's obligations under this Agreement to the
extent that Purchaser's action or inaction can control or influence the
satisfaction of such conditions.

      5.2 Required Governmental Approvals. Between the date of this Agreement
and the Closing Date, Purchaser will: (a) use its reasonable commercial efforts
to obtain, as promptly as practicable, all material Governmental Authorizations
required of Purchaser to consummate the transactions contemplated hereby; and
(b) reasonably cooperate with Seller in Seller's obtaining, as soon as
practicable, all material Governmental Authorizations required of Seller to
consummate the transactions contemplated hereby. Purchaser shall be entitled,
but not obligated, to solicit estoppel certificates from any third party to any
Lease of Real Property. Purchaser's failure to obtain any or all of such
estoppel certificates as of the Closing Date shall not be a condition precedent
to either party's obligation to close the transactions contemplated by this
Agreement.

      5.3 Certain Employee Matters.

            (a) During the period (the "Transition Period") commencing at the
Effective Time and ending immediately prior to 12:01 a.m. on the calendar day
immediately following the last day of the term of the Employee Leasing Agreement
as to each Hospital (as to each such Hospital, the "Transition Time"), each
Hospital Employee shall remain an employee of its employer as of the Effective
Time (whether such employer is Seller or an affiliate of Seller), subject to
normal personnel actions occurring in the ordinary course of business and the
terms of any applicable collective bargaining agreements. During the Transition
Period, or until such earlier time as any such Hospital Employee ceases to be an
employee of such employer, each such Hospital Employee shall be leased to
Purchaser from Seller or the employing affiliate on substantially the terms and
conditions as are set forth in the Employee Leasing Agreement. During the
Transition Period, each leased Hospital Employee shall continue to participate
in all Seller Plans on the same basis as in effect immediately prior to the
Effective Time, subject to the terms of the Employee Leasing Agreement.

                                      -41-
<PAGE>

            (b) Purchaser covenants and agrees that it shall make offers of
employment (in substantially equivalent positions), subject to the terms of the
labor union agreements described on Schedule 2.13(b) and Section 5.15, to all of
the persons who are employees of (i) Seller with respect to the operation of the
Hospitals or (ii) any affiliate of Seller which employs individuals at any of
the Hospitals (whether such employees are full time employees, part-time
employees or on leave of absence) as of the Transition Time (the "Hospitals'
Employees"); provided, however, that no Hospitals' Employee who is on any
disability or leave of absence at the Transition Time, other than leave of
absence pursuant to the Family and Medical Leave Act of 1993 or other similar
local law (such laws being collectively referred to herein as the "FMLA")
("Employee on Disability"), shall become a Hired Employee and, Purchaser shall
have no liability or obligation with respect to any Employee on Disability after
the Transition Time. Notwithstanding the foregoing, Purchaser acknowledges that
Seller has the right, but is not required, to retain any management-level
Hospitals' Employee who does not accept Purchaser's employment offer made under
this Section 5.3(b), which individuals will remain employed by Seller or its
applicable affiliate as of the Transition Time (the "Retained Management
Employees"). Any of the Hospitals' Employees who accept an offer of employment
with Purchaser as of or after the Transition Time shall be referred to in this
Agreement as the "Hired Employees". Purchaser shall ensure that the terms and
conditions of employment (including initial position, cash compensation, shifts,
benefits, including without limitation health, dental, disability, life
insurance) of each of the Hired Employees on and after the Transition Time are
substantially equivalent to that provided the Hospitals' Employees as of the
Effective Date; Purchaser shall also ensure that a 401(k) retirement plan option
is made available to the Hired Employees.

            (c) Purchaser shall give all Hired Employees full credit for
extended sick pay (Reserve Sick) as reflected by the Sick Pay Amount as of the
Closing Date, and all other paid time off pay, including CashPlus obligations of
Seller and/or Seller's affiliates to such employees, either by (i) crediting
such employees the time off reflected in the employment records of Seller and/or
any of its affiliates immediately prior to the Effective Time or (ii) by making
full payments to such employees of the amounts which such employees would have
received had they taken such paid time off; provided, however, this Section
5.3(c)(ii) shall not be applicable to the Sick Pay Amount as of the Closing
Date.

            (d) On and after the Transition Time, Hired Employees shall be
eligible for a medical and hospital plan sponsored by Purchaser. Hired Employees
shall be given credit for periods of employment with Seller and Seller's
affiliates, as applicable, prior to the Transition Time for purposes of
determining eligibility to participate and amount of benefits (including without
limitation vesting of benefits) with respect to paid time off plans and
retirement plans of Purchaser, and pre-existing condition limitations will be
waived with respect to Hired Employees and their covered dependents under
medical and hospital plans sponsored by Purchaser unless such pre-existing
condition limitations were applicable prior to the Transition Time. In addition,
if prior to the Transition Time a Hired Employee or his covered dependents paid
any amounts towards a deductible or out-of-pocket maximum in Seller's or its
affiliate's medical and health plan's current fiscal year, such amounts shall be
applied toward satisfaction of the deductible or out-of-pocket maximum in the
current fiscal year of Purchaser's medical and health plan that covers Hired
Employees on and after the Transition Time. Purchaser agrees that, for any
employee subject to any collective bargaining agreement, if any eligibility
described in this section differs from eligibility described by the collective
bargaining agreement, the eligibility descriptions of the collective bargaining
agreement shall prevail.

                                      -42-
<PAGE>

            (e) Within thirty (30) days after the Hospitals' Employees (other
than the Retained Management Employees) cease to be employees of Seller and
Seller's affiliates (as described in Section 4.9), such persons will be entitled
to a distribution of their accounts under the Tenet Healthcare Corporation
401(k) Retirement Savings Plan. Any such Person whose account remains with the
Tenet Healthcare Corporation 401(k) Retirement Savings Plan will be subject to
the distribution provisions of such plan. Purchaser shall provide Seller (i)
with periodic reports, at least quarterly, to identify termination dates for the
Hired Employees and (ii) upon Seller's reasonable request, prompt verification
of the termination dates for Hired Employees.

            (f) Seller shall be responsible to provide continuation coverage
pursuant to the requirements of Code section 4980B and Part 6 of Title I of
ERISA ("COBRA Coverage") with respect to the Hospitals' Employees (and their
dependents) whose qualifying event occurred prior to the date on which such
Hospitals' Employees become Hired Employees and for any of the Hospitals'
Employees who do not elect to become Hired Employees. Purchaser shall be
responsible to provide COBRA Coverage with respect to each of the Hired
Employees (and their dependents) whose qualifying event occurs on or after the
date on which such Hospitals' Employees become Hired Employees.

            (g) After the Transition Time, Purchaser's human resources
department will give reasonable assistance to Seller's and its affiliates' human
resources department with respect to Seller's and Seller's affiliates'
post-Transition Time administration of Seller's and Seller's affiliates'
pre-Transition Time employee pension benefit plans and employee health or
welfare benefit plans for the Hospitals' Employees (other than the Retained
Management Employees). Within fifteen (15) days after the Transition Time,
Purchaser shall provide to Seller a list of all the Hospitals' Employees who
were offered employment by Purchaser but refused such employment.

            (h) Purchaser acknowledges that affiliates of Seller are a party to
an Election Procedure Agreement with the SEIU, an Election Procedure Agreement
with United Nurses Association of California/Union of Health Care Professionals,
NUHHCE, AFSCME, AFL-CIO ("UNAC"), and an Election Procedure Agreement with the
California Nurses Association("CNA"), relating to and covering employees of the
Hospitals (individually, an "EPA" and, collectively, the "EPAs"). On and after
the Effective Time, Purchaser shall abide by and comply with Seller's
affiliates' obligations under the EPAs relating to and covering the employees of
the Hospitals (whether such employees are employed by Purchaser at the Effective
Time or at any time thereafter), as more specifically set forth in Section 5.15
of this Agreement. All changes made by Purchaser to the terms and conditions of
employment of union represented employees shall be subject to the terms of any
applicable collective bargaining agreement and related agreements between Seller
and any labor organization (including without limitation CNA, UNAC and SEIU
and/or its affiliated locals) covering such employees. The terms of this Section
5.3(h) shall not be subject to the time limitations contained in Section 10.1 of
the Agreement. The terms of this section and those set forth in Section 5.15 are
expressly limited to the facilities and/or Hospitals covered by this Agreement
and shall not extend to other facilities or operations owned or operated by
Purchaser at the time of execution of this Agreement or those that may be
acquired in the future. Purchaser disavows any obligations to recognize or
bargain with any union representatives not otherwise specified in this
Agreement.

                                      -43-
<PAGE>

            (i) On and after the Transition Time, Purchaser shall take any and
all action that may be necessary to comply with the terms and provisions of the
National Labor Relations Act or the Labor Management Relations Act as a result
of the consummation of the transactions contemplated by this Agreement,
including, without limitation, obligations thereunder to any of the Hired
Employees covered by the labor union agreements described on Schedule 2.13(b);
provided, however, Seller, shall, as soon as reasonably possible after the
Effective Date, provide to Purchaser all information reasonably necessary for
the Purchaser's understanding and implementation of employee wages, benefits,
and other conditions of employment required by these union agreements.

            (j) No provision of this Agreement (except with respect to expressly
assumed Contracts) shall create any third party beneficiary or other rights in
any employee or former employee (including any beneficiary or dependent thereof)
of Seller or of any of its affiliates in respect of continued employment (or
resumed employment) with Purchaser, and no provision of this Agreement (except
with respect to expressly assumed Contracts) shall create any such rights in any
such employee or former employee (or their respective dependents and
beneficiaries) in respect of any benefits that may be provided, directly or
indirectly, under any employee benefit plan or arrangement of Purchaser or any
of Purchaser's affiliates. Except as otherwise expressly provided above at
Section 5.3 and below at Section 5.15, no provision of this Agreement shall
constitute a limitation on the rights of Purchaser and its affiliates to amend,
modify or terminate after the Transition Time any employee benefit plans or
arrangements.

      5.4 Use of Business Names. Purchaser covenants that it and its affiliates
shall not use in their respective trades or businesses the names "Tenet
Healthcare Corporation", "Tenet", "Tenet HealthSystem", "OrNda HealthCorp", and
any other names or symbols not used exclusively at any of the Hospitals prior to
the Effective Time, any abbreviations or variations thereof or service marks,
symbols or logos related thereto, nor any promotional material, stationery,
supplies or other items of inventory bearing either such names, symbols or
abbreviations or variations thereof.

      5.5 Excluded Assets. As soon as practicable after the Closing Date,
Purchaser shall deliver to Seller or Seller's designee any intangible Excluded
Assets found at any of the Hospitals on and after the Effective Time, without
imposing any charge on Seller for Purchaser's storage or holding of same on and
after the Effective Time. Seller shall be responsible for removing any and all
tangible Excluded Assets within ten (10) business days after the Closing Date,
at Seller's expense.

                                      -44-
<PAGE>

      5.6 Confidentiality. Purchaser shall, and shall cause its employees,
representatives and agents to, hold in strict confidence, unless compelled to
disclose by judicial or administrative process or, in the opinion of Purchaser's
counsel, by other requirements of law, all Confidential Information (as
hereinafter defined), and Purchaser shall not disclose the Confidential
Information to any Person, except as otherwise may be reasonably necessary to
carry out the transactions contemplated by this Agreement, including any
business or diligence review by or on behalf of Purchaser. Purchaser's
obligations set forth in the immediately preceding sentence shall apply (a)
between the Effective Date and the Effective Time with respect to Confidential
Information which is among the Assets and (b) after the Effective Date for all
Confidential Information which is not described in subsection (a) above. For the
purposes hereof, "Confidential Information" shall mean all information of any
kind concerning Seller or the businesses of the Hospitals, in connection with
the transactions contemplated by this Agreement except information (i)
ascertainable or obtained from public or published information, (ii) received
from a third party not known by Purchaser to be under an obligation to Seller or
any affiliate of Seller to keep such information confidential, (iii) which is or
becomes known to the public (other than through a breach of this Agreement), or
(iv) which was in Purchaser's possession prior to disclosure thereof to
Purchaser in connection herewith. Notwithstanding the foregoing, but subject to
the terms of Section 12.8, Purchaser shall be permitted to disclose in an
offering circular, confidential offering memorandum, private placement
memorandum or similar documentation (the "Offering Circular") to prospective
investors historical financial information regarding the Hospitals. Purchaser
shall cause any Offering Circular to prominently contain the disclosures set
forth on Schedule 5.6. The rights of Seller under this Section 5.6 shall be in
addition to and not in substitution for the rights of Seller and Seller's
affiliates under that certain Confidentiality Agreement between THC and Mogel
Management Group, Inc., dated February 27, 2004 (the "Confidentiality
Agreement"), which Confidentiality Agreement shall survive the Closing.
Disclosure of Seller information by Purchaser to potential financing sources
with respect to Purchaser shall be permitted, subject to execution by such
financing sources of a confidentiality agreement reasonably acceptable to
Seller.

      5.7 Enforceability. Purchaser hereby acknowledges that the restrictions
contained in Section 5.6 above are reasonable and necessary to protect the
legitimate interests of Seller. The parties also hereby acknowledge and agree
that any breach of Section 5.6 would result in irreparable injury to Seller and
that any remedy at law for any breach of Section 5.6 would be inadequate.
Notwithstanding any provision to the contrary contained in this Agreement, the
parties therefore agree, and Purchaser hereby specifically consents that,
without necessity of proof of actual damage, Seller may be granted temporary or
permanent injunctive relief, that Seller shall be entitled to an equitable
accounting of all earnings, profits and other benefits arising from such breach,
and that Seller shall be entitled to recover its reasonable fees and expenses,
including attorneys' fees, incurred by Seller in enforcing the restrictions
contained in Section 5.6.

      5.8 Hart-Scott-Rodino Act Filings. Purchaser shall (a) take promptly all
actions necessary to make the filings required of Purchaser or its affiliates
under the HSR Act, (b) comply at the earliest practicable date with any request
for additional information received by Purchaser or its affiliates from the FTC
or the DOJ pursuant to the HSR Act, and (c) cooperate with Seller in connection
with Seller's or Seller's affiliates' filings under the HSR Act and in
connection with resolving any investigation or other regulatory inquiry
concerning the transactions contemplated by this Agreement commenced by either
the FTC or the DOJ. All filing fees imposed in connection with Purchaser's
filings under the HSR Act shall be borne by Purchaser. Notwithstanding the
foregoing, Purchaser shall not be required to comply with any conditions which
the FTC or DOJ may require as a condition to their approval of the transactions
contemplated by this Agreement, if in Purchaser's reasonable judgment such
conditions would materially and adversely affect Purchaser's rights and benefits
as originally contemplated under this Agreement.

                                      -45-
<PAGE>

      5.9 Waiver of Bulk Sales Law Compliance. Purchaser hereby waives
compliance by Seller with the requirements, if any, of Article 6 of the Uniform
Commercial Code as in force in any state in which the Assets are located and all
other similar laws applicable to bulk sales and transfers.

      5.10 Indigent and Low Income Care. After the Effective Time, Purchaser
shall comply in all material respects with all applicable laws related to the
provision of care to indigent and low-income patients at the Hospitals.

      5.11 Medical Staff. To ensure continuity of care in the community,
Purchaser agrees that each Hospital's medical staff members in good standing as
of the Effective Time shall maintain medical staff privileges at each such
Hospital as of the Effective Time. On and after the Effective Time, the medical
staff will be subject to each Hospital's Medical Staff Bylaws then in effect, to
the extent consistent with applicable law and regulations, and requirements of
JCAHO.

      5.12 Comfort With Respect to Post-Closing Obligations Arising Under this
Agreement. To provide Seller additional comfort regarding Purchaser's financial
wherewithal to satisfy its obligations under this Agreement following the
Closing, Purchaser shall provide quarterly summaries to Seller of the Hospitals'
operating performance, including but not limited to profit and loss and net cash
flow statements, and financial status, until the earlier to occur of the
expiration of all of Purchaser's obligations under Section 10.3.1 of this
Agreement or Seller's complete release and discharge of all obligations under
the Chapman Medical Center Leases. Subject to Section 12.2 of this Agreement,
Purchaser shall require that any purchaser or other assignee of substantially
all of the assets of any of the Hospitals agree, in the agreement evidencing
such transaction, to be jointly and severally liable with Purchaser for all of
Purchaser's obligations under Section 10.3.1 of this Agreement that are
attributable to the Hospital(s) being transferred to such purchaser or assignee
pursuant to such agreement. Purchaser shall not be released or discharged from
its obligations under Section 10.3.1 as to which the purchaser or assignee of a
Hospital becomes jointly and severally liable.

      5.13 Intentionally Omitted

      5.14 Group Purchasing Contract. Following the Closing Date, Purchaser
shall cause the Hospitals to participate in specified national purchasing
contracts of Seller and its affiliates. Seller agrees that it will make
available to Purchaser the opportunity for other health care facilities owned or
operated by Purchaser or its affiliates to participate in such contracts. At
Closing, Purchaser shall execute the "Group Purchasing Contract" attached hereto
in the form of Exhibit 5.14 for such purpose, which contract shall have a term
of no less than five (5) years after the Closing Date.

                                      -46-
<PAGE>

      5.15 Certain Collective Bargaining Matters. Purchaser shall cause each of
the Hospitals to abide by the obligations set forth below that are applicable to
such Hospital.

            (a) Chapman Medical Center.

                  (i) On and after the Effective Time, Purchaser agrees to abide
by the terms of the Election Procedure Agreements between Tenet California, Inc.
and SEIU, CNA and UNAC and any amendments or other agreements entered into
between Tenet California, Inc. and SEIU, CNA and/or UNAC prior to the Effective
Time as to Chapman Medical Center and any applicable collective bargaining
agreements..

                  (ii) Purchaser acknowledges that CNA is the collective
bargaining representative of a bargaining unit of all full-time, part-time and
per diem registered nurses employed at Chapman Medical Center. Purchaser
acknowledges that Chapman Medical Center and CNA are parties to a collective
bargaining agreement covering the above-described bargaining unit, a copy of
which has been provided to Purchaser. On or before the Transition Time,
Purchaser shall recognize CNA as the exclusive collective bargaining
representative of the above-described unit, shall adopt and assume the
collective bargaining agreement between Chapman Medical Center and CNA and all
agreements related to such collective bargaining agreement, and shall retain all
or substantially all of the employees covered by such collective bargaining
agreement.

                  (iii) Notwithstanding anything to the contrary in this
Agreement, neither Seller nor Seller's affiliates will voluntarily agree with
the SEIU prior to the Effective Time to conduct elections for employees of
Chapman Medical Center covered by the applicable Election Procedure Agreement
after the Effective Time. Upon selection of SEIU and/or any of its affiliated
local unions, including without limitation SEIU Local 399 and SEIU Local 121 RN,
United Nurses Association of California/Union of Health Care Professionals,
NUHHCE, AFSCME, AFL-CIO ("UNAC") or any other labor organization pursuant to a
representation election among employees of Chapman Medical Center covered by the
terms of the applicable Election Procedure Agreement prior to or after the
Effective Time, Purchaser shall recognize such labor organization as the
collective bargaining representative and shall adopt and assume the applicable
Western Regional Health Care Employees Model Contract and/or Western Regional
Registered Nurse Model Contract (as applicable to professional employees) and
all agreements related to such collective bargaining agreements. If such
employees select a collective bargaining representative under the terms of the
applicable Election Procedure Agreement prior to the Effective Time, Purchaser
shall retain all or substantially all of the bargaining unit employees covered
by the applicable collective bargaining agreement.

                  (iv) All offers of employment to employees of Chapman Medical
Center covered by an Election Procedure Agreement between Tenet California, Inc.
and CNA, SEIU and/or UNAC shall be subject to the terms and conditions of such
Election Procedure Agreement and any applicable collective bargaining agreement.

            (b) Coastal Communities Hospital.

                                      -47-
<PAGE>

                  (i) On and after the Effective Time, Purchaser agrees to abide
by the terms of the Election Procedure Agreements between Tenet California, Inc.
and SEIU, CNA and UNAC and any amendments or other agreements entered into
between Tenet California, Inc. and SEIU, CNA and/or UNAC prior to the Effective
Time as to Coastal Communities Hospital and any applicable collective bargaining
agreements.

                  (ii) Purchaser acknowledges that CNA is the collective
bargaining representative of a bargaining unit of all full-time, part-time and
per diem registered nurses employed at Coastal Communities Hospital. Purchaser
acknowledges that Coastal Communities Hospital and CNA are parties to a
collective bargaining agreement covering the above-described bargaining unit, a
copy of which has been provided to Purchaser. On or before the Effective Time,
Purchaser shall recognize CNA as the exclusive collective bargaining
representative of the above-described unit, shall adopt and assume the
collective bargaining agreement between Coastal Communities Hospital and CNA and
all agreements related to such collective bargaining agreement, and shall retain
all or substantially all of the employees covered by such collective bargaining
agreement.

                  (iii) Purchaser acknowledges that representation elections
were conducted on July 16, 2004 by the National Labor Relations Board in Cases
31-RC-8403 and 31-RC-8404 among employees at Coastal Communities Hospital in the
following bargaining units: (i) full-time, part-time and per diem service and
maintenance, technical, skilled maintenance and business office clerical
employees, and (ii) full-time, part-time and per diem professional employees
(excluding registered nurses and physicians). Purchaser acknowledges that after
such elections, SEIU Local 399 filed objections to both elections which
objections are currently pending. Notwithstanding anything to the contrary in
this Agreement, Purchaser agrees that neither Seller nor Seller's affiliates
will voluntarily agree with the SEIU prior to the Effective Time to conduct
elections for employees of Coastal Communities Hospital covered by the
applicable Election Procedure Agreement after the Effective Time. Upon selection
of SEIU Local 399 in either bargaining unit prior to or after the Effective
Time, Purchaser shall recognize SEIU Local 399 as the collective bargaining
representative and shall adopt and assume the applicable Western Regional Health
Care Employees Model Contract and/or Western Regional Registered Nurse Model
Contract (as applicable to professional employees) and all agreements related to
such collective bargaining agreements. If SEIU Local 399 is selected as the
collective bargaining representative prior to the Effective Time, Purchaser
shall retain all or substantially all of the bargaining unit employees covered
by the applicable collective bargaining agreement.

                  (iv) All offers of employment to employees of Coastal
Communities Hospital covered by an Election Procedure Agreement between Tenet
California, Inc. and CNA, SEIU and/or UNAC shall be subject to the terms and
conditions of such Election Procedure Agreement and any applicable collective
bargaining agreement.

            (c) Western Medical Center - Anaheim.

                  (i) On and after the Effective Time, Purchaser agrees to abide
by the terms of the Election Procedure Agreements between Tenet California, Inc.
and SEIU, CNA, and UNAC as to Western Medical Center - Anaheim and any
applicable collective bargaining agreements.

                                      -48-
<PAGE>

                  (ii) Purchaser acknowledges that CNA is the collective
bargaining representative of a bargaining unit of all full-time, part-time and
per diem registered nurses employed at Western Medical Center - Anaheim.
Purchaser acknowledges that Western Medical Center - Anaheim and CNA are parties
to a collective bargaining agreement covering the above-described bargaining
unit, a copy of which has been provided to Purchaser. On or before the Effective
Time, Purchaser shall recognize CNA as the exclusive collective bargaining
representative of the above-described unit, shall adopt and assume the
collective bargaining agreement between Western Medical Center - Anaheim and CNA
and all agreements related to such collective bargaining agreement, and shall
retain all or substantially all of the employees covered by such collective
bargaining agreement.

                  (iii) Purchaser acknowledges that SEIU Local 399 is the
collective bargaining representative of a bargaining unit of full-time,
part-time and per diem service and maintenance, technical, skilled maintenance
and business office clerical employees employed by Western Medical Center -
Anaheim at its hospital facility and its three (3) affiliated clinics. Purchaser
acknowledges that Western Medical Center - Anaheim and SEIU Local 399 are
parties to a collective bargaining agreement covering the above-described
bargaining unit, a copy of which has been provided to Purchaser. On or before
the Effective Time, Purchaser shall recognize SEIU Local 399 as the exclusive
collective bargaining representative of the above-described unit, shall adopt
and assume the collective bargaining agreement between Western Medical Center -
Anaheim and CNA and all agreements related to such collective bargaining
agreement, and shall retain all or substantially all of the employees covered by
such collective bargaining agreement.

                  (iv) All offers of employment to employees of Western Medical
Center - Anaheim covered by an Election Procedure Agreement between Tenet
California, Inc. and CNA, SEIU and/or UNAC shall be subject to the terms and
conditions of such Election Procedure Agreement and any applicable collective
bargaining agreement.

            (d) Western Medical Center - Santa Ana.

                  (i) On and after the Effective Time, Purchaser agrees to abide
by the terms of the Election Procedure Agreements between Tenet California, Inc.
and Service Employees International Union SEIU, CNA and UNAC and any amendments
or other agreements entered into between Tenet California, Inc. and SEIU, CNA
and/or UNAC prior to the Effective Time as to Western Medical Center - Santa Ana
and any applicable collective bargaining agreements.

                  (ii) Purchaser agrees that nothing in this Agreement prohibits
Seller and/or Seller's affiliates from agreeing with CNA prior to the Effective
Time to conduct elections for employees of Western Medical Center - Santa Ana
covered by the applicable Election Procedure Agreement whether such elections
occur prior to or after the Effective Time. Upon selection by registered nurses
of CNA, UNAC or any other labor organization as their collective bargaining
representative pursuant to a representation election under the terms of the
applicable Election Procedure Agreement prior to or after the Effective Time,
Purchaser shall recognize such labor organization and shall adopt and assume the
applicable registered nurses collective bargaining agreement and all agreements
related to such collective bargaining agreement. If such registered nurses
select a collective bargaining representative under the terms of the applicable
Election Procedure Agreement prior to the Effective Time, Purchaser shall retain
all or substantially all of the bargaining unit employees covered by the
applicable collective bargaining agreement.

                                      -49-
<PAGE>

                  (iii) Purchaser agrees that nothing in this Agreement
prohibits Seller and/or Seller's affiliates from agreeing with the SEIU prior to
the Effective Time to conduct elections for employees of Western Medical Center
- Santa Ana covered by the applicable Election Procedure Agreement whether such
elections occur prior to or after the Effective Time. Upon selection of SEIU
and/or any of its affiliated local unions, including without limitation SEIU
Local 399 and SEIU Local 121 RN, UNAC or any other labor organization pursuant
to a representation election among employees of Western Medical Center - Santa
Ana covered by the terms of the applicable Election Procedure Agreement prior to
or after the Effective Time, Purchaser shall recognize such labor organization
as the collective bargaining representative and shall adopt and assume the
applicable Western Regional Health Care Employees Model Contract and/or Western
Regional Registered Nurse Model Contract (as applicable to professional
employees) and all agreements related to such collective bargaining agreements.
If such employees select a collective bargaining representative under the terms
of the applicable Election Procedure Agreement prior to the closing of the sale,
the Purchaser shall retain all or substantially all of the bargaining unit
employees covered by the applicable collective bargaining agreement.

                  (iv) All offers of employment to employees of Western Medical
Center-Santa Ana covered by an Election Procedure Agreement between Tenet
California, Inc. and CNA, SEIU and/or UNAC shall be subject to the terms and
conditions of such Election Procedure Agreement and any applicable collective
bargaining agreement

                                   ARTICLE VI

                  CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER

      Seller's obligation to sell the Assets and to close the transactions as
contemplated by this Agreement shall be subject to the satisfaction of each of
the following conditions on or prior to the Closing Date unless specifically
waived in writing by Seller in whole or in part at or prior to the Closing:

      6.1 Signing and Delivery of Instruments. Purchaser shall have executed and
delivered all documents, instruments and certificates required to be executed
and delivered pursuant to the provisions of this Agreement. Purchaser
acknowledges that Purchaser shall not satisfy the condition precedent set forth
in this Section 6.1 (as it relates to the delivery of the amount set forth in
Section 1.7.1) unless Purchaser initiates the wire transfer of the amount set
forth in Section 1.7.1 to Seller, and provides to Seller a Federal Reserve wire
reference number with respect thereto, on or before 12:00 noon (Pacific time) on
the Closing Date.

      6.2 Unfavorable Action or Proceeding. On the Closing Date, no orders,
decrees, judgments or injunctions of any court or Governmental Entity shall be
in effect, and no claims, actions, suits, proceedings, arbitrations or
investigations shall be pending or threatened, which challenge or seek to
challenge, or which could prevent or cause the rescission of, the consummation
of the transactions contemplated in this Agreement.

                                      -50-
<PAGE>

      6.3 Performance of Covenants. Purchaser shall have in all respects
performed or complied with each and all of the obligations, covenants,
agreements and conditions required to be performed or complied with by it on or
prior to the Closing Date; provided, however, this condition will be deemed to
be satisfied unless (a) Purchaser was given written notice of such failure to
perform or comply and did not or could not cure such failure to perform or
comply within fifteen (15) business days after receipt of such notice and (b)
the respects in which such obligations, covenants, agreements and conditions
have not been performed have had or would more likely than not result in a
material adverse effect (whether individually or in the aggregate) on
Purchaser's ability to perform its obligations hereunder. Seller shall not be
required to give Purchaser the notice described in Section 6.3(a) unless and
until Seller is aware, or based on the applicable facts and circumstances, it is
reasonable that Seller should be aware of Purchaser's alleged failure to perform
or comply with the applicable terms of this Agreement.

      6.4 Opinion of Counsel for Purchaser. Seller shall have received the
favorable opinion of Purchaser's counsel, dated the Closing Date, in
substantially the form set forth in Exhibit 6.4 attached to this Agreement.

      6.5 Hart Scott Rodino Filings. All filings required to be made and notices
required to be given pursuant to the HSR Act shall have been made, all approvals
or consents required thereby shall have been obtained and the waiting periods
required thereby, if any, shall have expired or terminated.

      6.6 Governmental Authorizations. Purchaser shall have obtained all
material licenses, permits, certificates of need and authorizations from
Governmental Entities that are necessary or required for completion of the
transactions contemplated by this Agreement including reasonable assurances that
any material licenses, permits, certificates of need and authorizations not
actually issued as of the Closing will be issued following Closing (which may
include oral assurances from appropriate Governmental Entities).

      6.7 Schedules. The material provisions of the Exhibits, Disclosure
Schedule and schedules attached to this Agreement that were updated by Purchaser
after the Effective Date, if any, shall be acceptable to Seller in its
reasonable discretion provided, however, that Purchaser shall be deemed to have
obtained Seller's approval to any such material updates of the Exhibits,
Disclosure Schedule or schedules if Purchaser gives Seller written notice of an
update and Purchaser does not receive from Seller a written notice of objection
to such action within ten (10) business days after Seller receives Purchaser's
written notice.

      6.8 Representations and Warranties. The representations and warranties of
Purchaser contained in this Agreement will be true and correct in all respects,
except where the failure of such representations and warranties to be true and
correct would not have a material adverse effect (whether individually or in the
aggregate) on Purchaser's ability to consummate the transactions contemplated
hereby, when made and on and as of the Closing Date (or the date otherwise
specified herein) as though such representations and warranties had been made on
and as of such date.

                                      -51-
<PAGE>

                                  ARTICLE VII

                CONDITIONS PRECEDENT TO OBLIGATIONS OF PURCHASER

      Purchaser's obligation to purchase the Assets and to close the
transactions contemplated by this Agreement shall be subject to the satisfaction
of each of the following conditions on or prior to the Closing Date unless
specifically waived in writing by Purchaser in whole or in part at or prior to
the Closing.

      7.1 Governmental Authorizations. Purchaser shall have obtained all
material licenses, permits, certificates of need and authorizations (but not
provider numbers, which are governed by the second sentence of this Section 7.1)
from Governmental Entities that are necessary or required for the consummation
of the transactions herein, including for Purchaser to operate the Hospitals in
a manner consistent with Seller's operation of the Hospitals immediately prior
to the Closing, including reasonable assurances (which assurances are reasonably
acceptable to Purchaser) that any material licenses, permits, certificates of
need and authorizations (but not provider numbers) not actually issued as of the
Closing will be issued following Closing (which may include oral assurances from
appropriate Governmental Entities). Except with respect to those Medicare
numbers and agreements, if any, which Purchaser elects in its sole discretion to
assume on or before October 14, 2004, Purchaser shall have obtained reasonable
assurances (which assurances are reasonably acceptable to Purchaser) that it
will be issued new Medicare and Medi-Cal provider numbers following Closing
(which may include oral assurances from appropriate Governmental Entities).
Notwithstanding the foregoing, for purposes of this Section 7.1, (i) Purchaser
shall be deemed to have obtained reasonable assurances that it will be issued
new Medicare and Medi-Cal provider numbers following Closing upon the receipt of
written confirmation from the FI of the FI's approval of all of Purchaser's Form
855 applications, (ii) Purchaser's failure to have obtained a "tying notice" as
of the Closing Date indicating that Purchaser can bill under the Medicare and/or
Medi-Cal programs for services rendered at the Hospitals shall not be taken into
account for purposes of determining whether Purchaser has obtained reasonable
assurances that it will be issued new Medicare and Medi-Cal provider numbers
following the Closing, and (iii) if Medicare requires a survey of the
psychiatric sub-units of such Hospitals as a condition to the issuance of a new
Medicare number to the Hospitals, neither the completion of such survey, nor any
failures to obtain any licenses, permits, authorizations, provider numbers or
provider agreements at the Hospitals as a result thereof, shall constitute a
condition precedent to Purchaser's obligation to consummate the transactions
contemplated by this Agreement. Seller shall have obtained all material permits
and authorizations from Governmental Entities that are necessary or required for
the consummation of the transactions herein, including reasonable assurances
(which assurances are reasonably acceptable to Purchaser) that any such material
permits and authorizations not actually issued as of the Closing will be issued
following Closing (which may include oral assurances from appropriate
Governmental Entities).

                                      -52-
<PAGE>

      7.2 Signing and Delivery of Instruments. Seller shall have executed and
delivered all documents, instruments and certificates required to be executed
and delivered pursuant to all of the provisions of this Agreement.

      7.3 Performance of Covenants. Seller shall have in all material respects
performed or complied with each and all of the obligations, covenants,
agreements and conditions required to be performed or complied with by Seller on
or prior to the Closing Date; provided, however, this condition will be deemed
to be satisfied unless (a) Seller was given written notice of such failure to
perform or comply and did not or could not cure such failure to perform or
comply within fifteen (15) business days after receipt of such notice and (b)
the respects in which such obligations, covenants, agreements and conditions
have not been performed have had or would more likely than not result in a
material adverse effect (whether individually or in the aggregate) on the Assets
or the business of the Hospitals or Seller's ability to perform its obligations
hereunder. Purchaser shall not be required to give Seller the notice described
in Section 7.3(a) unless and until Purchaser is aware, or based on the
applicable facts and circumstances, it is reasonable that Purchaser should be
aware of Seller's alleged failure to perform or comply with the applicable terms
of this Agreement.

      7.4 Unfavorable Action or Proceeding. On the Closing Date, no orders,
decrees, judgments or injunctions of any court or Governmental Entity shall be
in effect, and no claims, actions, suits, proceedings, arbitrations or
investigations shall be pending or threatened, which challenge or seek to
challenge, or which could prevent or cause the rescission of, the consummation
of the transactions contemplated in this Agreement.

      7.5 Hart Scott Rodino Filings. All filings required to be made and notices
required to be given pursuant to the HSR Act shall have been made, all approvals
or consents required thereby shall have been obtained and the waiting periods
required thereby, if any, shall have expired or terminated.

      7.6 Opinion of Counsel. Purchaser shall have received the favorable
opinion of Seller's in-house counsel dated the Closing Date, in substantially
the form attached hereto as Exhibit 7.6.

      7.7 Title Insurance Policy. Purchaser shall have received a fully
effective Owner's Title Policy issued to Purchaser by the Title Company covering
the Owned Real Property and a fully effective Leasehold Title Policy covering
any ground lease or other lease of record specified on Schedule 4.8 in the
amount of the full insurable value of the Owned Real Property and any such
ground lease or other lease of record, respectively (which amount shall be set
forth in Schedule 11.1(b)). The Owner's Title Policy shall show fee simple title
to the Owned Real Property vested in Purchaser, and the Leasehold Title Policy
shall show valid leasehold title to the Leased Real Property which is subject to
any ground lease or other lease of record specified on Schedule 4.8, subject
only to: (a) current real estate taxes not yet due and payable; and (b) the
permitted title exceptions listed in Schedule 7.7 hereto (the "Permitted
Exceptions"). The Title Policy shall have all standard and general exceptions
deleted so as to afford full "extended form coverage".

                                      -53-
<PAGE>

      7.8 Environmental Survey. Purchaser shall have received the Environmental
Survey referred to in Section 4.12.

      7.9 Exhibits and Schedules. The material provisions of the Exhibits,
Disclosure Schedule and all schedules attached to this Agreement that were
updated by Seller after the Effective Date, if any, shall be acceptable to
Purchaser in its reasonable discretion provided, however, that Seller shall be
deemed to have obtained Purchaser's approval to any such material updates of the
Exhibits, Disclosure Schedule or schedules if Seller gives Purchaser written
notice of an update and Seller does not receive from Purchaser a written notice
of objection to such action within ten (10) business days after Purchaser
receives Seller's written notice.

      7.10 Representations and Warranties. The representations and warranties of
Seller contained in this Agreement will be true and correct in all respects,
except where the failure of such representations and warranties to be true and
correct would not have a material adverse effect (whether individually or in the
aggregate) on Seller's ability to consummate the transactions contemplated
hereby and the operation of the Hospital following the Closing Date, when made
and on and as of the Closing Date (or the date otherwise specified herein) as
though such representations and warranties had been made on and as of such date.

                                  ARTICLE VIII

                                   TERMINATION

      8.1 Termination. This Agreement may be terminated at any time prior to
Closing:

            (a) by the mutual written consent of the parties;

            (b) by Seller if a material breach of this Agreement has been
committed by Purchaser and such breach has not been (i) waived in writing by
Seller or (ii) cured by Purchaser to the reasonable satisfaction of Seller
within fifteen (15) business days after service by Seller upon Purchaser of a
written notice which describes the nature of such breach; provided, however,
that if the obligation which Purchaser fails to perform is other than the
failure to make payment of money, and greater than fifteen (15) business days
are required to cure or perform said obligation, then Purchaser shall not be in
default of this Agreement and the Agreement shall not terminated as provided
hereinabove if Purchaser commences to cure the non-performance within said
fifteen (15) day period and diligently pursues said cure to completion within
five (5) business days thereafter;

            (c) by Purchaser if a material breach of this Agreement has been
committed by Seller and such breach has not been (i) waived in writing by
Purchaser or (ii) cured by Seller to the reasonable satisfaction of Purchaser
within fifteen (15) business days after service by Purchaser upon Seller of a
written notice which describes the nature of such breach; provided, however,
that if the obligation which Seller fails to perform is other than the failure
to make payment of money, and greater than fifteen (15) business days are
required to cure or perform said obligation, then Seller shall not be in default
of this Agreement and the Agreement shall not terminated as provided hereinabove
if Seller commences to cure the condition of non-performance within said fifteen
(15) day period and diligently pursues said cure to completion within five (5)
business days thereafter;

                                      -54-
<PAGE>

            (d) by Purchaser if any of the conditions in Article VII have not
been satisfied as of the Closing Date or if satisfaction of any condition in
Article VII is or becomes impossible and Purchaser has not waived such condition
in writing on or before the Closing Date (provided that the failure to satisfy
the applicable condition or conditions has occurred by reason other than (i)
through the failure of Purchaser to comply with its obligations under this
Agreement or (ii) Seller's failure to provide its closing deliveries on the
Closing Date as a result of Purchaser not being ready, willing and able to close
the transaction on the Closing Date);

            (e) by Seller if any of the conditions in Article VI have not been
satisfied as of the Closing Date or if satisfaction of any such condition in
Article VI is or becomes impossible and Seller has not waived such condition in
writing on or before the Closing Date (provided that the failure to satisfy the
applicable condition or conditions has occurred by reason other than (i) through
the failure of Seller to comply with its obligations under this Agreement or
(ii) Purchaser's failure to provide its closing deliveries on the Closing Date
as a result of Seller not being ready, willing and able to close the transaction
on the Closing Date);

            (f) by Purchaser, upon the delivery of a Casualty Termination Notice
to Seller in accordance with Section 1.14;

            (g) by either Purchaser or Seller if the Closing has not occurred
(other than through the failure of any party seeking to terminate this Agreement
to comply fully with its obligations under this Agreement) on or before December
31, 2004 (the "Termination Date");

            (h) by Purchaser, if, since the Effective Date, there has occurred
any event, change or development that has had a "material adverse effect" on the
assets, financial condition, or operations of the Hospitals considered in the
aggregate; provided, however, that notwithstanding anything to the contrary
contained in this Agreement, the following will be presumed not to give rise to
a "material adverse effect": (a) changes or proposed changes to any law,
reimbursement rates or policies of governmental agencies or bodies that are
generally applicable to hospitals or healthcare facilities and (b) requirements,
reimbursement rates, policies or procedures of third party payors or
accreditation commissions or organizations that are generally applicable to
hospitals or healthcare facilities;

            (i) by Seller, unless Purchaser has previously waived the condition
precedent set forth at Section 7.1 relating to obtaining licensure with respect
to Hospitals and "reasonable assurances" of issuance of a Medicare provider
number, if Purchaser has not received, on or before December 15, 2004, written
confirmation from the FI of its approval of the Purchaser's Form 855, and such
failure by Purchaser to receive approval from the FI within such time frame is
not attributable to a breach by Seller of its covenant to cooperate set forth in
Section 4.4 of this Agreement provided, however, that no such breach by Seller
shall be deemed to have occur for purposes of this Section 8.1(i) unless
Purchaser has provided not less than fifteen (15) days prior written notice to
Seller detailing, with reasonably particularity, the nature of such alleged
breach of Section 4.4 and Seller has failed to cure such breach to the
reasonable satisfaction of Purchaser by the end of such fifteen (15) day period;
or

                                      -55-
<PAGE>

            (j) by Purchaser, on or before October 6, 2004, if in Purchaser's
reasonable discretion any item(s) identified in the Surveys, individually or in
the aggregate, would materially adversely affect the ability of Purchaser to
obtain commercial financing with respect to the acquisition of the Hospitals and
the Assets.

      8.2 Termination Consequences. If this Agreement is terminated pursuant to
Section 8.1: (a) all further obligations of the parties under this Agreement
shall terminate, except that the obligations in Sections 1.4, 5.6, 12.3, 12.6,
12.8, and 12.12 shall survive; (b) each party shall pay the costs and expenses
incurred by it in connection with this Agreement, except as provided in Section
12.12; and (c) nothing shall prevent any party hereto from pursuing any of its
legal rights or remedies that may be granted to any such party by law against
any other party to this Agreement, except that no party shall be entitled to
obtain Consequential Damages.

                                   ARTICLE IX

                              POST-CLOSING MATTERS

      9.1 Excluded Assets and Excluded Liabilities; Misdirected Payments.

            (a) Subject to Section 11.2 hereof, any asset (including Accounts
Receivable) or any liability, all other remittances and all mail and other
communications that is an Excluded Asset or an Excluded Liability (a) pursuant
to the terms of this Agreement, (b) as otherwise determined by the parties'
mutual written agreement or (c) absent such agreement, as determined by
adjudication by a court or similar tribunal, and which comes into the
possession, custody or control of Purchaser (or its respective
successors-in-interest, assigns or affiliates) shall within ten (10) business
days following receipt be transferred, assigned or conveyed by Purchaser (and
its respective successors-in-interest, assigns and affiliates) to Seller at
Seller's cost, unless otherwise agreed by the Parties. The portion of any
disproportionate share payments received by Purchaser that are treated as
Excluded Assets pursuant to Section 9.1(c) below shall be remitted to Seller in
accordance with the foregoing requirements. Until such transfer, assignment and
conveyance, Purchaser (and its respective successors-in-interest, assigns and
affiliates) shall not have any right, title or interest in or obligation or
responsibility with respect to such asset or liability except that Purchaser
shall hold such asset in trust for the benefit of Seller. Purchaser (and its
respective successors-in-interest, assigns and affiliates) shall have neither
the right to offset amounts payable to Seller under this Section 9.1(a) against,
nor the right to contest its obligation to transfer, assign and convey to Seller
because of, outstanding claims, liabilities or obligations asserted by Purchaser
against Seller including but not limited to pursuant to the post-Closing Cash
Purchase Price adjustment of Section 1.3 and the indemnification provisions of
Section 10.2. If Purchaser does not remit any payments or remittances due to
Seller under this Section 9.1(a) in accordance with the first sentence of this
Section 9.1(a), such payments or remittances shall bear interest at the Prime
Rate in effect on the calendar day upon which such payment was required to be
made to Seller (the "Seller Payment Due Date"), plus five percent (5%) per annum
(or the maximum rate allowed by law, whichever is less), compounded daily, such
interest accruing after the Seller Payment Due Date until payment including all
interest thereon, is made to Seller. With respect to payment received by
Purchaser on account of Transition Services, this Section 9.1(a) shall be
subject to the provisions of Section 11.3. The terms of this Article IX shall
not be subject to the time limitations contained in Section 10.1 of this
Agreement.

                                      -56-
<PAGE>

            (b) Any asset or any liability, all other remittances and all mail
and other communications that is an Asset or an Assumed Liability (a) pursuant
to the terms of this Agreement, (b) as otherwise determined by the parties'
mutual written agreement or (c) absent such agreement, as determined by
adjudication by a court or similar tribunal, and which comes into the
possession, custody or control of Seller (or its respective
successors-in-interest, assigns or affiliates) shall within ten (10) business
days following receipt be transferred, assigned or conveyed by Seller (and its
respective successors-in-interest, assigns and affiliates) to Purchaser at
Purchaser's cost, unless otherwise agreed by the Parties. Until such transfer,
assignment and conveyance, Seller (and its respective successors-in-interest,
assigns and affiliates) shall not have any right, title or interest in or
obligation or responsibility with respect to such asset or liability except that
Seller shall hold such asset in trust for the benefit of Purchaser. Seller (and
its respective successors-in-interest, assigns and affiliates) shall have
neither the right to offset amounts payable to Purchaser under this Section
9.1(b) against, nor the right to contest its obligation to transfer, assign and
convey to Purchaser because of, outstanding claims, liabilities or obligations
asserted by Seller against Purchaser including but not limited to pursuant to
the indemnification provisions of Section 10.3. If Seller does not remit any
payments or remittances due to Purchaser under this Section 9.1(b) in accordance
with the first sentence of this Section 9.1(b), such payments or remittances
shall bear interest at the Prime Rate in effect on the calendar day upon which
such payment was required to be made to Purchaser (the "Purchaser Payment Due
Date"), plus five percent (5%) per annum (or the maximum rate allowed by law,
whichever is less), compounded daily, such interest accruing after the Purchaser
Payment Due Date until payment including all interest thereon, is made to
Seller. The terms of this Article IX shall not be subject to the time
limitations contained in Section 10.1 of this Agreement.

            (c) Notwithstanding any other terms herein to the contrary, the
parties agree that any disproportionate share Medi-Cal payments (whether 855 or
1255) received related to the Hospitals shall be allocated between the parties
as follows: (a) any disproportionate share Medi-Cal payments made in connection
with the State of California's 2003- 2004 fiscal year (ending June 30, 2004)
shall constitute an Excluded Asset; (b) Seller shall be paid a fraction of the
disproportionate share Medi-Cal payments received in connection with the State's
2004- 2005 fiscal year (beginning July 1, 2004) for the Hospitals ("2005 DSH
Payments") based on a fraction the numerator of which is the number of days from
and including July 1, 2004 through the Closing Date and the denominator of which
is three hundred sixty (360), and the remainder of all such 2005 DSH Payments
shall be retained by, and the property of, the Purchaser; and (c) all
disproportionate share Medi-Cal payments received in connection with the
Hospitals relating to periods after the State's 2004-2005 fiscal year shall be
fully retained by, and be the property of, the Purchaser.

      9.2 Preservation and Access to Records After the Closing.

                                      -57-
<PAGE>

            (a) From the Closing Date until seven (7) years after the Closing
Date or such longer period as required by law (the "Document Retention Period"),
Purchaser shall keep and preserve all medical records, patient records, medical
staff records and other books and records which are among the Assets as of the
Effective Time, but excluding any records which are among the Excluded Assets.
Purchaser will afford to the representatives of Seller, including its counsel
and accountants, full and complete access to, and copies (including, without
limitation, color laser copies) of, such records with respect to time periods
prior to the Effective Time (including, without limitation, access to records of
patients treated at the Hospitals prior to the Effective Time) during normal
business hours after the Effective Time, to the extent reasonably needed by
Seller or Seller's affiliates for business purposes. Purchaser acknowledges
that, as a result of entering into this Agreement and operating the Hospitals,
it will gain access to patient records and other information which are subject
to rules and regulations concerning confidentiality. Purchaser shall abide by
any such rules and regulations relating to the confidential information it
acquires. Purchaser shall maintain the patient and medical staff records at the
Hospitals in accordance with applicable law and the requirements of relevant
insurance carriers. After the expiration of the Document Retention Period, if
Purchaser intends to destroy or otherwise dispose of any of the documents
described in this Section 9.2(a), Purchaser shall provide written notice to
Seller of Purchaser's intention no later than forty-five (45) calendar days
prior to the date of such intended destruction or disposal. Seller shall have
the right, at its sole cost, to take possession of such documents during such
forty-five (45) calendar day period. If Seller does not take possession of such
documents during such forty-five (45) calendar day period, Purchaser shall be
free to destroy or otherwise dispose of such documentation upon the expiration
of such forty-five (45) calendar day period. Any access granted to Seller shall
be at Seller's sole cost and expense, and shall be at such a time and in such a
manner as does not unreasonably interfere with the operations of the Hospitals
and is permitted by HIPAA and other applicable confidentiality laws.

            (b) Purchaser shall give full cooperation to Seller, Seller's
affiliates and their insurance carriers in respect of the defense of claims by
third parties against Seller or any affiliate of Seller, in respect of events
occurring prior to the Effective Time with respect to the operation of the
Hospitals. Such cooperation shall include, without limitation, making the Hired
Employees available for interviews, depositions, hearings and trials. Such
cooperation shall also include making all of its employees available to assist
in the securing and giving of evidence and in obtaining the presence and
cooperation of witnesses (all of which shall be done without payment of any fees
or expenses to Purchaser or to such employees). In addition, Seller and Seller's
affiliates shall be entitled to remove from the Hospitals originals of any such
records, but only for purposes of pending litigation involving the persons to
whom such records refer, as certified in writing prior to removal by counsel
retained by Seller or any of Seller's affiliates in connection with such
litigation. Any records so removed from the Hospitals shall be promptly returned
to Purchaser following Seller's or its applicable affiliate's use of such
records. Any access granted to Seller shall be at Seller's sole cost and
expense, and shall be at such a time and in such a manner as does not
unreasonably interfere with the operations of the Hospitals and is permitted by
HIPAA and other applicable confidentiality laws.

            (c) In connection with (i) the transition of the Hospitals pursuant
to the transaction contemplated by this Agreement, (ii) Seller's rights to the
Excluded Assets, (iii) Seller's obligations under the Excluded Liabilities and
(iv) Seller's preparation of the Final Balance Sheet pursuant to Section 1.3,
Purchaser shall after the Effective Time give Seller, Seller's affiliates and
their respective representatives access during normal business hours to
Purchaser's books, accounts and records and all other relevant documents and
information with respect to the assets, liabilities and businesses of the
Hospitals as representatives of Seller and Seller's affiliates may from time to
time reasonably request, all in such manner as not to unreasonably interfere
with the operations of the Hospitals. Seller acknowledges that it shall
coordinate its activities contemplated by this Section 9.2(c) through Larry
Anderson and William Thomas, or their designee.

                                      -58-
<PAGE>

            (d) Purchaser and its representatives shall be given access by
Seller during normal business hours to the extent reasonably needed by Purchaser
for business purposes to all documents, records, correspondence, work papers and
other documents retained by Seller pertaining to any of the Assets or with
respect to the operation of the Hospitals prior to the Effective Time, all in
such manner as to not interfere unreasonably with Seller's business. Such
documents and other materials shall be, at Seller's option, either (i) copied by
Seller for Purchaser at Purchaser's expense, or (ii) removed by Purchaser from
the premises, copied by Purchaser and promptly returned to Seller.

            (e) Purchaser shall comply with, and be solely responsible for, all
obligations under the Standards for Privacy of Individually Identifiable Health
Information (45 CFR Parts 160 and 164) promulgated pursuant to the Health
Insurance Portability and Accountability Act of 1996 with respect to the
operation of the Hospitals on and after the Effective Time.

            (f) Purchaser shall cooperate with Seller, on a timely basis and as
reasonably requested by Seller, in connection with the provision of data of the
Hospitals and other information required by Seller for reporting to the JCAHO
for the remainder of the quarterly period in which the Closing has occurred.

            (g) To the maximum extent permitted by law, if any Person requests
or demands, by subpoena or otherwise, any documents relating to the Excluded
Liabilities, including without limitation, documents relating to the operations
of any of the Hospitals or any of the Hospitals' committees prior to the
Effective Time, prior to any disclosure of such documents, Purchaser shall
notify Seller and shall provide Seller with the opportunity to object to, and
otherwise coordinate with respect to, such request or demand; provided, however,
Seller shall be responsible for raising any such objections in a timely fashion.

      9.3 Provision of Benefits of Certain Contracts. If, as of the Effective
Time, Seller is unable to obtain any consent to the assignment of Seller's
interest in a Material Contract or a Material Lease, or if Purchaser is unable
to enter into a new contract with respect to an Excluded Multi-Facility
Contract, until such consent is obtained or a new contract is obtained by
Purchaser prior to or following the Closing (Seller shall use reasonable
commercial efforts to cooperate with Purchaser's efforts to obtain any such
consent or new contract prior to or following the Closing), Seller shall use
reasonable commercial efforts to provide Purchaser the benefits of any such
Material Contract or Material Lease and the applicable Hospital's portion of any
Excluded Multi-Facility Contract selected by Purchaser, cooperate in any
reasonable and lawful arrangement designed to provide such benefits to
Purchaser, and allow Purchaser to directly enforce such Material Contract or
Material Lease against the applicable third parties thereto. Purchaser shall use
reasonable commercial efforts to perform, on behalf of Seller, the obligations
of Seller thereunder or in connection therewith arising on and after the
Effective Time, if Seller has previously obtained (or Purchaser will obtain) any
benefits thereunder, but only to the extent that such action would not result in
a material default thereunder or in connection therewith and such obligation
would have been, in the case of an Excluded Multi-Facility Contract, an
obligation of Purchaser had it entered into a new contract on substantially
similar terms.

                                      -59-
<PAGE>

      9.4 Closing of Financials. Purchaser shall cause each of the CFOs to
complete the standardized closing of Seller's financial records through the
Closing Date including, without limitation, the closing of general ledger
account reconciliations (collectively, the "Closing of Financials"). Purchaser
shall cause each of the CFOs to use his or her good faith efforts to complete
the Closing of Financials by no later than the date which is thirty (30) days
after the Closing Date. Seller shall reimburse Purchaser for all payroll charges
and other out-of-pocket expenses of Purchaser associated with the time which
each of the CFOs devotes to the Closing of Financials. Such reimbursement shall
occur no later than the date which is thirty (30) days after Purchaser provides
a written statement to Seller which details such charges and expenses. Seller
shall hold Purchaser harmless for any errors which are made by any of the CFOs
during the course of the Closing of Financials, provided that such errors are
not the result of gross negligence, fraud or intentional misconduct.

      9.5 Medicare Bad Debts

            (a) With respect to any service provided at the Hospitals as to
which Purchaser elects to take assignment of Seller's provider number, Seller
shall be entitled to receive Medicare bad debt reimbursement associated with
services furnished prior to Closing ("Seller's Bad Debts"). Seller shall have
the right, in its sole discretion, to require that Purchaser submit a claim for
reimbursement to the Center for Medicare Services ("CMS") for a Seller's Bad
Debt on Purchaser's cost report(s) for the period in which such Seller's Bad
Debt becomes uncollectible by Seller.

            (b) If Seller requests that Purchaser submit one or more Seller's
Bad Debt claims to CMS, as contemplated by this Section 9.5, Seller shall
provide to Purchaser a list of the Seller's Bad Debts to be claimed with a
certification reasonably acceptable to Purchaser and Seller.

            (c) Purchaser shall remit to Seller the full amount of reimbursement
received by Purchaser for Seller's Bad Debts within ten (10) business days of
the tentative settlement of any cost report in which Seller's Bad Debts have
been claimed pursuant to this Section 9.5. The parties will reconcile the prior
payment made based on the tentative settlement pursuant to the immediately
preceding sentence, with the final amount set forth in the final settlement of
the cost report(s), by the making of a cash payment so as to cause the net
aggregate amount paid by Purchaser to Seller with respect to any given Seller's
Bad Debt to be equal to the amount set forth on the final settlement. Any
additional payment due to Seller by Purchaser as a result of the cost report
audit of Seller's Bad Debts claims submitted by Purchaser and/or any Final
Settlement shall be remitted to Seller within ten (10) days of Purchaser's
receipt of the Notice of Program Reimbursement (NPR) for the cost report(s) in
question. Any payment due to Purchaser from Seller as a result of a cost report
audit and/or final settlement shall be remitted to Purchaser within ten (10)
days of written notice regarding the final settlement from Purchaser.

                                      -60-
<PAGE>

      9.6 OSHPD; OSHPD Reporting.

            (a) The California Office of Statewide Health Planning and
Development ("OSHPD") has requested that Seller and its affiliates provide to
OSHPD certain assurances that the purchaser of the Hospitals be informed
regarding California law applicable to seismic conditions relating to acute care
hospital facilities and, in particular, the condition and/or status of the
Hospitals relative to such requirements. Accordingly, Purchaser acknowledges
that it has received from Seller the due diligence information that is listed on
Schedule 9.6 with respect to matters relating to the seismic condition of the
Hospitals.

            (b) As of the Effective Date, Seller is in discussions with OSHPD
regarding the potential requirement (in connection with the sale of the
Hospitals) that Seller prepare and provide to OSHPD a nonstructural evaluation
and list of all nonstructural deficiencies with respect to the Hospitals (the
"Nonstructural Evaluation"). If OSHPD requires that Seller in fact prepare and
provide to OSHPD the Nonstructural Evaluation and Seller is required to
undertake any portion of the Nonstructural Evaluation after the Closing Date,
Purchaser shall provide Seller, Seller's affiliates and their respective
representatives access during normal business hours to the Hospitals in order to
undertake the Nonstructural Evaluation, as representatives of Seller and
Seller's affiliates may from time to time reasonably request, all in such manner
as not to unreasonably interfere with the operations of the Hospitals. Seller
shall bear the costs incurred by Seller, Seller's affiliates and their
respective representatives associated with the preparation and filing of the
Nonstructural Evaluation. Subsequent to filing the Nonstructural Evaluation,
Seller shall provide Purchaser with a copy of the Nonstructural Evaluation.

                                   ARTICLE X

                          SURVIVAL AND INDEMNIFICATION

      10.1 Survival. Except as expressly set forth in this Agreement to the
contrary, all representations, warranties, covenants, agreements and
indemnifications of Purchaser and Seller, respectively, contained in this
Agreement or in any document delivered pursuant hereto shall be deemed to be
material and to have been relied upon by Purchaser and Seller, respectively, and
shall continue to be fully effective and enforceable following the Closing Date
for two (2) years and shall thereafter be of no further force and effect,
provided, however, that the covenants contained in Sections 4.13 (non-compete
and non-solicit as to Hospital Employees), 4.14 (enforceability), 4.18
(maintenance of insurance), 5.4 (use of names), 9.1 (excluded liabilities), 9.2
(access to records), Article XII and the indemnifications in Sections 10.2.1(c),
10.2.1(d), 10.3.1(c) and 10.3.1(d) shall continue to be fully effective and
enforceable following the Closing Date without any time limitation or any
limitation on available remedies, unless a time limitation is set forth in the
particular Section; provided, further that the indemnifications in Sections
10.2.1(e) through 10.2.1(i) and Sections 10.3.1(e) through 10.3.1(j) shall
continue to be fully effective and enforceable following the Closing Date
without any time limitation subject only to the applicable statute of
limitations; provided, however, that if there is an outstanding notice of a
claim at the end of such applicable period in compliance with the terms of
Section 10.4, such applicable period shall not end in respect of such claim
until such claim is resolved.

                                      -61-
<PAGE>

      10.2 Indemnification of Purchaser by Seller.

            10.2.1 Indemnification. Seller shall keep and save Purchaser, and
its directors, officers, employees, agents and other representatives (the
"Purchaser Parties"), forever harmless from and shall indemnify and defend the
Purchaser Parties against any and all obligations, judgments, liabilities,
penalties, violations, fees, fines, claims, losses, costs, demands, damages,
liens, encumbrances and expenses including reasonable attorneys' fees
(collectively, "Damages"), to the extent connected with or arising or resulting
from (a) any breach of any representation or warranty of Seller under this
Agreement, (b) any breach or default by Seller of any covenant or agreement of
Seller under this Agreement, (c) the Excluded Liabilities, (d) the Excluded
Assets, (e) all federal, state and local income taxes relating to Seller
("Seller Tax Claims"), (f) any professional liability claim arising out of the
business operations of the Hospitals prior to the Effective Time, (g) any act,
conduct or omission of Seller that has accrued, arisen, occurred or come into
existence at any time prior to the Effective Time, (h) any of those certain
pending governmental investigations of Seller or its affiliates which are
described on Schedule 10.2.1 and (i) cost reports (and all claims with respect
thereto) relating to Seller with respect to Medicare, Medi-Cal, TRICARE or Blue
Cross programs or any other third-party payor for all periods prior to the
Effective Time. Seller's obligations under this Section 10.2.1 shall remain
subject to, and shall be limited by, the provisions contained in Section 1.13 as
modified by Article II. No provision in this Agreement shall prevent Seller from
pursuing any of its legal rights or remedies that may be granted to Seller by
law against any Person or legal entity other than Purchaser.

            10.2.2 Indemnification Limitations. (a) Notwithstanding any
provision to the contrary contained in this Agreement, Seller shall be under no
liability to indemnify Purchaser under Section 10.2.1 and no claim under Section
10.2.1 of this Agreement shall:

                  (i) be made unless notice thereof shall have been given by or
on behalf of Purchaser to Seller in the manner provided in Section 10.4, unless
failure to provide such notice in a timely manner does not materially impair
Seller's ability to defend its rights, mitigate damages, seek indemnification
from a third party or otherwise protect its interests;

                  (ii) be made to the extent that any loss may be recovered
under a policy of insurance in force on the date of loss; provided, however,
that this Section 10.2.2(a)(ii) shall not apply to the extent that coverage
under the applicable policy of insurance is denied by the applicable insurance
carrier;

                  (iii) be made to the extent that such claim relates to a
liability arising out of or relating to any act, omission, event or occurrence
connected with:

                        (A) the use, ownership or operation of any of the
                        Hospitals or

                        (B) the use, ownership or operation of any of the
                        Assets,

                        on and after the Effective Time (without regard to
                        whether such use, ownership or operation is consistent
                        with Seller's policies, procedures and/or practices
                        prior to the Effective Time); other than as specifically
                        included in the Excluded Liabilities;

                                      -62-
<PAGE>

                  (iv) be made under Section 10.2.1(a) to the extent that such
claim (or the basis therefor) is set forth in the Disclosure Schedule, any
Exhibit or Schedule to this Agreement;

                  (v) Intentionally Omitted;

                  (vi) be made to the extent such claim relates to Seller's
failure to comply with or the Assets' failure to be in compliance with (A) the
Americans with Disabilities Act or (B) the Alfred E. Alquist Hospital Facilities
Seismic Safety Act of 1983, as amended by the California Hospitals Facilities
Seismic Safety Act (codified at California Health and Safety Code ss.129675
through ss.130070); provided, however, this Section 10.2.2(a)(vi) shall not
apply to the extent that such claim arises as a result of a claim brought by a
non-governmental third party who has suffered personal injury prior to the
Effective Time provided that this 10.2.2(a)(vi) shall not be construed to limit
Purchaser's rights to indemnification under Section 10.2.1(a) for a breach by
Seller of any representation or warranty under this Agreement;

                  (vii) be made to the extent such claim seeks Damages which are
consequential in nature (as opposed to direct), including, without limitation,
loss of future revenue or income or loss of business reputation or opportunity
(collectively, "Consequential Damages"); provided, however, the limitation
contained in this Section 10.2.2(a)(vii) shall not apply to the extent (A) of
any payments which Purchaser is required to make to a third party (other than
any third party which is an affiliate of, investor of or lender to Purchaser)
which are in the nature of Consequential Damages and (B) such third party's
claim is unrelated to the failure to obtain any or all of the Contract and Lease
Consents; and

                  (viii) accrue to Purchaser under Section 10.2.1(a) unless and
only to the extent that (A) the actual liability of Seller in respect of any
single claim under Section 10.2.1(a) exceeds Five Thousand Dollars ($5,000) (a
"Relevant Claim") and (B) the total actual liability of Seller in respect of all
Relevant Claims under Section 10.2.1(a) in the aggregate exceeds Two Million
Five Hundred Thousand Dollars ($2,500,000) (the "Aggregate Amount"), in which
event Purchaser shall be entitled to seek indemnification under Section
10.2.1(a) for all Relevant Claims only in an amount of Damages which exceed the
Aggregate Amount; provided, however, that the exception set forth in this
Section 10.2.2(viii) shall not be construed to limit the indemnification
available to Purchaser under Sections 10.2.1(b), (c), (d), (e), (f), (g), (h)
and (i).

            (b) Notwithstanding any provision to the contrary contained in this
Agreement, the maximum aggregate liability of Seller to Purchaser under this
Agreement shall not exceed the Cash Purchase Price.

            (c) If Purchaser is entitled to recover any sum (whether by payment,
discount, credit or otherwise) from any third party in respect of any matter for
which a claim of indemnity could be made against Seller hereunder, Purchaser
shall use its reasonable endeavors to recover such sum from such third party and
any sum recovered will reduce the amount of the claim. If Seller pays to
Purchaser an amount in respect of a claim, and Purchaser subsequently recovers
from a third party a sum which is based on the same claim, Purchaser shall
forthwith repay to Seller so much of the amount paid by it as does not exceed
the sum recovered from the third party less all reasonable costs, charges and
expenses (including reasonable attorneys fees) incurred by Purchaser in
obtaining payment in respect of that claim and in recovering that sum from the
third party.

                                      -63-
<PAGE>

      10.3 Indemnification of Seller by Purchaser.

            10.3.1 Indemnification. Purchaser shall keep and save Seller, and
Seller's respective directors, officers, employees, agents and other
representatives, forever harmless from and shall indemnify and defend Seller and
Seller's affiliates against any and all Damages, to the extent connected with or
arising or resulting from (a) any breach of any representation or warranty of
Purchaser under this Agreement, (b) any breach or default by Purchaser under any
covenant or agreement of Purchaser under this Agreement, (c) cost reports (and
all claims with respect thereto) relating to Purchaser with respect to Medicare,
Medi-Cal, TRICARE or Blue Cross programs or any other third-party payor for all
periods beginning on and after the Effective Time, (d) the Assumed Obligations,
(e) any professional liability claim arising out of the business operations of
the Hospitals on and after the Effective Time, (f) liabilities to the Hired
Employees arising out of actions of Purchaser based wholly or in part upon the
contents of the personnel records of such employees, (g) involuntary termination
of the Hired Employees on and after the Effective Time, which termination would
constitute a "mass layoff" or a "plant closing" within the meaning of WARN, (h)
any act, conduct or omission of Purchaser that has accrued, arisen, occurred or
come into existence at any time, (i) any securities litigation involving (i)
Purchaser and/or (ii) any financing obtained by Purchaser which is utilized to
fund, in whole or in part, the Cash Purchase Price, other than to the extent
arising out of any willful misconduct of Seller or its employees, or
intentionally false or intentionally misleading statements of Seller or its
employees and (j) any Offering Circular or other materials or brochures provided
to prospective investors in the Hospitals (whether provided by Purchaser, any
affiliate of Purchaser, any Person which has or will have an equity interest in
Purchaser or any affiliate of Purchaser, or any other third party) (whether any
such Offering Circular, materials or brochures are issued or otherwise provided
before, on or after the Effective Date), including, without limitation, any
claim, suit or other action brought by any third party or Person in connection
with any Offering Circular, materials or brochures (whether any such Offering
Circular, materials or brochures are issued before, on or after the Effective
Date) or the securities offering in connection therewith. In no event shall
Purchaser's obligations under Section 10.3.1(j) in any way limit Seller's
obligations to Purchaser under Section 10.2.1(a). No provision in this Agreement
shall prevent Purchaser from pursuing any of its legal rights or remedies that
may be granted to Purchaser by law against any Person or legal entity other than
Seller or any affiliate of Seller.

            10.3.2 Indemnification Limitations. (a) Notwithstanding any
provision to the contrary contained in this Agreement, Purchaser shall be under
no liability to indemnify Seller under 10.3.1 and no claim under Section 10.3.1
of this Agreement shall:

                  (i) be made unless notice thereof shall have been given by or
on behalf of Seller to Purchaser in the manner provided in Section 10.4, unless
failure to provide such notice in a timely manner does not materially impair
Purchaser's ability to defend its rights, mitigate damages, seek indemnification
from a third party or otherwise protect its interests;

                  (ii) be made to the extent that any loss may be recovered
under a policy of insurance in force on the date of loss; provided, however,
that this Section 10.3.2(a)(ii) shall not apply to the extent that coverage
under the applicable policy of insurance is denied by the applicable insurance
carrier;

                                      -64-
<PAGE>

                  (iii) be made to the extent that such claim relates to a
liability of Seller arising out of or relating to any act, omission, event or
occurrence connected with:

                        (A) the use, ownership or operation of any of the
                        Hospitals, or

                        (B) the use, operation or ownership of any of the
                        Assets,

                        prior to the Effective Time, other than as specifically
                        included in the Assumed Obligations;

                  (iv) be made to the extent such claim relates to an obligation
or liability for which Seller has agreed to indemnify Purchaser pursuant to
Section 10.2;

                  (v) be made to the extent such claim seeks Consequential
Damages; provided, however, the limitation contained in this Section
10.3.2(a)(v) shall not apply to the extent of any payments which Seller or any
affiliate of Seller is required to make to a third party which are in the nature
of Consequential Damages; and

                  (vi) accrue to Seller under Section 10.3.1(a) unless and only
to the extent that (A) the actual liability of Purchaser in respect of any
single claim under Section 10.3.1(a) exceeds the Relevant Claim threshold and
(B) the total actual liability of Purchaser in respect of all Relevant Claims
under Section 10.3.1(a) in the aggregate exceeds the Aggregate Amount, in which
event Seller shall be entitled to seek indemnification under Section 10.3.1(a)
for all Relevant Claims only in an amount of Damages which exceed the Aggregate
Amount.

            (b) Notwithstanding any provision to the contrary contained in this
Agreement, the maximum aggregate liability of Purchaser to Seller under this
Agreement, subsequent to Purchaser paying the Cash Purchase Price at Closing,
shall not exceed an additional amount equal to the Cash Purchase Price.

            (c) If Seller is entitled to recover any sum (whether by payment,
discount, credit or otherwise) from any third party in respect of any matter for
which a claim of indemnity could be made against Purchaser hereunder, Seller
shall use its reasonable endeavors to recover such sum from such third party and
any sum recovered will reduce the amount of the claim. If Purchaser pays to
Seller an amount in respect of a claim, and Seller subsequently recovers from a
third party a sum which is based on the same claim, Seller shall forthwith repay
to Purchaser so much of the amount paid by it as does not exceed the sum
recovered from the third party less all reasonable costs, charges and expenses
(including reasonable attorneys fees) incurred by Seller in obtaining payment in
respect of that claim and in recovering that sum from the third party.

      10.4 Method of Asserting Claims. All claims for indemnification by any
Person entitled to indemnification (the "Indemnified Party") under this Article
X will be asserted and resolved as follows:

                                      -65-
<PAGE>

            (a) In the event any claim or demand, for which a party hereto (an
"Indemnifying Party") would be liable for the Damages to an Indemnified Party,
is asserted against or sought to be collected or withheld from such Indemnified
Party by a Person other than Seller, Purchaser or their affiliates (a "Third
Party Claim"), the Indemnified Party shall deliver a notice of its claim (a
"Claim Notice") to the Indemnifying Party within forty (40) calendar days after
the Indemnified Party receives written notice of such Third Party Claim;
provided, however, that notice shall be provided to the Indemnifying Party
within thirty (30) calendar days after receipt of a complaint, petition or
institution of other formal legal action by the Indemnified Party. If the
Indemnified Party fails to provide the Claim Notice within such applicable time
period after the Indemnified Party receives written notice of such Third Party
Claim and thereby materially impairs the Indemnifying Party's ability to protect
its interests, the Indemnifying Party will not be obligated to indemnify the
Indemnified Party with respect to such Third Party Claim to the extent that the
Indemnifying Party demonstrates that it has been materially prejudiced thereby.
The Indemnifying Party will notify the Indemnified Party within thirty (30)
calendar days after receipt of the Claim Notice (the "Notice Period") whether
the Indemnifying Party desires, at the sole cost and expense of the Indemnifying
Party, to defend the Indemnified Party against such Third Party Claim.

                  (i) If the Indemnifying Party notifies the Indemnified Party
within the Notice Period that the Indemnifying Party desires to defend the
Indemnified Party with respect to the Third Party Claim pursuant to this Section
10.4(a), then the Indemnifying Party will have the right to defend, at its sole
cost and expense, such Third Party Claim by all appropriate proceedings, which
proceedings will be prosecuted by the Indemnifying Party to a final conclusion
or will be settled at the discretion of the Indemnifying Party. The Indemnifying
Party will have full control of such defense and proceedings, including any
compromise or settlement thereof. Notwithstanding the foregoing, the Indemnified
Party may, at its sole cost and expense, file during the Notice Period any
motion, answer or other pleadings that the Indemnified Party may deem necessary
or appropriate to protect its interests or those of the Indemnifying Party and
which is not prejudicial, in the reasonable judgment of the Indemnifying Party,
to the Indemnifying Party. Except as provided in Section 10.4(a)(ii) hereof, if
an Indemnified Party takes any such action that is prejudicial and causes a
final adjudication that is adverse to the Indemnifying Party, the Indemnifying
Party will be relieved of its obligations hereunder with respect to the portion
of such Third Party Claim prejudiced by the Indemnified Party's action. If
requested by the Indemnifying Party, the Indemnified Party agrees, at the sole
cost and expense of the Indemnifying Party, to cooperate with the Indemnifying
Party and its counsel in contesting any Third Party Claim that the Indemnifying
Party elects to contest, or, if appropriate and related to the Third Party Claim
in question, in making any counterclaim against the Person asserting the Third
Party Claim, or any cross-complaint against any Person (other than the
Indemnified Party or any of its affiliates). The Indemnified Party may
participate in, but not control, any defense or settlement of any Third Party
Claim controlled by the Indemnifying Party pursuant to this Section 10.4(a)(i),
and except as specifically provided in this Section 10.4(a)(i), the Indemnified
Party will bear its own costs and expenses with respect to such participation.
The Indemnifying Party shall give sufficient prior notice to the Indemnified
Party relating to a settlement of a Third Party Claim to allow the Indemnified
Party to participate therein.

                                      -66-
<PAGE>

                  (ii) If the Indemnifying Party fails to notify the Indemnified
Party within the Notice Period that the Indemnifying Party desires to defend the
Indemnified Party pursuant to this Section 10.4(a), or if the Indemnifying Party
gives such notice but fails to prosecute diligently or settle the Third Party
Claim, or if the Indemnifying Party fails to give any notice whatsoever within
the Notice Period, then the Indemnified Party will have the right to defend, at
the sole cost and expense of the Indemnifying Party, the Third Party Claim by
all appropriate proceedings, which proceedings will be promptly and reasonably
prosecuted by the Indemnified Party to a final conclusion or will be settled at
the discretion of the Indemnified Party. The Indemnified Party will have full
control of such defense and proceedings, including any compromise or settlement
thereof; provided, however, that if requested by the Indemnified Party, the
Indemnifying Party agrees, at the sole cost and expense of the Indemnifying
Party, to cooperate with the Indemnified Party and its counsel in contesting any
Third Party Claim which the Indemnified Party is contesting, or, if appropriate
and related to the Third Party Claim in question, in making any counterclaim
against the Person asserting the Third Party Claim, or any cross-complaint
against any Person (other than the Indemnifying Party or any of its affiliates).
Notwithstanding the foregoing provisions of this Section 10.4(a)(ii), if the
Indemnifying Party has notified the Indemnified Party with reasonable promptness
that the Indemnifying Party disputes its liability to the Indemnified Party with
respect to such Third Party Claim and if such dispute is resolved in favor of
the Indemnifying Party, the Indemnifying Party will not thereafter be required
to bear the costs and expenses of the Indemnified Party's defense pursuant to
this Section 10.4(a)(ii) or of the Indemnifying Party's participation therein at
the Indemnified Party's request, and the Indemnified Party will reimburse the
Indemnifying Party in full for all reasonable costs and expenses incurred by the
Indemnifying Party in connection with such litigation. Subject to the above
terms of this Section 10.4(a)(ii), the Indemnifying Party may participate in,
but not control, any defense or settlement controlled by the Indemnified Party
pursuant to this Section 10.4(a)(ii), and the Indemnifying Party will bear its
own costs and expenses with respect to such participation. The Indemnified Party
shall give sufficient prior notice to the Indemnifying Party of the initiation
of any discussions relating to the settlement of a Third Party Claim to allow
the Indemnifying Party to participate therein.

            (b) In the event any Indemnified Party should have a claim against
any Indemnifying Party hereunder that either (i) does not involve a Third Party
Claim being asserted against or sought to be collected from the Indemnified
Party or (ii) is a Seller Tax Claim, the Indemnified Party shall deliver an
Indemnity Notice (as hereinafter defined) to the Indemnifying Party. (The term
"Indemnity Notice" shall mean written notification of a claim for indemnity
under Article X hereof (which claim does not involve a Third Party Claim or is a
Seller Tax Claim) by an Indemnified Party to an Indemnifying Party pursuant to
this Section 10.4, specifying the nature of and specific basis for such claim
and the amount or the estimated amount of such claim.) The failure by any
Indemnified Party to give the Indemnity Notice shall not impair such party's
rights hereunder except to the extent that an Indemnifying Party demonstrates
that it has been materially prejudiced thereby.

            (c) If the Indemnifying Party does not notify the Indemnified Party
within thirty (30) calendar days following its receipt of a Claim Notice or an
Indemnity Notice that the Indemnifying Party disputes its liability to the
Indemnified Party hereunder, such claim specified by the Indemnified Party will
be conclusively deemed a liability of the Indemnifying Party hereunder and the
Indemnifying Party shall pay the amount of such liability to the Indemnified
Party on demand, or on such later date (i) in the case of a Third Party Claim,
as the Indemnified Party suffers the Damages in respect of such Third Party
Claim, (ii) in the case of an Indemnity Notice in which the amount of the claim
is estimated, when the amount of such claim becomes finally determined or (iii)
in the case of a Seller Tax Claim, within fifteen (15) calendar days following
final determination of the item giving rise to the claim for indemnity. If the
Indemnifying Party has timely disputed its liability with respect to such claim,
as provided above, the Indemnifying Party and the Indemnified Party agree to
proceed in good faith to negotiate a resolution of such dispute, and if not
resolved through negotiations, such dispute will be resolved by adjudication by
a court or similar tribunal.

                                      -67-
<PAGE>

            (d) The Indemnified Party agrees to give the Indemnifying Party
reasonable access to the books and records and employees of the Indemnified
Party in connection with the matters for which indemnification is sought
hereunder, to the extent the Indemnifying Party reasonably deems necessary in
connection with its rights and obligations hereunder and to the extent legally
permitted.

            (e) In connection with any Third Party Claim, the Indemnified Party
shall assist and cooperate in a commercially reasonable manner with the
Indemnifying Party in the conduct of litigation, the making of settlements and
the enforcement of any right of contribution to which the Indemnified Party may
be entitled from any Person or entity in connection with the subject matter of
any litigation subject to indemnification hereunder. In addition, in connection
with any Third Party Claim, the Indemnified Party shall, upon reasonable request
by the Indemnifying Party or counsel selected by the Indemnifying Party (without
payment of any fees or expenses to the Indemnified Party or an employee thereof,
except reasonable out-of-pocket expenses), use commercially reasonable efforts
to attend hearings and trials, reasonably assist in the securing and giving of
evidence, reasonably assist in obtaining the presence or cooperation of
witnesses, and make available its own personnel; and shall do whatever else is
necessary and appropriate to support the Indemnifying Party's efforts in
connection with such litigation. The Indemnified Party shall not make any demand
upon the Indemnifying Party or counsel for the Indemnifying Party in connection
with any litigation subject to indemnification hereunder, except a general
demand for indemnification as provided hereunder. If the Indemnified Party shall
fail to perform such obligations as Indemnified Party hereunder or to reasonably
cooperate with the Indemnifying Party in Indemnifying Party's defense of any
suit or proceeding, such cooperation to include, without limitation, attendance
at all depositions and the provision of all documents (subject to appropriate
privileges and legal requirements) relevant to the defense of any claim, then,
after notice to the Indemnified Party and provision of such five (5) business
days to cure, the Indemnifying Party shall be released from all of its
obligations under this Agreement with respect to the prejudiced suit, claim or
proceeding and any other claims which had been raised in such suit or proceeding
to the extent the Indemnifying Party can demonstrate it has been prejudiced
thereby.

            (f) Following indemnification as provided for hereunder, the
Indemnifying Party shall be subrogated to all rights of the Indemnified Party
with respect to all Persons relating to the matter for which indemnification has
been made; provided, however, that the Indemnifying Party shall have no
subrogation rights to seek reimbursement through or from the Indemnified Party's
insurance policies, program, coverage, carriers or beneficiaries.

      10.5 Exclusive. Other than claims for fraud or equitable relief (which
equitable relief claims are nevertheless subject to Section 10.1), any claim
arising under this Agreement or in connection with or as a result of the
transactions contemplated by this Agreement or any Damages or injury alleged to
be suffered by any party as a result of the actions or failure to act by any
other party shall, unless otherwise specifically stated in this Agreement, be
governed solely and exclusively by the provisions of this Article X. If Seller
and Purchaser cannot resolve such claim by mutual agreement, such claim shall be
determined by adjudication by a court or similar tribunal subject to the
provisions of this Article X.

                                      -68-
<PAGE>

                                   ARTICLE XI

                           TAX AND COST REPORT MATTERS

      11.1 Tax Matters; Allocation of Purchase Price.

            (a) After the Closing Date, the parties shall cooperate fully with
each other and shall make available to each other, as reasonably requested, all
information, records or documents relating to tax liabilities or potential tax
liabilities attributable to Seller with respect to the operation of the
Hospitals for all periods prior to the Effective Time and shall preserve all
such information, records and documents at least until the expiration of any
applicable statute of limitations or extensions thereof. The parties shall also
make available to each other as reasonably required, and at the reasonable cost
of the requesting party (for out-of-pocket costs and expenses only), personnel
responsible for preparing or maintaining information, records and documents in
connection with tax matters.

            (b) The Purchase Price shall be allocated among each category of the
Assets and among each of the Hospitals in accordance with Schedule 11.1(b).
Seller and Purchaser hereby agree to allocate the Purchase Price in accordance
with Schedule 11.1(b), to be bound by such allocations, to account for and
report the purchase and sale of the Assets contemplated hereby for federal and
state tax purposes in accordance with such allocations, and not to take any
position (whether in tax returns, tax audits, or other tax proceedings), which
is inconsistent with such allocations without the prior written consent of the
other parties.

      11.2 Cost Report Matters.

            (a) Seller shall prepare and timely file all cost reports relating
to the periods ending prior to the Effective Time or required as a result of the
consummation of the transactions described in this Agreement relating to
Medicare, Medi-Cal or TRICARE (the "Seller Cost Reports"). Purchaser shall
forward to Seller any and all correspondence relating to the Accounts
Receivable, the Seller Cost Reports or rights to settlements and retroactive
adjustments on the Seller Cost Reports ("Agency Settlements") within ten (10)
business days of receipt by Purchaser. Purchaser shall not reply to any such
correspondence without Seller's written approval. Purchaser shall remit any
receipts relating to the Accounts Receivable, the Seller Cost Reports or the
Agency Settlements within ten (10) business days after receipt by Purchaser
(except those receipts to be retained by Purchaser pursuant to Section 11.3) and
will forward any demand for payments within ten (10) business days. Purchaser
(and its respective successors-in-interest, assigns and affiliates) shall have
neither the right to offset amounts payable to Seller under this Section 11.2
against, nor the right to contest its obligation to transfer, assign and convey
to Seller because of, outstanding claims, liabilities or obligations asserted by
Purchaser against Seller including but not limited to pursuant to the
post-closing Cash Purchase Price adjustment of Section 1.3 and the
indemnification provisions of Section 10.2. If Purchaser does not remit the
receipts relating to the Accounts Receivable, the Seller Cost Reports or the
Agency Settlements to Seller in accordance with the fourth sentence of this
Section 11.2(a), such receipts shall bear interest at the Prime Rate in effect
on the calendar day upon which such payment was required to be made to Seller
(the "Settlement Due Date") plus five percent (5%) (or the maximum rate allowed
by law, whichever is less), such interest accruing on each calendar day after
the Settlement Due Date until the receipts relating to the Accounts Receivable,
the Seller Cost Reports or the Agency Settlements and all interest thereon is
made to Seller. Seller shall retain all rights to the Seller Cost Reports and to
the Accounts Receivable including, without limitation, any payables resulting
therefrom or receivables relating thereto and the right to appeal any Medicare
determinations relating to the Agency Settlements and the Seller Cost Reports.
Seller will furnish copies of the Receivables Records to Purchaser upon request
and allow Purchaser and its representatives reasonable access to such documents.

                                      -69-
<PAGE>

            (b) Upon reasonable notice and during normal business office hours,
Purchaser will cooperate with Seller in regard to the preparation, filing,
handling, and appeals of the Seller Cost Reports. Upon reasonable notice and
during normal business office hours, Purchaser will cooperate with Seller in
connection with any cost report disputes and/or other claim adjudication matters
relative to governmental program reimbursement. Such cooperation shall include
obtaining files at the Hospitals and Purchaser's provision to Seller of data and
statistics, including, without limitation, the items set forth on Schedule
11.2(b), and the coordination with Seller pursuant to adequate notice of
Medicare and Medi-Cal exit conferences or meetings. Purchaser shall provide to
Seller such data, statistics and items requested by Medicare or Medi-Cal, within
such time period(s) as reasonably requested by Seller, at Seller's sole cost and
expense (subject to appropriate privileges and legal requirements).

            (c) Upon reasonable notice and during normal business office hours,
Seller will cooperate with Purchaser in connection with any cost report disputes
and/or other claim adjudication matters relative to governmental program
reimbursement which may relate to or be impacted by the Seller Cost Reports or
any actions or omissions by or payments to Seller. Such cooperation shall
include sharing any relevant Seller files, data and statistics related to the
Hospitals not obtained by Purchaser hereunder, within such time period(s) as
reasonably requested by Purchaser.

      11.3 Acute Transition Services. In the event Purchaser elects (as
contemplated by Section 1.10(v) of this Agreement), on or before October 15,
2004, to reject Seller's provider numbers relating to the Acute Care Hospitals,
to equitably compensate the parties for services rendered and medicine, drugs,
and supplies provided prior to and after the Effective Time at any of the Acute
Care Hospitals, including any distinct part psychiatric sub-providers with
respect thereto (the "Acute Transition Services"), with respect to patients
whose medical care is paid for, in whole or in part, by Medicare, Medicaid,
TRICARE/CHAMPUS, Blue Cross or any other third party payor who pays on a DRG,
case rate or other similar arrangement, and who are admitted to any of the
Seller Businesses prior the Effective Time but who are not discharged until
after the Effective Time ("Governmental Program Acute Transition Patients"), the
parties shall take the following action:

                                      -70-
<PAGE>

            (a) In the event any payor payments are made following the Effective
Time to one party with respect to services furnished in part by both parties (as
opposed to separate payments to each party determined by the payor with respect
to the services furnished by that party), as soon as practicable after the
Effective Time, the party receiving such payments shall deliver to the other
party a statement itemizing the inpatient hospital Acute Transition Services
provided by the receiving party (with Seller's itemization being limited to the
operation of the Hospitals prior to the Effective Time with respect to
Governmental Program Acute Transition Patients and the Purchaser's itemization
being limited to the operation of the Hospitals on and after the Effective Time
with respect to Governmental Program Acute Transition Patients). Furthermore,
Seller shall continue to bill Medicare under Seller's provider number(s) for all
inpatient hospital services furnished to patients who were admitted prior to the
Effective Time through the earlier to occur of (i) such patients' discharge date
or (ii) the date which is thirty (30) days after the Effective Time (i.e., the
effective date of Seller's voluntary termination from participation in the
Medicare program). With respect to any payments received by either party from a
payor for Acute Transition Services, each party that has received such payments
shall pay to the other party an amount equal to the DRG and outlier payments,
the case rate payment or other similar payment received by that party with
respect to a Governmental Program Acute Transition Patient, multiplied by a
fraction (the "Fraction"), the numerator of which shall be the total charges for
the Acute Transition Services provided to such Governmental Program Acute
Transition Patient by the other party and the denominator of which shall be the
sum of the total charges for the Acute Transition Services provided to such
Governmental Program Acute Transition Patient by the other party plus the total
charges for the Acute Transition Services provided to such Governmental Program
Acute Transition Patient by the party that received the payment from the payor
after the Effective Time. The parties shall reconcile the payments within ninety
(90) calendar days after both the tentative and final Medicare cost report
settlement and any other payor settlement affecting the Governmental Program
Acute Transition Patients (the "Reconciliation").

            (b) Payments made pursuant to Section 11.3(a) shall be made monthly,
on the twenty fifth (25th) day of each month, for payments received during the
previous month, accompanied by copies of remittances and other supporting
documentation as is reasonably requested by the other party provided, however,
that a payment shall be made to the other party within five (5) business days of
the date, if any, that the aggregate amount held by the receiving party subject
to Section 11.3(a) equals or exceeds Fifty Thousand Dollars ($50,000). Any other
payments required to be made by Seller to Purchaser, or by Purchaser to Seller,
as the case may be, as a result of (i) the Reconciliation, (ii) a notice of
program reimbursement with respect to the operations of any Hospitals or (iii)
other notice from a governmental agency or third party payor with respect to
Transition Services shall be made within thirty (30) calendar days after the
Reconciliation or the receipt of any such notice, as applicable. In the event
that Purchaser and Seller are unable to agree on the amount to be paid to Seller
or Purchaser, as the case may be, under this Section 11.3, then such amount
shall be determined by the Independent Auditor at their joint expense.

            (c) The parties acknowledge that all charges for outpatient and
other cost-based services shall be made (i) by Seller for all periods prior to
the Effective Time and (ii) by Purchaser for all periods on and after the
Effective Time.

                                      -71-
<PAGE>

            (d) Notwithstanding the first sentence of Section 11.3(b), Purchaser
or Seller shall make a distribution to the other party within three (3) business
days if at any time during the applicable calendar month the funds to be
distributed to such first party pursuant to Section 11.3(a) exceed One Hundred
Fifty Thousand Dollars ($150,000). The amount of such distribution shall be all
amounts payable to the receiving party pursuant to Section 11.3(a) which have
not been previously distributed. All such distributions shall be made by wire
transfer of immediately available funds to Seller or Purchaser, as the case may
be, to the account(s) specified by the receiving party to the paying party in
writing from time to time.

            (e) Neither party (and its respective successors-in-interest,
assigns and affiliates) shall have the right to offset amounts payable to the
other party under this Section 11.3 against, nor the right to contest its
obligation to transfer, assign and convey to such party because of, outstanding
claims, liabilities or obligations asserted by the paying party against the
receiving party including but not limited to pursuant to the indemnification
provisions of Article X. If a party does not remit to the other party the
amounts payable to the receiving party pursuant to Section 11.3(b) or 11.3(d) in
accordance with the terms thereof, such amounts shall bear interest at the Prime
Rate in effect on the calendar day upon which such payment was required to be
made (the "Straddle Payment Due Date") plus five percent (5%) (or the maximum
rate allowed by law, whichever is less), such interest accruing on each calendar
day after the Straddle Payment Due Date until payment of the amount due pursuant
to Section 11.3(b) or 11.3(d) and all interest thereon is made.

            (f) If the FI requires or requests that Seller and Purchaser use a
billing method for services rendered to Transition Patients that differs from
the method described in Section 11.3(a) Seller and Purchaser shall comply with
the FI's requirement or request and shall equitably adjust the aggregate
reimbursement received by Seller and Purchaser for such services to ensure that
each party receives the same proportion of the aggregate reimbursement as such
party would have received had the parties followed the method described in this
Section

      11.4 Non-Acute Transition Services. To compensate Seller for services
rendered and medicine, drugs, and supplies provided before the Effective Time
with respect to any portion of the Hospitals as to which Purchaser takes
assignment of Seller's provider numbers and/or provider agreements including
without limitation any of the Seller's distinct part Skilled Nursing Units (the
"Non-Acute Transition Services") with respect to patients whose medical care is
paid for, in whole or in part, by Medicare, Medicaid, TRICARE, Blue Cross or any
other third party payor who pays on a DRG, case rate or other similar
arrangement, and who are admitted to any of the Non-Acute Providers prior to the
Effective Time but who are not discharged until on or after the Effective Time
("Governmental Program Non-Acute Transition Patients"), the parties shall take
the following action:

            (a) As soon as practicable after the Closing Date, Seller shall
deliver to Purchaser a statement itemizing the Non-Acute Transition Services
provided by Seller with respect to the operation of the Non-Acute Providers
prior to the Effective Time to Governmental Program Non-Acute Transition
Patients. For the Non-Acute Transition Services, Purchaser shall pay to Seller
an amount equal to the per diem, the case rate payment or other payments
received by Purchaser on behalf of a Governmental Program Non-Acute Transition
Patient, multiplied by a fraction (the "Fraction"), the numerator of which shall
be the total charges for the Non-Acute Transition Services provided to such
Governmental Program Non-Acute Transition Patient by Seller and the denominator
of which shall be the sum of the total charges for the Non-Acute Transition
Services provided to such Governmental Program Non-Acute Transition Patient by
Seller plus the total charges for the Non-Acute Transition Services provided to
such Governmental Program Non-Acute Transition Patient by Purchaser on and after
the Effective Time. The parties shall reconcile the payments within ninety (90)
calendar days after both the tentative and final Medicare cost report settlement
and any other payor settlement affecting the Governmental Program Non-Acute
Transition Patients (the "Reconciliation").

                                      -72-
<PAGE>

            (b) Subject to Section 11.4(d), payments made pursuant to Section
11.4(a) shall be made to Seller monthly, on the twenty-fifth (25th) day of each
month, for payments received by Purchaser during the previous month, accompanied
by copies of remittances and other supporting documentation as is reasonably
requested by Seller. Any other payments required to be made by Seller to
Purchaser, or by Purchaser to Seller, as the case may be, as a result of (i) the
Reconciliation, (ii) a notice of program reimbursement with respect to the
operations of any Hospital or (iii) other notice from a governmental agency or
third party payor with respect to Transition Services shall be made within
thirty (30) calendar days after the Reconciliation or the receipt of any such
notice, as applicable. In the event that Purchaser and Seller are unable to
agree on the amount to be paid to Seller or Purchaser, as the case may be, under
this Section 11.4, then such amount shall be determined by the Independent
Auditor at their joint expense.

            (c) The parties acknowledge that all charges for outpatient and
other cost-based services shall be made (i) by Seller for all periods prior to
the Effective Time and (ii) by Purchaser for all periods on and after the
Effective Time.

            (d) Notwithstanding the first sentence of Section 11.4(b), Purchaser
shall make a distribution to Seller within three (3) business days if at any
time during the applicable calendar month the funds to be distributed to Seller
pursuant to Section 11.4(a) exceed One Hundred Fifty Thousand Dollars
($150,000). The amount of such distribution shall be all amounts payable to
Seller pursuant to Section 11.4(a) which have not been previously distributed to
Seller. All such distributions shall be made by wire transfer of immediately
available funds to Seller to the account(s) specified by Seller to Purchaser in
writing from time to time.

            (e) Purchaser (and its respective successors-in-interest, assigns
and affiliates) shall have neither the right to offset amounts payable to Seller
under this Section 11.4 against, nor the right to contest its obligation to
transfer, assign and convey to Seller because of, outstanding claims,
liabilities or obligations asserted by Purchaser against Seller including but
not limited to pursuant to the post-closing Cash Purchase Price adjustment of
Section 1.4 and the indemnification provisions of Section 10.2. If Purchaser
does not remit to Seller the amounts payable to Seller pursuant to Section
11.4(b) or 11.4(d) in accordance with the terms thereof, such amounts shall bear
interest at the Prime Rate in effect on the calendar day upon which such payment
was required to be made to Seller (the "Straddle Payment Due Date") plus five
percent (5%) (or the maximum rate allowed by law, whichever is less), such
interest accruing on each calendar day after the Straddle Payment Due Date until
payment of the amount due pursuant to Section 11.4(b) or 11.4(d) and all
interest thereon is made to Seller.

                                      -73-
<PAGE>

            (f) If the Hospitals' fiscal intermediary requires or requests that
Seller and Purchaser use a billing method for services rendered to Transition
Patients that differs from the method described in Section 11.4(a) Seller and
Purchaser shall comply with the fiscal intermediary's requirement or request and
shall equitably adjust the aggregate reimbursement received by Seller and
Purchaser for such services to ensure that each party receives the same
proportion of the aggregate reimbursement as such party would have received had
the parties followed the method described in this Section.

                                  ARTICLE XII

                            MISCELLANEOUS PROVISIONS

      12.1 Further Assurances and Cooperation. Seller shall execute, acknowledge
and deliver to Purchaser any and all other assignments, consents, approvals,
conveyances, assurances, documents and instruments reasonably requested by
Purchaser at any time and shall take any and all other actions reasonably
requested by Purchaser at any time for the purpose of more effectively
assigning, transferring, granting, conveying and confirming to Purchaser, the
Assets. Seller shall make Eric Tuckman available to Purchaser prior to Closing
of the transaction contemplated by this Agreement for the purpose of
communicating with financing sources identified by, and upon the reasonable
request of, Purchaser; provided that any such financing source shall have
delivered to Seller the executed confidentiality agreement described in the last
sentence of Section 5.6. After consummation of the transaction contemplated in
this Agreement, the parties agree to cooperate with each other and take such
further actions as may be necessary or appropriate to effectuate, carry out and
comply with all of the terms of this Agreement, the documents referred to in
this Agreement and the transactions contemplated hereby.

      12.2 Successors and Assigns. All of the terms and provisions of this
Agreement shall be binding upon and shall inure to the benefit of and be
enforceable by the respective successors and assigns of the parties hereto;
provided, however, that no party hereto may assign any of its rights or delegate
any of its duties under this Agreement without the prior written consent of the
other parties, except that Purchaser may assign any of its rights or delegate
any of its duties under this Agreement to (a) the separate affiliates of
Purchaser that Purchaser intends to establish as designated assignees of
Purchaser for each of the Hospitals, upon Seller's receipt of Purchaser's
guaranty of such affiliates' obligations, in a form acceptable to Seller in its
reasonable discretion or (b) any other assignee approved in writing by Seller,
which approval may be given or withheld in Seller's sole discretion and, if
approved by Seller, upon Seller's receipt of Purchaser's guaranty of such other
assignee's obligations, in a form acceptable to Seller. Notwithstanding the
foregoing sentence, an assignment of this Agreement by Purchaser that would be
subject to subclause (b) of this Section 12.2 and, thereby, Seller's approval
thereof in its sole discretion shall, instead, be subject to Seller's approval
in its reasonable discretion if such assignee is required to become jointly and
severally liable for obligations of Purchaser under Section 10.3.1 of this
Agreement pursuant to the last sentence of this Section 12.2. As provided in
Section 5.12 of this Agreement, Purchaser shall require that any purchaser or
other assignee of substantially all of the assets of any of the Hospitals agree,
in the agreement evidencing such transaction, to be jointly and severally liable
for all of Purchaser's obligations under Section 10.3.1 of this Agreement that
are attributable to the Hospital(s) being transferred to such purchaser or
assignee pursuant to such agreement provided, however, that this sentence shall
not be construed to limit the ability of any lender to sell any of the Owned
Real Property or other Assets in connection with a foreclosure thereon or sale
in lieu thereof.

                                      -74-
<PAGE>

      12.3 Governing Law; Venue. This Agreement shall be governed by and
construed and enforced in accordance with the laws of the State of California as
applied to contracts made and performed within the State of California. The
parties hereby waive their right to assert in any proceeding involving this
Agreement that the law of any jurisdiction other than the State of California
shall apply to such dispute; and the parties hereby covenant that they shall
assert no such claim in any dispute arising under this Agreement. Any proceeding
which arises out of or relates in any way to the subject matter of this
Agreement shall be brought in the Superior Court of California, County of Orange
or the United States District Court for the Central District of California. The
parties hereby consent to the jurisdiction of the State of California and waive
their right to challenge any proceeding involving or relating to this Agreement
on the basis of lack of jurisdiction over the Person or forum non convenience.

      12.4 Amendments. This Agreement may not be amended other than by written
instrument signed by the parties hereto.

      12.5 Exhibits, Schedules and Disclosure Schedule. The Disclosure Schedule
and all exhibits and schedules referred to in this Agreement shall be deemed to
have been attached hereto and incorporated by reference herein on the Effective
Date provided, however, that Purchaser may update Schedule 1.6.15 on or before
October 14, 2004 to reflect Seller's decision as to whether it will reject or
take assignment of the provider numbers associated with the Hospitals. From the
Effective Date until the Closing, the parties agree that Seller may update the
Disclosure Schedule and either party may update the schedules as necessary,
subject to the terms of Sections 6.7 and 7.9 of this Agreement including without
limitation that any update shall be deemed approved by the other party if not
acted on within ten (10) business days by the other party. Any matter disclosed
in this Agreement or in the Disclosure Schedule with reference to any Section of
this Agreement shall be deemed a disclosure in respect of all sections to which
such disclosure may apply.

      12.6 Notices. Any notice, demand or communication required, permitted, or
desired to be given hereunder shall be deemed effectively given when personally
delivered, when received by telegraphic or other electronic means (including
facsimile) or overnight courier, or five (5) calendar days after being deposited
in the United States mail, with postage prepaid thereon, certified or registered
mail, return receipt requested, addressed as follows:

         If to Seller:              Tenet HealthSystem
                                    13737 Noel Road, Suite 100
                                    Dallas, Texas  75240
                                    Attention:  Paul O'Neill
                                    Facsimile No.:  (469) 893-2214

                                      -75-
<PAGE>

         With a copy to:            Tenet HealthSystem
                                    13737 Noel Road, Suite 100
                                    Dallas, Texas  75240
                                    Attention:  J. Brent McDonald, Esq.
                                    Facsimile No.:  (469) 893-7508

         With a copy to:            McDermott Will & Emery LLP
                                    2049 Century Park East
                                    Suite 3400
                                    Los Angeles, California  90067
                                    Attention: Ira J. Rappeport, Esq.
                                    Facsimile No.:   (310) 277-4730

         If to Purchaser:           Integrated Healthcare Holdings, Inc.
                                    c/o Mogel Management Group, LLC
                                    695 Town Center Drive, Suite 260
                                    Costa Mesa, CA  92626
                                    Attention:  Larry Anderson
                                    Facsimile No.: (714) 434-9505

         With a copy to:            Integrated Healthcare Holdings, Inc.
                                    c/o Strategic Global Management, Inc.
                                    6800 Indiana Avenue, Suite 130
                                    Riverside, CA  92506
                                    Attention:  Kali P. Chaudhuri, M.D.
                                                and William E. Thomas
                                    Facsimile (951) 782-8850

         With a copy to:            Hooper, Lundy & Bookman, Inc.
                                    1875 Century Park East, Suite 1600
                                    Los Angeles, California 90067
                                    Attention: Robert W. Lundy, Esq.
                                    Facsimile No.: (310) 551-8181

or at such other address as one party may designate by notice hereunder to the
other parties.

      12.7 Headings. The section and other headings contained in this Agreement
and in the Disclosure Schedule, exhibits and schedules to this Agreement are
included for the purpose of convenient reference only and shall not restrict,
amplify, modify or otherwise affect in any way the meaning or interpretation of
this Agreement or the Disclosure Schedule, exhibits and schedules hereto.

                                      -76-
<PAGE>

      12.8 Confidentiality and Publicity. The parties hereto shall hold in
confidence the information contained in this Agreement, and all information
related to this Agreement, which is not otherwise known to the public, shall be
held by each party hereto as confidential and proprietary information and shall
not be disclosed without the prior written consent of the other parties;
provided, however, Seller shall be permitted to provide a copy of this Agreement
to (a) any applicable governmental or administrative authorities in connection
with Seller's pursuit of any appeal of any real and personal property tax
assessments on the Assets for periods prior to the Effective Time and (b)
Purchaser shall be permitted to disclose in the Offering Circular to prospective
investors a summary of the material terms contained in the body of this
Agreement. Accordingly, except as set forth in the immediately preceding
sentence, Purchaser and Seller shall not discuss with, or provide nonpublic
information to, any third party (except for such party's attorneys, accountants,
directors, officers and employees, the directors, officers and employees of any
affiliate of any party hereto, and other consultants and professional advisors)
concerning this transaction prior to the Effective Time, except: (a) as required
in governmental filings or judicial, administrative or arbitration proceedings,
including without limitation the filings to be made by the parties with respect
to the HSR Act; (b) pursuant to public announcements made with the prior written
approval of Seller and Purchaser, or (c) as otherwise expressly permitted by
this Agreement. The rights of Seller under this Section 12.8 shall be in
addition and not in substitution for the rights of Seller and Seller's
affiliates under the Confidentiality Agreement, which shall survive Closing.

      12.9 Fair Meaning. This Agreement shall be construed according to its fair
meaning and as if prepared by all parties hereto.

      12.10 Gender and Number; Construction. All references to the neuter gender
shall include the feminine or masculine gender and vice versa, where applicable,
and all references to the singular shall include the plural and vice versa,
where applicable. Unless otherwise expressly provided, the word "including"
followed by a listing does not limit the preceding words or terms and shall mean
"including, without limitation."

      12.11 Third Party Beneficiary. None of the provisions contained in this
Agreement are intended by the parties, nor shall they be deemed, to confer any
benefit on any Person not a party to this Agreement.

      12.12 Expenses and Attorneys' Fees. Except as otherwise provided in this
Agreement, each party shall bear and pay its own costs and expenses relating to
the preparation of this Agreement and to the transactions contemplated by, or
the performance of or compliance with any condition or covenant set forth in,
this Agreement, including without limitation, the disbursements and fees of
their respective attorneys, accountants, advisors, agents and other
representatives, incidental to the preparation and carrying out of this
Agreement, whether or not the transactions contemplated hereby are consummated.
The parties expressly agree that the following shall be borne equally by
Purchaser and Seller: (a) all costs of the Title Commitment and the Title Policy
(including the cost of any endorsements thereto) provided, however, that the
cost of any zoning endorsement to the Title Commitment or Title Policy shall, as
contemplated by Section 4.8 of this Agreement, be borne solely by Purchaser; and
(b) all costs of the Surveys. All costs of the Environmental Surveys shall be
borne solely by the Seller. All documentary transfer taxes and recording charges
in connection with the conveyance of the Assets to Purchaser and Purchaser's
Lender Title Policy, if any, shall be borne solely by the Purchaser. If any
action is brought by any party to enforce any provision of this Agreement, the
prevailing party shall be entitled to recover its court costs and reasonable
attorneys' fees.

                                      -77-
<PAGE>

      12.13 Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same Agreement, binding on all of the
parties hereto.

      12.14 Entire Agreement. This Agreement, the Disclosure Schedule, the
exhibits and schedules, and the documents referred to in this Agreement contain
the entire understanding between the parties with respect to the transactions
contemplated hereby and supersede all prior or contemporaneous agreements,
understandings, representations and statements, oral or written, between the
parties on the subject matter hereof (the "Superseded Agreements"), which
Superseded Agreements shall be of no further force or effect.

      12.15 No Waiver. Any term, covenant or condition of this Agreement may be
waived at any time by the party which is entitled to the benefit thereof but
only by a written notice signed by the party expressly waiving such term or
condition. The subsequent acceptance of performance hereunder by a party shall
not be deemed to be a waiver of any preceding breach by any other party of any
term, covenant or condition of this Agreement, other than the failure of such
other party to perform the particular duties so accepted, regardless of the
accepting party's knowledge of such preceding breach at the time of acceptance
of such performance. The waiver of any term, covenant or condition shall not be
construed as a waiver of any other term, covenant or condition of this
Agreement.

      12.16 Severability. If any term, provision, condition or covenant of this
Agreement or the application thereof to any party or circumstance shall be held
to be invalid or unenforceable to any extent in any jurisdiction, then the
remainder of this Agreement and the application of such term, provision,
condition or covenant in any other jurisdiction or to Persons or circumstances
other than those as to whom or which it is held to be invalid or unenforceable,
shall not be affected thereby, and each term, provision, condition and covenant
of this Agreement shall be valid and enforceable to the fullest extent permitted
by law.

      12.17 Time is of the Essence. Time is of the essence for all dates and
time periods set forth in this Agreement and each performance called for in this
Agreement.

      12.18 Consents. The Parties acknowledge that, unless otherwise expressly
provided in connection with any provision of this Agreement, any references
herein requiring the consent of either party shall be deemed to require that the
party from which consent is required shall not unreasonably withhold or delay
such consent and, except as otherwise expressly provided hereunder or with
respect to monetary obligations, each Party shall be deemed to have met each
obligation hereunder if such Party has performed such obligation in all material
respects. This Section 12.18 shall not be applicable to any consent described in
Section 12.2(b).

                          [REMAINDER OF PAGE IS BLANK]

                                      -78-
<PAGE>

      IN WITNESS WHEREOF, this Agreement has been entered into as of the day and
year first above written.

                                   PURCHASER:

                                   Integrated Healthcare Holdings, Inc., a
                                   Nevada corporation

                                   By: /s/ Larry Anderson
                                      ------------------------------------------
                                   Name: Larry Anderson
                                        ----------------------------------------
                                   Its: President
                                       -----------------------------------------

                                   SELLER:

                                   AHM CGH, Inc., a California corporation

                                   By: /s/
                                      ------------------------------------------
                                   Name:
                                        ----------------------------------------
                                   Its:
                                       -----------------------------------------

                                   Health Resources Corporation of America -
                                   California, a Delaware corporation

                                   By: /s/
                                      ------------------------------------------
                                   Name:
                                        ----------------------------------------
                                   Its:
                                       -----------------------------------------

                                   UWMC Hospital Corporation, a California
                                   corporation

                                   By: /s/
                                      ------------------------------------------
                                   Name:
                                        ----------------------------------------
                                   Its:
                                       -----------------------------------------

                                   SHL/O Corp., a Delaware corporation

                                   By: /s/
                                      ------------------------------------------
                                   Name:
                                        ----------------------------------------
                                   Its:
                                       -----------------------------------------

                                      -79-
<PAGE>

                                LIST OF SCHEDULES

         SCHEDULE                       DESCRIPTION

         Those schedules provided in the Disclosure Schedule; and

         A-1                            Acute Care Hospitals

         A-2                            MOBs

         A-3                            Other Businesses

         1.2-b                          Interim Balance Sheet

         1.6.15                         Medicare Numbers Assigned to Purchaser

         1.9(a)                         Owned Real Property

         1.9(b)                         Leased Real Property

         1.9(c)                         Personal Property

         1.9(d)                         Licenses

         1.9(e)                         Material Leases

         1.9(f)                         Material Contracts

         1.9(g)                         Prepaids

         1.9(m)                         Names of Hospitals

         1.9(p)                         Marketing Materials and Brochures

         1.10(b)                        Excluded Current Asset Categories

         1.10(c)                        Excluded Proprietary Assets

         1.10(v)                        Privileged and Protected Items

         1.10(w)                        Excluded Website Content

         1.10(y)                        Other Excluded Assets

         1.11(b)                        Capital Leases

         1.11(h)                        Other Assumed Obligations
<PAGE>

         SCHEDULE                       DESCRIPTION

         2.4(d)                         Excluded Multi-Facility Contracts

         2.5                            Consents

         2.6(a)                         Compliance with Law

         2.7(b)                         Real Property Encumbrances

         2.7(c)                         HVAC, Electrical and Plumbing

         2.7(e)                         Assets Not Included in Transaction

         2.8(b)                         JCAHO Accreditation Periods

         2.8(c)                         Threatened Medicare or Medi-Cal
                                        Investigations

         2.8(d)                         Audit Periods

         2.8(f)                         Medical Staff

         2.10                           Financial Statements

         2.11                           Legal Proceedings

         2.12                           Seller Plans

         2.12(c)                        Seller Plan Audits

         2.13(a)                        Personnel List

         2.13(b)                        Collective Bargaining Agreements

         2.14                           Insurance

         3.5                            Brokers - Purchaser

         3.7                            Legal Proceedings - Purchaser

         4.8                            Ground Leases or Leases of Record

         5.6                            Offering Circular Disclosures

         7.7                            Permitted Exceptions
<PAGE>

         SCHEDULE                       DESCRIPTION

         10.2.1                         Certain Governmental Investigations

         11.1(b)                        Allocation of Purchase Price

         11.2(b)                        Seller Cost Report Data
<PAGE>

                                LIST OF EXHIBITS

         SCHEDULE                       DESCRIPTION

         1.4-a                          Escrow Agreement

         1.4-b                          Guaranty Agreement

         1.6.1                          Bills of Sale

         1.6.2                          Real Estate Assignments

         1.6.3                          Grant Deeds

         1.6.9                          Transitional Services Agreements

                                        -Information Technology Transition
                                        Services Agreement
                                        -Item Master Maintenance and Service
                                        Agreement
                                        -QRS License Agreement
                                        -License Agreement for Policy and
                                        Procedure Manuals

         1.6.10                         Business Services Agreement

         1.6.12                         Power of Attorney

         1.6.14                         THC Guaranty Agreement

         1.6.15                         Medicare Assignment Agreement

         4.12                           Environmental Survey

         5.15                           Group Purchasing Contract

         6.4                            Opinion of Purchaser's Counsel

         7.6                            Opinion of Seller's In-House Counsel

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]